AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON APRIL 15, 2008

REGISTRATION NO. 333-147215

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

Post-Effective Amendment No. 1

on

 

FORM S-1

to

FORM SB-2 and FORMS S-3

 

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 


 

IMAGEWARE SYSTEMS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

7372

 

33-0224167

(State or other jurisdiction of
incorporation or organization)

 

(Primary Standard Industrial Classification
Code Number)

 

(I.R.S. Employer Identification
Number)

 


 

10883 Thornmint Road

San Diego, CA  92127

(858) 673-8600

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

S. James Miller, Jr.

Chief Executive Officer

ImageWare Systems, Inc.

10883 Thornmint Road

San Diego, CA 92127

(858) 673-8600

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 


 

Copies to:

Carl Sanchez, Esq.

Paul, Hastings, Janofsky & Walker LLP

3579 Valley Centre Drive

San Diego, California  92130

(858) 720-2500

 

APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC:  From time to time after the effective date of this registration statement, as determined by the selling stockholder .

 

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. x

 

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. o

 

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. o

 

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer o

 

Accelerated filer  o

Non-accelerated filer x

 

Smaller reporting company  o

(Do not check if a smaller reporting company)

 

 

 


 

CALCULATION OF REGISTRATION FEE

 

Title of each class of

 

 

 

Proposed maximum

 

Proposed maximum

 

 

 

securities to be

 

Amount to be

 

offering price per

 

aggregate offering

 

Amount of

 

registered

 

registered (1)

 

share (2)

 

price (2)

 

registration fee(3)

 

Common stock, par value $0.01 per share

 

17,151,664

 

$

1.125

 

$

19,295,622

 

$

758.32

 

(1)         Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the shares being registered hereunder include such indeterminate number of shares of the Registrant’s common stock that may become issuable with respect to the shares being registered hereunder to prevent dilution resulting from stock dividends, stock splits, or similar transactions.

 

(2)         Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) of the Securities Act.  The proposed maximum offering price per share and proposed maximum aggregate offering price are based upon the average of the high ($1.15) and low ($1.10) sales prices of the Registrant’s common stock on April 9, 2008, as reported on the American Stock Exchange.  It is not known how many shares will be sold under this registration statement or at what price or prices such shares will be sold.

 

(3)         This Registration Statement on Form S-1 carries forward the registration of (i) 6,005,445 shares of common stock on Form SB-2, filed January 12, 2004 (Registration No. 333-111842), as amended, (ii) 2,381,100 shares of common stock on Form S-3, filed June 9, 2004 (Registration No. 333-114613), as amended, (iii) 1,990,418 shares of common stock on Form S-3, filed August, 25, 2005 (Registration No. 333-127829), as amended, (iv) 2,425,415 shares of common stock on Form S-3, filed December 29, 2006 (Registration No. 333-139735), as amended, (v) 848,676 shares of common stock on Form S-3, filed April 23, 2007 (Registration No. 333-142295), and (vi) 3,500,610 shares of common stock on Form S-3, filed November 7, 2007 (Registration No. 333-147215), as amended.  Registration fees aggregating $4,406.78 were previously paid to register these securities.  As a result, no additional registration fee is required.

 

PURSUANT TO RULE 429 UNDER THE SECURITIES ACT, THE PROSPECTUS INCLUDED IN THIS REGISTRATION STATEMENT RELATES TO SHARES OF COMMON STOCK OF THE REGISTRANT PREVIOUSLY REGISTERED UNDER REGISTRATION STATEMENT ON FORM SB-2 NO. 333-111842 AND REGISTRATION STATEMENTS ON FORM S-3 NOS. 333-114613, 333-127829, 333-139735, 333-142295, AND 333-147215 AND CONSTITUTES A POST-EFFECTIVE AMENDMENT TO SUCH REGISTRATION STATEMENTS.  THESE POST EFFECTIVE AMENDMENTS SHALL HEREAFTER BECOME EFFECTIVE CONCURRENTLY WITH THE EFFECTIVENESS OF THIS REGISTRATION STATEMENT IN ACCORDANCE WITH SECTION 8 OF THE SECURITIES ACT.  PURSUANT TO RULE 401(B) UNDER THE SECURITIES ACT, THE COMPANY IS FILING THIS POST-EFFECTIVE AMENDMENT ON FORM S-1, AS IT IS CURRENTLY INELIGIBLE TO FILE A REGISTRATION STATEMENT ON FORM S-3.

 

This Post-Effective Amendment No. 1 on Form S-1 to Registration Statement on Form SB-2 and Forms S-3 shall become effective on such date as the Securities and Exchange Commission, acting pursuant to Section 8(c) of the Securities Act may determine.

 

The information in this preliminary prospectus is not complete and may be changed. The selling stockholders may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective.  This prospectus is not an offer to sell these securities, and the selling stockholders are not soliciting offers to buy these securities, in any jurisdiction where the offer or sale of these securities is not permitted.

 

 



 

SUBJECT TO COMPLETION, DATED APRIL 15, 2008

 

PROSPECTUS

 

17,151,664 SHARES

 

IMAGEWARE SYSTEMS, INC.

 

COMMON STOCK

 

This prospectus relates to the resale of up to 17,151,664 shares of common stock of ImageWare Systems, Inc., a Delaware corporation, by the selling stockholders identified in this prospectus. The selling stockholders acquired the shares offered by this prospectus in various private placement and debt financings that took place between May 2002 and September 2007.

 

We will not receive any of the proceeds from the sale of the shares of our common stock by the selling stockholders.

 

The price or prices at which the selling stockholders may sell the shares will be determined by the prevailing market price for the shares or in negotiated transactions.

 

Our common stock is quoted on the American Stock Exchange under the symbol “IW”. On April 9, 2008, the last reported sales price of our common stock, as reported on the American Stock Exchange, was $1.12 per share.

 

INVESTING IN OUR COMMON STOCK INVOLVES SUBSTANTIAL RISKS.  SEE THE SECTION ENTITLED “RISK FACTORS” BEGINNING ON PAGE 2 OF THIS PROSPECTUS TO READ ABOUT FACTORS YOU SHOULD CONSIDER BEFORE BUYING SHARES OF OUR COMMON STOCK.

 

NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR PASSED UPON THE ADEQUACY OR ACCURACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

 

The date of this prospectus is                        , 2008.

 



 

TABLE OF CONTENTS

 

Prospectus Summary

1

 

 

Risk Factors

2

 

 

Cautionary Statement Concerning Forward-Looking Information

11

 

 

Use of Proceeds

12

 

 

Management

12

 

 

Executive Compensation

14

 

 

Director Compensation

24

 

 

Securities Authorized for Issuance Under Equity Compensation Plans

25

 

 

Related Party Transactions

26

 

 

Director Independence

27

 

 

Compensation Committee Interlocks and Insider Participation

27

 

 

Legal Proceedings

27

 

 

Market Price Information

28

 

 

Quantitative and Qualitative Disclosures About Market Risk

28

 

 

The Selling Stockholders

29

 

 

Relationship of Selling Stockholders to the Company

61

 

 

Principal Stockholders

61

 

 

Plan of Distribution

62

 

 

Experts

64

 

 

Legal Matters

64

 

 

Where You Can Find More Information

64

 

 

Incorporation of Certain Information by Reference

64

 

You should rely only on the information contained in this prospectus or any related prospectus supplement, including the content of all documents now or in the future incorporated by reference into the registration statement of which this prospectus forms a part.  We have not authorized, and the selling stockholders may not authorize anyone to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it.  We are not, and the selling stockholders are not, making an offer of the shares of our common stock to be sold under this prospectus in any jurisdiction where the offer or sale is not permitted. You should not assume that the information contained in this prospectus or any related prospectus supplement is accurate as of any date other than the date on the front cover of this prospectus or the related prospectus supplement, or that the information contained in any document incorporated by reference is accurate as of any date other than the date of the document incorporated by reference.  Our business, financial condition, results of operations and prospects may have changed since such date.  Other than as required under the federal securities laws, we undertake no obligation to publicly update or revise such information, whether as a result of new information, future events or any other reason.

 

i



 

PROSPECTUS SUMMARY

 

This summary highlights information contained elsewhere in this prospectus.  This summary does not contain all the information that you should consider before investing in our common stock.  You should read this entire prospectus, including all documents incorporated by reference, carefully, especially “Risk Factors” and our financial statements and related notes incorporated by reference herein.  Please see the section entitled “Where You Can Find More Information” on page 64 of this prospectus.

 

We use the terms “we,” “us,” “our,” “the Company” and “ImageWare” in this prospectus to refer to ImageWare Systems, Inc. and its consolidated subsidiaries.

 

Our Business

 

ImageWare Systems, Inc. is a leader in the emerging market for software-based identity management solutions, providing biometric, secure credential, law enforcement and enterprise authorization.  Our “flagship” product is the IWS Biometric Engine.  Scalable for small city business or worldwide deployment, our biometric engine is a multi-biometric platform that is hardware and algorithm independent, enabling the enrollment and management of unlimited population sizes.  Our identification products are used to manage and issue secure credentials, including national IDs, passports, driver licenses, smart cards and access control credentials. Our law enforcement products provide law enforcement with integrated mug shot, fingerprint LiveScan and investigative capabilities. We also provide comprehensive authentication security software, as well as real-time voice recognition, multilingual speech translation and voice analytics technologies.  Biometric technology is now an integral part of all markets we address, and all of our products are integrated into the Biometric Engine Platform.  Elements of the IWS Biometric Engine can be used as investigative tools for law enforcement utilizing multiple biometrics and forensic data elements, and to enhance security and authenticity of public and private sector credentials.

 

Our biometric technology is a core software component of an organization’s security infrastructure and includes a multi-biometric identity management solution for enrolling, managing, identifying and verifying the identities of people by the physical characteristics of the human body. We develop, sell and support various identity management capabilities within government (federal, state and local), law enforcement, commercial enterprises, and transportation and aviation markets for identification and verification purposes. Our IWS Biometric Engine is a biometric identity management platform for multi-biometric enrollment, management and authentication, managing population databases of virtually unlimited sizes. It is also offered as a Software Development Kit (SDK) based search engine, enabling developers and system integrators to implement a biometric solution or integrate biometric capabilities into existing applications without having to derive biometric functionality from pre-existing applications.  The IWS Biometric Engine combined with our secure credential platform, IWS EPI Builder, provides a comprehensive, integrated biometric and secure credential solution that can be leveraged for high-end applications such as passports, driver licenses, national IDs, and other secure documents. It can also be utilized within our law enforcement systems to incorporate any number of various multiple biometrics into one system.

 

We recently added next generation voice recognition, multilingual speech translation and voice analytics capabilities to our suite of biometric identity management solutions, enabling users to facilitate and improve communication across major language groups globally. The ImageWare Mediator products are offered standalone or integrated with our Biometric Engine platform, providing an advanced multilingual communications capability. Government, intelligence, defense, public safety and border control customers are able to realize language translation and voice recognition capabilities whereby an English-speaking user can understand and be understood in numerous languages including Spanish, German, French, Korean, Arabic and Polish, among others. ImageWare Mediator products support speech to speech translation, multilingual collaboration, conversational environments, which are represented for both voice and text and include biometric functionality for speaker identification and voice analytics.

 

Our law enforcement solutions enable agencies to quickly capture, archive, search, retrieve, and share digital images, fingerprints and criminal history records on a stand-alone, networked, wireless or Web-based platform. We develop, sell and support a suite of modular software products used by law enforcement and public safety agencies to create and manage criminal history records and to investigate crime. Our IWS Law Enforcement solution consists of six software modules: a Capture and Investigative module, which provides a criminal booking system and related database; a Facial Recognition module, which uses biometric facial recognition to identify suspects; a Suspect ID module, which facilitates the creation of full-color, photo-realistic suspect composites; a wireless module, which provides access to centrally stored records over the Internet in a connected or wireless fashion; a PDA add-on module, which enables access to centrally stored records while in the field on a handheld Pocket PC compatible device combined with central repository services which allows for inter-agency data sharing on a local, regional, and/or national level; and a LiveScan module, which incorporates LiveScan capabilities into

 

1



 

IWS Law Enforcement providing integrated fingerprint and palm print biometric management for civil and law enforcement use.

 

Our Secure Credential ID solutions empower customers to create secure and smart digital identification documents with complete ID systems. We develop, sell and support software and design systems which utilize digital imaging in the production of photo identification cards and credentials and identification systems. Our products in this market consist of IWS EPI Suite, IWS EPI Builder (SDK), Identifier for Windows and ID Card Maker.  These products allow for the production of digital identification cards and related databases and records and can be used by, among others, schools, airports, hospitals, corporations or governments.  We have recently added the ability to incorporate multiple biometrics into the ID systems we offer with the addition of our new IWS Biometric Engine to our product line.

 

Our enterprise authentication software includes the IWS Desktop Security product which is a comprehensive authentication management infrastructure solution providing added layers of security to workstations, networks and systems through advanced encryption and authentication technologies. IWS Desktop Security is optimized to enhance network security and usability, and uses multi-factor authentication methods to protect access, verify identity and help secure the computing environment without sacrificing ease-of-use features such as quick login. Additionally, IWS Desktop Security provides an easy integration with various smart card-based credentials including the Common Access Card (CAC), Homeland Security Presidential Directive 12 (HSPD-12) Personal Identity Verification (PIV) credential, and Transportation Worker Identification Credential (TWIC) with an organization’s access control process. IWS Desktop Security provides the crucial end-point component of a Logical Access Control System (LACS), and when combined with a Physical Access Control System (PACS), organizations benefit from a complete door to desktop access control and security model.

 

Our offices are located at 10883 Thornmint Road, San Diego, California 92127, and our telephone number at this address is (858) 673-8600.  Our website address is www.iwsinc.com.  Information contained on our website, or that can be accessed through our website, is not a part of this prospectus.  See the section entitled “Where You Can Find More Information” on page 64 of this prospectus.

 

Our common stock is traded on the American Stock Exchange (“AMEX”) under the symbol “IW”.

 

The Offering

 

This prospectus relates to the resale of up to 17,151,664 shares of common stock of the Company, by the selling stockholders identified in this prospectus. The selling stockholders acquired the shares offered by this prospectus in various private placements and debt financings that took place between May 2002 and September 2007, all as more fully described in the section entitled “The Selling Stockholders” beginning on page 29 of this prospectus.

 

RISK FACTORS

 

An investment in our common stock involves a high degree of risk. Before investing in our common stock, you should consider carefully the specific risks detailed in this “Risk Factors” section and any applicable prospectus supplement, together with all of the other information contained in this prospectus and any prospectus supplement. If any of these risks occur, our business, results of operations and financial condition could be harmed, the price of our common stock could decline, and you may lose all or part of your investment.

 

Risks Related to Our Business

 

We have incurred net losses in our six most recent fiscal years and AMEX has issued us a letter that it intends to remove our common stock from listing and registration on the exchange .

 

The AMEX Company Guide (the “Company Guide”) provides that AMEX will normally consider suspending dealings in, or removing from the list, securities of a company which sustains net losses in its five most recent fiscal years and has shareholders’ equity of less than $6,000,000, unless the company has total market capitalization of at least $50,000,000, or total assets and revenue of $50,000,000. We have sustained net losses during our six most recent fiscal years, and as of December 31, 2007, our shareholders’ equity was approximately $3,527,000. In addition, we do not meet the alternative minimum market capitalization or total asset and revenue requirements.

 

On December 14, 2007, we received a letter from AMEX indicating that we do not comply with AMEX’s continued listing standards due to our inability to maintain compliance with Sections 1003(a)(ii), 1003(a)(iii) and 1003(a)(iv) of the Company Guide and that AMEX intends to remove our common stock from listing and registration on AMEX by filing a delisting

 

2



 

application with the Securities and Exchange Commission (“SEC”).  The letter from AMEX states that we were not in compliance with (i) Section 1003(a)(ii) of the Company Guide because our shareholders’ equity was less than $4,000,000 and we sustained losses from continuing operations and/or net losses in three out of our four most recent fiscal years, and (ii) Section 1003(a)(iii) of the Company Guide because our shareholders’ equity was less than $6,000,000 and we sustained losses from continuing operations and/or net losses in our five most recent fiscal years.  We had also been notified by AMEX that we were not in compliance with Section 1003(a)(iv) of the Company Guide in that we had sustained losses which are so substantial in relation to our overall operations or our existing financial resources, or our financial condition had become so impaired that it appeared questionable, in the opinion of AMEX, as to whether we would be able to continue operations and/or meet our obligations as they matured.

 

We filed an appeal of AMEX’s determination and requested an oral hearing before an AMEX Listing Qualifications Panel (a “Qualifications Panel”).  On March 10, 2008, we received a letter from AMEX granting our request.  Our hearing with a Qualifications Panel is scheduled for April 16, 2008.  If the Qualifications Panel does not grant the relief sought, our common stock will be delisted from AMEX following which it is expected that our common stock would be quoted on the Over-the-Counter Bulletin Board .  As a consequence of any such delisting, the public price of our common stock could be adversely affected and a stockholder would likely find it more difficult to dispose of, or to obtain accurate quotations as to the prices of, our common stock.

 

We have a history of significant recurring losses totaling approximately $75.9 million, and these losses may continue in the future .

 

As of December 31, 2007, we had an accumulated deficit of $75.9 million, and these losses may continue in the future. We will need to raise capital to fund our continuing operations, and financing may not be available to us on favorable terms or at all. In the event financing is not available in the time frame required, we will be forced to sell certain of our assets or license our technologies to others. We expect to continue to incur significant sales and marketing, research and development, and general and administrative expenses. As a result, we will need to generate significant revenues to achieve profitability and we may never achieve profitability.

 

Our operating results have fluctuated in the past and are likely to fluctuate significantly in the future. We may experience fluctuations in our quarterly results of operations as a result of:

 

·                   varying demand for and market acceptance of our technology and products;

 

·                   changes in our product or customer mix;

 

·                   the gain or loss of one or more key customers or their key customers, or significant changes in the financial condition of one or more of our key customers or their key customers;

 

·                   our ability to introduce, certify and deliver new products and technologies on a timely basis;

 

·                   the announcement or introduction of products and technologies by our competitors;

 

·                   competitive pressures on selling prices;

 

·                   costs associated with acquisitions and the integration of acquired companies, products and technologies;

 

·                   our ability to successfully integrate acquired companies, products and technologies, including the assets recently acquired from Sol Logic, Inc. (“Sol Logic”);

 

·                   our accounting and legal expenses; and

 

·                   general economic conditions.

 

These factors, some of which are not within our control, may cause the price of our stock to fluctuate substantially. To respond to these and other factors, we may need to make business decisions that could result in failure to meet financial expectations. If our quarterly operating results fail to meet or exceed the expectations of securities analysts or investors, our stock price could drop suddenly and significantly. Most of our expenses, such as employee compensation, inventory and debt repayment obligations, are relatively fixed in the short term. Moreover, our expense levels are based, in part, on our

 

3



 

expectations regarding future revenue levels. As a result, if our revenue for a particular period were below our expectations, we would not be able to proportionately reduce our operating expenses for that period. Any revenue shortfall would have a disproportionately negative effect on our operating results for the period.

 

We received a “going concern” opinion from our independent registered public accounting firm for the fiscal years ended December 31, 2006  and 2007, which may negatively impact our business.

 

We received a report from Stonefield Josephson, Inc., our independent registered public accounting firm (“Stonefield Josephson”), regarding our consolidated financial statements for the fiscal year ended December 31, 2006 and 2007, which included an explanatory paragraph stating that the consolidated financial statements were prepared assuming we will continue as a going concern. The report also stated that our substantial net losses and monetary liabilities have raised substantial doubt about our ability to continue as a going concern.  The “going concern” opinion for the fiscal year ended December 31, 2007, may fail to dispel any continuing doubts about our ability to continue as a going concern and could adversely affect our ability to enter into collaborative relationships with business partners, to raise additional capital and to sell our products, and could have a material adverse effect on our business, financial condition and results of operations.

 

We currently have limited cash resources and we will require additional funding to finance our working capital requirements for at least the next twelve months .

 

We currently have limited cash resources and we will require financing to fund our anticipated working capital requirements for at least the next twelve months. If we are not able to generate positive cash flows from operations in the near future, we will be required to seek additional funding through public or private equity or debt financing. There can be no assurance that additional financing will be available on acceptable terms, or at all. If we are required to sell equity to raise additional funds, our existing stockholders may incur substantial dilution and any shares so issued may have rights, preferences and privileges superior to the rights, preferences and privileges of our outstanding common stock. If we seek debt financing, the terms of the financing may require us to agree to restrictive covenants or impose other obligations that limit our ability to grow our business, acquire necessary assets or take other actions that we consider necessary or desirable.  Also, we may be required to obtain funds through arrangements with third parties that require us to relinquish rights to certain of our technologies or products that we would seek to develop or commercialize ourselves. In addition, our ability to raise additional capital may be dependent upon our common stock being listed on AMEX. We have not satisfied the criteria for continued listing on AMEX in the past and we cannot guarantee that we will be able to satisfy the criteria for continued listing on AMEX in the future.

 

Our current ineligibility to use the Registration Statement on Form S-3 may affect our ability to finance our working capital requirements for the next twelve months .

 

As a result of the fact that our Current Report on Form 8-K, filed with the SEC on December 21, 2007, was filed after the deadline for its filing, we became ineligible through December 2008 to register shares of our common stock on a Form S-3 Registration Statement. Certain investors, for whom the ability to resell their shares relatively soon after they acquire them is important, may only be willing to participate in private financings by us if we can register their shares using a Form S-3 Registration Statement.  Therefore, our ineligibility to use Form S-3 could limit our ability to raise additional capital for at least the next 12 months or such longer period that we are ineligible to use the Form S-3 Registration Statement.

 

We depend upon a small number of large system sales ranging from $500,000 to in excess of $2,000,000, and we may fail to achieve one or more large system sales in the future .

 

Historically, we have derived a substantial portion of our revenues from a small number of sales of large, relatively expensive systems, typically ranging in price from $500,000 to $2,000,000. If we fail to receive orders for these large systems in a given sales cycle on a consistent basis, our business could be significantly harmed. Further, our quarterly results are difficult to predict because we cannot predict in which quarter, if any, large system sales will occur in a given year. As a result, we believe that quarter-to-quarter comparisons of our results of operations are not a good indication of our future performance. In some future quarters, our operating results may be below the expectations of securities analysts and investors, in which case the market price of our common stock may decrease significantly.

 

4



 

Our lengthy sales cycle may cause us to expend significant resources for as long as one year in anticipation of a sale to certain customers, yet we still may fail to complete the sale .

 

When considering the purchase of a large computerized identity management system, potential customers of ours may take as long as one year to evaluate different systems and obtain approval for the purchase. Under these circumstances, if we fail to complete a sale, we will have expended significant resources and received no revenue in return. Generally, customers consider a wide range of issues before committing to purchase our products, including product benefits, ability to operate with their current systems, product reliability and their own budgetary constraints. While potential customers are evaluating our products, we may incur substantial selling costs and expend significant management resources in an effort to accomplish potential sales that may never occur.

 

A significant number of our customers and potential customers are government agencies that are subject to unique political and budgetary constraints and have special contracting requirements which may affect our ability to obtain new and retain current government customers .

 

A significant number of our customers are government agencies. These agencies often do not set their own budgets and therefore have little control over the amount of money they can spend from quarter-to-quarter or year-to-year. In addition, these agencies experience political pressure that may dictate the manner in which they spend money. Due to political and budgetary processes and other scheduling delays that may frequently occur relating to the contract or bidding process, some government agency orders may be canceled or substantially delayed, and the receipt of revenues or payments from these agencies may be substantially delayed. In addition, future sales to government agencies will depend on our ability to meet government contracting requirements, certain of which may be onerous or impossible to meet, resulting in our inability to obtain a particular contract. Common requirements in government contracts include bonding requirements, provisions permitting the purchasing agency to modify or terminate at will the contract without penalty, and provisions permitting the agency to perform investigations or audits of our business practices, any of which may limit our ability to enter into new contracts or maintain our current contracts.

 

We may fail to create new applications for our products and enter new markets, which may have an adverse effect on our operations, financial condition and prospects .

 

We believe our future success depends in part on our ability to develop and market our technology for applications other than booking systems for the law enforcement market. If we fail in these goals, our business strategy and ability to generate revenues and cash flow would be significantly impaired. We intend to expend significant resources to develop new technology, but the successful development of new technology cannot be predicted and we cannot guarantee we will succeed in these goals.

 

We occasionally rely on systems integrators to manage our large projects, and if these companies do not perform adequately, we may lose business .

 

We occasionally act as a subcontractor to systems integrators who manage large projects that incorporate our systems, particularly in foreign countries. We cannot control these companies, and they may decide not to promote our products or may price their services in such a way as to make it unprofitable for us to continue our relationship with them. Further, they may fail to perform under agreements with their customers, in which case we might lose sales to these customers. If we lose our relationships with these companies, our business, financial condition and results of operations may suffer.

 

If the patents we own or license, or our other intellectual property rights, do not adequately protect our products and technologies, we may lose market share to our competitors and our business, financial condition and results of operations would be adversely affected .

 

Our success depends significantly on our ability to protect our rights to the technologies used in our products. We rely on patent protection, trade secrets, as well as a combination of copyright and trademark laws and nondisclosure, confidentiality and other contractual arrangements to protect our technology. However, these legal means afford only limited protection and may not adequately protect our rights or permit us to gain or keep any competitive advantage. In addition, we cannot be assured that any of our current and future pending patent applications will result in the issuance of a patent to us. The U.S. Patent and Trademark Office (“PTO”) may deny or require significant narrowing of claims in our pending patent applications, and patents issued as a result of the pending patent applications, if any, may not provide us with significant commercial protection or be issued in a form that is advantageous to us. We could also incur substantial costs in proceedings before the PTO. These proceedings could result in adverse decisions as to the claims included in our patents.

 

5



 

Our issued and licensed patents and those that may be issued or licensed in the future may be challenged, invalidated or circumvented, which could limit our ability to stop competitors from marketing related products. Additionally, upon expiration of our issued or licensed patents, we may lose some of our rights to exclude others from making, using, selling or importing products using the technology based on the expired patents. We also must rely on contractual rights with the third parties that license technology to us to protect our rights in the technology licensed to us. Although we have taken steps to protect our intellectual property and technology, there is no assurance that competitors will not be able to design around our patents. We also rely on unpatented proprietary technology. We cannot assure you that we can meaningfully protect all our rights in our unpatented proprietary technology or that others will not independently develop substantially equivalent proprietary products or processes or otherwise gain access to our unpatented proprietary technology. We seek to protect our know-how and other unpatented proprietary technology with confidentiality agreements and intellectual property assignment agreements with our employees. However, such agreements may not provide meaningful protection for our proprietary information in the event of unauthorized use or disclosure or other breaches of the agreements or in the event that our competitors discover or independently develop similar or identical designs or other proprietary information. In addition, we rely on the use of registered and common law trademarks with respect to the brand names of some of our products. Our common law trademarks provide less protection than our registered trademarks. Loss of rights in our trademarks could adversely affect our business, financial condition and results of operations.

 

Furthermore, the laws of foreign countries may not protect our intellectual property rights to the same extent as the laws of the United States. If we fail to apply for intellectual property protection or if we cannot adequately protect our intellectual property rights in these foreign countries, our competitors may be able to compete more effectively against us, which could adversely affect our competitive position, as well as our business, financial condition and results of operations.

 

If third parties claim that we infringe their intellectual property rights, we may incur liabilities and costs and may have to redesign or discontinue selling certain products .

 

Whether a product infringes a patent involves complex legal and factual issues, the determination of which is often uncertain. We face the risk of claims that we have infringed on third parties’ intellectual property rights. Searching for existing intellectual property rights may not reveal important intellectual property and our competitors may also have filed for patent protection, which is not as yet a matter of public knowledge, or claimed trademark rights that have not been revealed through our availability searches. Our efforts to identify and avoid infringing on third parties’ intellectual property rights may not always be successful. Any claims of patent or other intellectual property infringement, even those without merit, could:

 

·                   increase the cost of our products;

 

·                   be expensive and time consuming to defend;

 

·                   result in us being required to pay significant damages to third parties;

 

·                   force us to cease making or selling products that incorporate the challenged intellectual property;

 

·                   require us to redesign, reengineer or rebrand our products;

 

·                   require us to enter into royalty or licensing agreements in order to obtain the right to use a third party’s intellectual property, the terms of which may not be acceptable to us;

 

·                   require us to indemnify third parties pursuant to contracts in which we have agreed to provide indemnification to such parties for intellectual property infringement claims;

 

·                   divert the attention of our management; and

 

·                   result in our customers or potential customers deferring or limiting their purchase or use of the affected products until the litigation is resolved.

 

In addition, new patents obtained by our competitors could threaten a product’s continued life in the market even after it has already been introduced.

 

6



 

The failure to successfully integrate any business or asset acquisitions into our existing operations, or if we discover previously undisclosed liabilities, could negatively affect our business, financial condition and results of operations .

 

We completed the acquisition of certain assets of Sol Logic in December 2007, and we plan to continue to review potential acquisition candidates. Our business and our strategy include building our business through acquisitions. However, acceptable acquisition candidates may not be available in the future or may not be available on terms and conditions acceptable to us.

 

Successful acquisitions depend upon our ability to identify, negotiate, complete and integrate suitable acquisitions and to obtain any necessary financing. Even if we complete acquisitions, we may experience:

 

·                   difficulties in integrating any acquired companies, personnel and products into our existing business;

 

·                   delays in realizing the benefits of the acquired company or products;

 

·                   diversion of our management’s time and attention from other business concerns;

 

·                   limited or no direct prior experience in new markets or countries we may enter;

 

·                   higher costs of integration than we anticipated; and

 

·                   difficulties in retaining key employees of the acquired business who are necessary to manage these acquisitions.

 

In addition, an acquisition could materially impair our operating results by causing us to incur debt or requiring us to amortize acquisition expenses and acquired assets. We may also discover deficiencies in internal controls, data adequacy and integrity, product quality, regulatory compliance and product liabilities that we did not uncover prior to our acquisition of such businesses, which could result in us becoming subject to penalties or other liabilities. Any difficulties in the integration of acquired businesses or unexpected penalties or liabilities in connection with such businesses could have a material adverse effect on our business, financial condition and results of operations.

 

We operate in foreign countries and are exposed to risks associated with foreign political, economic and legal environments and with foreign currency exchange rates .

 

With our acquisition of G&A Imaging Ltd. in 2001, we have significant foreign operations. As a result, we are exposed to risks, including among others, risks associated with foreign political, economic and legal environments and with foreign currency exchange rates. Our results may be adversely affected by, among other things, changes in government policies with respect to laws and regulations, anti-inflation measures, currency conversions, remittance abroad and rates and methods of taxation.

 

We depend on key personnel, the loss of any of whom could materially adversely affect future operations .

 

Our success will depend to a significant extent upon the efforts and abilities of our executive officers and other key personnel. The loss of the services of one or more of these key employees and any negative market or industry perception arising from the loss of such services could have a material adverse effect on us and the trading price of our common stock.  Our business will also be dependent upon our ability to attract and retain qualified personnel. Acquiring and keeping these personnel could prove more difficult or cost substantially more than estimated and we cannot be certain that we will be able to retain such personnel or attract a high caliber of personnel in the future.

 

Compliance with Section 404 of the Sarbanes-Oxley Act of 2002 may result in substantial costs to us and a diversion of management attention and resources, and failure to maintain adequate internal controls over financial reporting could result in our business being harmed and our stock price declining .

 

Section 404 of the Sarbanes-Oxley Act of 2002 requires us to document and test the effectiveness of our internal controls over financial reporting in accordance with an established control framework and to report on our management’s conclusion as to the effectiveness of these internal controls over financial reporting beginning with the fiscal year ending December 31, 2007.  This section also requires that our independent registered public accounting firm provide an attestation report on our internal control over financial reporting beginning with the fiscal year ending December 31, 2008.  Our management completed its evaluation of the effectiveness of our disclosure controls and procedures as of December 31, 2007 and concluded that our internal controls over financial reporting were effective as of that date.

 

7



 

The standards that must be met for management to continue to assess the internal control over financial reporting are complex and will require significant documentation, testing and possible remediation to meet the detailed standards.  In addition, the attestation process that must be performed by our independent registered public accounting firm is new and complex. We may encounter problems or delays in completing the activities necessary to continue to make assessments of our internal control over financial reporting, completing the implementation of any requested improvements, or receiving an unqualified attestation of our assessment by our independent registered public accountants.  Ensuring that we have adequate internal financial and accounting controls and procedures in place is a costly and time-consuming effort that needs to be evaluated frequently, so compliance with these new rules could require us to incur substantial costs and may require a significant amount of time and attention of management, which could seriously harm our business, financial condition and results of operations. If we are unable to continue to assess our internal control over financial reporting as effective, or if our independent registered public accounting firm is unable to provide an unqualified attestation report on our assessment, investors may lose confidence in us and our stock price may be negatively impacted.

 

We face competition from companies with greater financial, technical, sales, marketing and other resources, and, if we are unable to compete effectively with these competitors, our market share may decline and our business could be harmed .

 

We face competition from other established companies. A number of our competitors have longer operating histories, larger customer bases, significantly greater financial, technological, sales, marketing and other resources than we do.  As a result, our competitors may be able to respond more quickly than we can to new or changing opportunities, technologies, standards or client requirements, more quickly develop new products or devote greater resources to the promotion and sale of their products and services than we can.  Likewise, their greater capabilities in these areas may enable them to better withstand periodic downturns in the identity management solutions industry and compete more effectively on the basis of price and production.  In addition, new companies may enter the markets in which we compete, further increasing competition in the identity management solutions industry.

 

We believe that our ability to compete successfully depends on a number of factors, including the type and quality of our products and the strength of our brand names, as well as many factors beyond our control. We may not be able to compete successfully against current or future competitors, and increased competition may result in price reductions, reduced profit margins, loss of market share and an inability to generate cash flows that are sufficient to maintain or expand the development and marketing of new products, any of which would adversely impact our results of operations and financial condition.

 

Risks Related to Our Securities

 

The holders of our preferred stock have certain rights and privileges that are senior to our common stock, and we may issue additional shares of preferred stock without stockholder approval that could have a material adverse effect on the market value of the common stock .

 

Our Board of Directors (“Board”) has the authority to issue a total of up to 4,000,000 shares of preferred stock and to fix the rights, preferences, privileges, and restrictions, including voting rights, of the preferred stock, which typically are senior to the rights of the common stockholders, without any further vote or action by the common stockholders. The rights of our common stockholders will be subject to, and may be adversely affected by, the rights of the holders of the preferred stock that have been issued, or might be issued in the future. Preferred stock also could have the effect of making it more difficult for a third party to acquire a majority of our outstanding voting stock. This could delay, defer, or prevent a change in control. Furthermore, holders of preferred stock may have other rights, including economic rights, senior to the common stock. As a result, their existence and issuance could have a material adverse effect on the market value of the common stock. We have in the past issued and may from time to time in the future issue, preferred stock for financing or other purposes with rights, preferences, or privileges senior to the common stock. As of December 31, 2007, we had three series of preferred stock outstanding, Series B preferred stock, Series C 8% convertible preferred stock and Series D 8% convertible preferred stock.

 

The provisions of our Series B Preferred Stock prohibit the payment of dividends on the common stock unless the dividends on those preferred shares are first paid. In addition, upon a liquidation, dissolution or sale of our business, the holders of the Series B Preferred Stock will be entitled to receive, in preference to any distribution to the holders of common stock, initial distributions of $2.50 per share, plus all accrued but unpaid dividends.  Pursuant to the terms of our Series B Preferred Stock we are obligated to pay cumulative cash dividends on shares of Series B Preferred Stock from legally available funds at the annual rate of $0.2125 per share, payable in two semi-annual installments of $0.10625 each, which cumulative dividends must be paid prior to payment of any dividend on our common stock. As of December 31, 2007, we had cumulative undeclared dividends on the Series B Preferred Stock of approximately $9,000.

 

8


 


 

The Series C Preferred Stock has a liquidation preference equal to its stated value, plus any accrued and unpaid dividends thereon and any other fees or liquidated damages owing thereon. The Series C Preferred Stock accrues cumulative dividends at the rate of 8.0% of the stated value per share per annum.  At the option of the Company, the dividend payment may be made in the form of cash, after the payment of cash dividends to the holders of Series B Preferred Stock, or common stock issuable upon conversion of the Series C Preferred Stock.  Each share of Series C Preferred Stock is convertible at any time at the option of the holder into a number of shares of common stock equal to the stated value (initially $1,000 per share, subject to adjustment), plus any accrued and unpaid dividends, divided by the conversion price (initially $1.50 per share, subject to adjustment). Subject to certain limitations, the conversion price per share shall be adjusted in the event of certain subsequent stock dividends, splits, reclassifications, dilutive issuances, rights offerings, and reclassifications.  Certain activities may not be undertaken by the Company without the affirmative vote of a majority of the holders of the outstanding shares of Series C Preferred Stock. As of December 31, 2007, we had cumulative undeclared dividends on the Series C Preferred Stock of approximately $234,000.

 

The Series D Preferred Stock has a liquidation preference equal to its stated value, plus any accrued and unpaid dividends thereon and any other fees or liquidated damages owing thereon. The Series D Preferred Stock accrues cumulative dividends at the rate of 8.0% of the stated value per share per annum.  At the option of the Company, the dividend payment may be made in the form of cash, after the payment of cash dividends to the holders of Series B and Series C Preferred Stock, or common stock issuable upon conversion of the Series D Preferred Stock.  Each share of Series D Preferred Stock is convertible at any time at the option of the holder into a number of shares of common stock equal to the stated value (initially $1,000 per share, subject to adjustment), plus any accrued and unpaid dividends, divided by the conversion price (initially $1.90 per share, subject to adjustment). Subject to certain limitations, the conversion price per share shall be adjusted in the event of certain subsequent stock dividends, splits, reclassifications, dilutive issuances, rights offerings, and reclassifications.  Certain activities may not be undertaken by the Company without the affirmative vote of a majority of the holders of the outstanding shares of Series D Preferred Stock. As of December 31, 2007, we had cumulative undeclared dividends on the Series D Preferred Stock of approximately $98,000.

 

Our stock price has been volatile, and your investment in our common stock could suffer a decline in value .

 

There has been significant volatility in the market price and trading volume of equity securities, which is unrelated to the financial performance of the companies issuing the securities. These broad market fluctuations may negatively affect the market price of our common stock. You may not be able to resell your shares at or above the price you pay for those shares due to fluctuations in the market price of our common stock caused by changes in our operating performance or prospects and other factors.

 

Some specific factors that may have a significant effect on our common stock market price include:

 

·                   actual or anticipated fluctuations in our operating results or future prospects;

 

·                   our announcements or our competitors’ announcements of new products;

 

·                   the public’s reaction to our press releases, our other public announcements and our filings with the SEC;

 

·                   strategic actions by us or our competitors, such as acquisitions or restructurings;

 

·                   new laws or regulations or new interpretations of existing laws or regulations applicable to our business;

 

·                   changes in accounting standards, policies, guidance, interpretations or principles;

 

·                   changes in our growth rates or our competitors’ growth rates;

 

·                   developments regarding our patents or proprietary rights or those of our competitors;

 

·                   our inability to raise additional capital as needed;

 

·                   substantial sales of common stock underlying warrants and preferred stock;

 

·                   concern as to the efficacy of our products;

 

9



 

·                   changes in financial markets or general economic conditions;

 

·                   sales of common stock by us or members of our management team; and

 

·                   changes in stock market analyst recommendations or earnings estimates regarding our common stock, other comparable companies or our industry generally.

 

Our future sales of our common stock could adversely affect its price and our future capital-raising activities could involve the issuance of equity securities, which would dilute your investment and could result in a decline in the trading price of our common stock .

 

We may sell securities in the public or private equity markets if and when conditions are favorable, even if we do not have an immediate need for additional capital at that time. Sales of substantial amounts of our common stock, or the perception that such sales could occur, could adversely affect the prevailing market price of our common stock and our ability to raise capital. We may issue additional common stock in future financing transactions or as incentive compensation for our executive management and other key personnel, consultants and advisors. Issuing any equity securities would be dilutive to the equity interests represented by our then-outstanding shares of common stock. The market price for our common stock could decrease as the market takes into account the dilutive effect of any of these issuances. Furthermore, we may enter into financing transactions at prices that represent a substantial discount to the market price of our common stock. A negative reaction by investors and securities analysts to any discounted sale of our equity securities could result in a decline in the trading price of our common stock.

 

If registration rights that we have previously granted are exercised, then the price of our common stock may be adversely affected .

 

We have agreed to register with the SEC up to 17,151,664 shares of common stock which are included in the registration statement of which this prospectus is a part.  In the event these securities are registered with the SEC, they may be freely sold in the open market provided the registration statement of which this prospectus forms a part remains effective and subject to trading restrictions to which our affiliates holding the shares may be subject from time to time. We expect that we also will be required to register any securities sold in future private financings. Additionally, the number of shares of our common stock underlying issued and outstanding warrants and preferred stock registered under prior registration statements, many of which are now available for resale under Rule 144 of the Securities Act of 1933, as amended (the “Securities Act”), is substantial and sales of such underlying stock could cause significant dilution.  The sale of a significant amount of shares in the open market, or the perception that these sales may occur, could cause the trading price of our common stock to decline or become highly volatile.

 

Our corporate documents and Delaware law contain provisions that could discourage, delay or prevent a change in control of our company .

 

Provisions in our certificate of incorporation and bylaws may discourage, delay or prevent a merger or acquisition involving us that our stockholders may consider favorable. For example, our certificate of incorporation authorizes preferred stock, which carries special rights, including voting and dividend rights. With these rights, preferred stockholders could make it more difficult for a third party to acquire us.

 

We are also subject to the anti-takeover provisions of Section 203 of the Delaware General Corporation Law. Under these provisions, if anyone becomes an “interested stockholder,” we may not enter into a “business combination” with that person for three years without special approval, which could discourage a third party from making a takeover offer and could delay or prevent a change of control. For purposes of Section 203, “interested stockholder” means, generally, someone owning 15% or more of our outstanding voting stock or an affiliate of ours that owned 15% or more of our outstanding voting stock during the past three years, subject to certain exceptions as described in Section 203.

 

We do not expect to pay cash dividends on our common stock for the foreseeable future .

 

We have never paid cash dividends on our common stock and do not anticipate that any cash dividends will be paid on the common stock for the foreseeable future. The payment of any cash dividend by us will be at the discretion of our board of directors and will depend on, among other things, our earnings, capital, regulatory requirements and financial condition. Furthermore, the terms of our Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock directly limit our ability to pay cash dividends on our common stock.

 

10



 

Securities analysts may not continue to cover our common stock or may issue negative reports, and this may have a negative impact on our common stock’s market price .

 

There is no guarantee that securities analysts will continue to cover our common stock. If securities analysts do not cover our common stock, the lack of research coverage may adversely affect our common stock’s market price. The trading market for our common stock relies in part on the research and reports that industry or financial analysts publish about our business or us. If one or more of the analysts who cover us downgrades our stock, our stock price may decline rapidly. If one or more of these analysts ceases coverage of our common stock, we could lose visibility in the market, which in turn could cause our stock price to decline. In addition, rules mandated by the Sarbanes-Oxley Act of 2002, and a global settlement reached between the SEC, other regulatory analysts and a number of investment banks in April 2003, may lead to a number of fundamental changes in how analysts are reviewed and compensated. In particular, many investment banking firms will now be required to contract with independent financial analysts for their stock research. It may be difficult for companies with smaller market capitalizations, such as our company, to attract independent financial analysts that will cover our common stock, which could have a negative effect on our market price.

 

The large number of holders and lack of concentration of ownership of our common stock may make it difficult for us to reach a quorum or obtain an affirmative vote of our stockholders at future stockholder meetings .

 

Our stock is held in a large number of individual accounts. As a result, it may be difficult for us to reach a quorum or obtain an affirmative vote of a majority of our stockholders where either of those thresholds are measured based on the total number of shares of our common stock outstanding. Difficulty in obtaining a stockholder vote could impact our ability to complete any financing or strategic transaction requiring stockholder approval or effect basic corporate governance changes, such as an increase in the authorized number of shares of our preferred stock and our common stock.

 

CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING INFORMATION

 

This prospectus contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to the financial condition, results of operations, business strategies, operating efficiencies or synergies, competitive positions, growth opportunities for existing patents, technologies, products, plans and objectives of management, markets for stock of ImageWare and other matters. Statements in this prospectus that are not historical facts are hereby identified as “forward-looking statements” for the purpose of the safe harbor provided by Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Section 27A of the Securities Act. Such forward-looking statements, including, without limitation, those relating to the future business prospects, revenues and income of ImageWare, wherever they occur, are necessarily estimates reflecting the best judgment of our senior management on the date on which they were made, or if no date is stated, as of the date of this prospectus. These forward-looking statements are subject to risks, uncertainties and assumptions, including those described in the section entitled “Risk Factors,” may affect the operations, performance, development and results of our business. Because the factors discussed in this prospectus could cause actual results or outcomes to differ materially from those expressed in any forward-looking statements made by us or on our behalf, you should not place undue reliance on any such forward-looking statements. New factors emerge from time to time, and it is not possible for us to predict which factors will arise. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

 

You are advised to read carefully the section titled “Risk Factors” beginning on page 2 of this prospectus.

 

We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or any other reason. All subsequent forward-looking statements attributable to ImageWare or any person acting on our behalf are expressly qualified in their entirety by the cautionary statements contained or referred to herein. In light of these risks, uncertainties and assumptions, the forward-looking events discussed in this prospectus may not occur. Except as required under the federal securities laws and the rules and regulations of the SEC, we do not have any intention or obligation to update publicly any forward-looking statements after we distribute this prospectus, whether as a result of new information, future events or otherwise.

 

11



 

USE OF PROCEEDS

 

All of our common stock being offered under this prospectus is being sold by or for the account of the selling stockholders.  We will not receive any proceeds from the sale of our common stock by or for the account of the selling stockholders.  However, we will receive proceeds to the extent the selling stockholders exercise their warrants for cash.  Any such proceeds will be used for general corporate purposes.  General corporate purposes may include capital expenditures, repayment of debt, possible acquisitions, investments and any other purposes that we may specify in any prospectus supplement.

 

MANAGEMENT

 

Directors

 

The following table sets forth information regarding our directors as of April 1, 2008:

 

Name

 

Age

 

Principal Occupation/Position
Held With the Company

 

Mr. S. James Miller, Jr.

 

54

 

Chief Executive Officer and Chairman of the Board of Directors

 

Mr. John Callan

 

61

 

Director

 

Mr. David Carey

 

63

 

Director

 

Mr. Guy Steven Hamm

 

60

 

Director

 

Mr. John Holleran

 

81

 

Director

 

Mr. David Loesch

 

63

 

Director

 

 

On March 16, 2008, Mr. Patrick Downs, a member of our board of directors, passed away.  We have not yet filled the vacancy resulting from Mr. Downs’ untimely passing.

 

S. James Miller, Jr. has served as our Chief Executive Officer since 1990 and Chairman of the Board since 1996. He also served as our President from 1990 until 2003. From 1980 to 1990, Mr. Miller was an executive with Oak Industries, Inc., a manufacturer of components for the telecommunications industry. While at Oak Industries, Mr. Miller served as a director and as Senior Vice President, General Counsel, Corporate Secretary and Chairman/President of Oak Industries’ Pacific Rim subsidiaries. He has a J.D. from the University of San Diego School of Law and a B.A. from the University of California, San Diego.

 

John Callan was appointed to the Board in September 2000. Since February 2007, Mr. Callan has served as Vice President, Strategy and Business Development at DHL Global Mail, Americas. From March 2006 to February 2007, Mr. Callan served DHL Global Mail as Vice President - Domestic Product Management. From 2001 to 2006, Mr. Callan served as Principal of Ursa Major Associates, LLC, the logistics strategy consulting firm he co-founded. From 1997 to 2002, he was an independent business strategy consultant in the imaging and logistics fields. From 1995 to 1997, Mr. Callan served as Chief Operating Officer for Milestone Systems, a shipping systems software company. From 1987 to 1995, he served as Director of Entertainment Imaging at Polaroid Corporation. Mr. Callan is a graduate of the University of North Carolina.

 

David Carey was appointed to the Board in February 2006. Mr. Carey is a former Executive Director of the Central Intelligence Agency. Since April 2005, Mr. Carey has served as Executive Director for Blackbird Technologies, which provides state-of-the-art IT security expertise, where he assists the company with business development and strategic planning. Prior to joining Blackbird Technologies, Mr. Carey was Vice President, Information Assurance for Oracle Corporation from September 2001 to April 2005. In addition, Mr. Carey worked for the CIA for 32 years until 2001. During his career at the CIA, Mr. Carey held several senior positions including that of Executive Director, often referred to as the Chief Operating Officer, or No. 3 person in the agency, from 1997 to 2001. Before assuming that position, Mr. Carey was Director of the DCI Crime and Narcotics Center, the Director of the Office of Near Eastern and South Asian Analysis, and Deputy Director of the Office of Global Issues. Mr. Carey is a graduate of Cornell University and the University of Delaware.

 

Guy Steven Hamm was appointed to the Board in October 2004. Mr. Hamm served Aspen Holding, a privately held insurance provider, as CFO from December 2005 to February 2007. In 2002, Mr. Hamm retired from PricewaterhouseCoopers, where he was a national partner-in-charge of middle market. Mr. Hamm was instrumental in growing the Audit Business Advisory Services (ABAS) Middle Market practice at PricewaterhouseCoopers, where he was responsible for $300 million in revenue and more than 100 partners. Mr. Hamm is a graduate of San Diego State University.

 

12



 

John Holleran was appointed to the Board in May 1996. Since 1974, Mr. Holleran has been a management and investment consultant. Prior to consulting, Mr. Holleran served as the Chief Financial Officer, Executive Vice President and Chief Operating Officer of Southwest Gas Corporation. He served as Executive Vice President of the Hawaii Corporation, a diversified holding company, and as President and Chairman of Property Research Financial Corporation, a real estate investment and syndication firm, from 1972 to 1974. Mr. Holleran has also served as a director of Kilroy Industries, a national office building and office park developer, as a director of Walker & Lee, a national full service real estate firm, and as a director of NTN Communications, Inc., a company engaged in the interactive television business. Mr. Holleran is a graduate of Woodbury University.

 

David Loesch was appointed to the Board in September 2001 after 29 years of service as a Special Agent with the Federal Bureau of Investigations (“FBI”). At the time of his retirement from the FBI, Mr. Loesch was the Assistant Director in Charge of the Criminal Justice Information Services Division of the FBI. Mr. Loesch was awarded the Presidential Rank Award for Meritorious Executive in 1998 and has served on the board of directors of the Special Agents Mutual Benefit Association since 1996. He is also a member of the International Association of Chiefs of Police and the Society of Former Special Agents of the FBI, Inc. Mr. Loesch served in the United States Army as an Officer with the 101st Airborne Division in Vietnam. He holds a Bachelor’s degree from Canisius College and a Master’s degree in Criminal Justice from George Washington University. Mr. Loesch is currently a private consultant on public safety and criminal justice solutions.

 

Executive Officers

 

The following table sets forth the names, ages and positions for our executive officers and certain significant employees not discussed above as of April 1, 2008:

 

Name

 

Age

 

Principal Position(s) Held With the Company

 

Mr. Wayne Wetherell

 

55

 

Sr. Vice President, Administration, Chief Financial Officer, Secretary and Treasurer

 

Mr. Charles AuBuchon

 

64

 

Vice President, Business Development

 

Mr. David Harding

 

38

 

Vice President and Chief Technical Officer

 

 

Wayne Wetherell has served as our Senior Vice President, Administration and Chief Financial Officer since May 2001 and additionally as our Secretary and Treasurer since October 2005. From 1996 to May 2001, he served as Vice President of Finance and Chief Financial Officer. From 1991 to 1996, Mr. Wetherell was the Vice President and Chief Financial Officer of Bilstein Corporation of America, a manufacturer and distributor of automotive parts. Mr. Wetherell holds a B.S. degree in Management and an M.S. degree in Finance from San Diego State University.

 

Significant Employees

 

Chuck AuBuchon has served as our Vice President, Business Development since January 2007. From 2004 to 2007 he served as Vice President, Sales. From 2003 to 2004, he served as Director of North American Sales. From 2000 to 2003, Mr. AuBuchon was Vice President Sales & Marketing at Card Technology Corporation, a manufacturer of Card Personalization Systems, where he was responsible for distribution within the Americas, Asia Pacific and EMEA (Europe, Middle East and Africa) regions. From 1992 to 2000, Mr. AuBuchon held various sales management positions, including Vice President Sales and Marketing, for Gemplus and Datacard. Mr. AuBuchon is a graduate of Pennsylvania State University.

 

David Harding has served as our Vice President and Chief Technology Officer since January 2006. Before joining us, Mr. Harding was the Chief Technology Officer at IC Solutions, Inc., where he was responsible for all technology departments including the development and management of software development, IT and quality assurance as well as their respective hardware, software and human resource budgets from 2001 to 2003. He was the Chief Technology Officer at Thirsty.com from 1999 to 2000, the Chief Technology Officer at Fulcrum Point Technologies, Inc., from 1996 to 1999, and consultant to Access360, which is now part of IBM/Tivoli, from 1995 to 1996.

 

13



 

EXECUTIVE COMPENSATION

 

Compensation Discussion and Analysis

 

Overview of Compensation Program and Philosophy

 

Our compensation program is intended to support the achievement of our specific annual and long-term operational and strategic goals by attracting and rewarding employees for superior results. A key objective of the program is to align executives’ interests with those of the stockholders by rewarding performance above established goals, with the ultimate objective of improving stockholder value.

 

The Compensation Committee of our Board of Directors has responsibility for establishing, implementing and monitoring adherence to the Company’s compensation philosophy. The Compensation Committee seeks to ensure that the total compensation paid to our executive officers is fair, reasonable and competitive.

 

The Compensation Committee evaluates both performance and compensation in an effort to ensure that we maintain our ability to attract and retain individuals of superior ability and managerial talent in key positions and that compensation provided to key employees remains competitive relative to the compensation paid to similarly situated executives of our peer companies. To that end, the Compensation Committee believes executive compensation packages we provide to our executive officers should include both cash and stock-based compensation that rewards individual and corporate performance as measured against established goals.

 

Role of Executive Officers in Compensation Decisions

 

The Compensation Committee makes all compensation decisions for our executive officers. Regarding the establishment of base salary levels payable throughout 2007 and cash and equity incentives in respect of 2007 performance, our Chief Executive Officer, S. James Miller, provided input and arranged for the Compensation Committee to have access to our records and personnel for purposes of its deliberations. Our Sr. Vice President Administration, Chief Financial Officer, Secretary and Treasurer, Wayne G. Wetherell, also provided input to the Compensation Committee to this end. With respect to compensation levels of executive officers in 2008 with respect to 2007 performance, S. James Miller reviewed the performance of each executive officer (other than his own, which was reviewed by the Compensation Committee) and provided such input and observations to the Compensation Committee. The conclusions reached and recommendations based on these reviews, including with respect to salary adjustments for 2008 for 2007 performance, were presented to the Compensation Committee. The Compensation Committee can exercise its discretion in modifying any recommended adjustments or awards to executive officers.

 

Setting Executive Compensation

 

Based on the foregoing objectives, the Compensation Committee has structured our annual and long-term incentive-based cash and non-cash executive compensation in an effort to motivate our executive officers to achieve the business goals set by us and reward them for achieving such goals. In furtherance of these objectives, in 2005 the Compensation Committee engaged Compensia, an outside consulting firm, to assess and evaluate its total compensation program for our executive officers and provide the Compensation Committee with relevant market data and recommendations to consider when developing compensation packages for the executive officers. Compensia provided market data for peer-group companies such as ActiveCard, Authentidate Holding Corp., CAM Solutions, Cogent, Connetix, CSP, Identix, IPIX, Lasercard, Loudeye, Merge Technologies, Raining Data, SAFLINK, Smith Micro Software, Vasco Data, Viewpoint and Viisage Technology.

 

Management plays a significant role with respect to the process of setting compensation for executive officers, other than the Chairman and Chief Executive Officer, by:

 

·                   providing performance evaluations;

·                   developing and recommending targets for performance and objectives; and

·                   recommending salary levels, incentives and equity awards.

 

Management provides the Compensation Committee and the Board of Directors with material for each Compensation Committee meeting and the Chairman and Chief Executive Officer, at the Compensation Committee’s request to provide:

 

14



 

·                   background relative to strategic objectives;

·                   discussion relative to performance evaluations of the executive officers; and

·                   compensation recommendations as to executive officers (other than himself).

 

In making compensation decisions, the Compensation Committee compared each element of the executive’s total compensation package with the research and recommendations of Compensia.

 

The Compensation Committee believes that we compete with many companies for top executive-level talent. Accordingly, the Compensation Committee strives to implement compensation packages for our executive officers that are competitive with total compensation paid to similarly situated executives. Variations to this objective may occur as dictated by the experience level of the individual and market factors. A significant percentage of total compensation for our executive officers is allocated to incentives as a result of the philosophy mentioned above. Nevertheless, strictly speaking, there is no pre-established policy or target for the allocation between either cash and non-cash or short-term and long-term incentive compensation. Income from such incentive compensation is realized as a result of our performance the individual’s performance, depending on the type of award, compared to established goals.

 

2007 Executive Compensation Components

 

For the fiscal year ended December 31, 2007, the principal components of compensation for executive officers were:

 

·                   base salary; and

·                   long-term equity incentive compensation in the form of stock options and restricted stock.

 

Base Salary. We provide our executive officers and other employees with a base salary to compensate them for services rendered during the fiscal year. Base salary ranges for executive officers are determined for each executive based on his or her position and responsibility by using market data.

 

During its review of base salaries for executive officers for 2007, the Compensation Committee primarily considered:

 

·                   market data provided by our outside consultant and data published by independent third-party sources;

·                   internal review of the executive’s compensation, both individually and relative to other executive officers; and

·                   individual performance and responsibility of the executive.

 

Salary levels for named executives not under employment contracts are considered annually as part of our performance review process as well as upon a promotion or other material change in job responsibility. Merit-based increases to salaries of executive officers are determined upon assessment of the individual’s performance and responsibility.

 

Long-Term Equity Incentive Compensation. Our long-term incentive compensation program is designed to recognize the executive’s scope of responsibilities, reward demonstrated performance and leadership, motivate future superior performance, align the interests of the executives with our stockholders and retain the executives through the term of the awards. When making equity-award decisions, the Compensation Committee considers market data, the grant size, the forms of long-term equity compensation available to it under existing plans and the status of awards granted in previous years. The amount of equity incentive compensation granted in 2007 was based upon our strategic, operational and financial performance overall and reflects the executives’ expected contributions to our future success. Existing ownership levels are not a factor in award determination, as the Compensation Committee does not want to discourage executives from holding significant amounts of our stock.

 

Effective January 1, 2006, we adopted the requirements of Statement of Financial Accounting Standards No. 123R, Share-Based Payment (“SFAS 123R”), which requires companies to estimate the fair value of share-based payment option awards on the date of grant using an option-pricing model. The value of the awards that are ultimately expected to vest are recognized as compensation expense over the requisite service periods using the straight-line method. When determining the appropriate form of incentive award (for example whether stock options, restricted stock, restricted stock units, or stock appreciation rights, each of which our Amended and Restated 1999 Stock Award Plan (the “1999 Plan”) permits, should be used) the Compensation Committee’s goal is to weigh the cost of these grants with their potential benefits as a compensation tool.

 

Retirement and Other Benefits. All of our employees in the United States are eligible to participate in the 401(k) Savings Plan (the “Savings Plan”). The Savings Plan is a tax-qualified retirement savings plan pursuant to which all

 

15



 

U.S. based employees, including the named executive officers, are able to contribute. The Savings Plan provides for annual contributions by us of 50% of employee contributions not to exceed 8% of employee compensation. Participants may contribute up to 100% of the annual contribution limitations determined by the Internal Revenue Service. Employees are fully vested in their share of our contributions after the completion of five years of service.

 

Tax and Accounting Implications. As part of its role, the Compensation Committee reviews and considers the deductibility of executive compensation under Section 162(m) of the Internal Revenue Code of 1986, as amended (the “Code”), which provides that we may not deduct compensation of more than $1,000,000 that is paid to certain individuals. To qualify for deductibility under Section 162(m), compensation in excess of $1,000,000 per year paid to the named executive officers at the end of such fiscal year generally must be “performance-based” compensation as determined under Section 162(m). The Compensation Committee generally intends to comply with the requirements for full deductibility of executive compensation under Section 162(m). However, the Compensation Committee will balance the costs and burdens involved in such compliance against the value to us and our stockholders of the tax benefits that we would obtain as a result, and may in certain instances pay compensation that is not fully deductible if, in its determination, such costs and burdens outweigh such benefits.

 

Summary Compensation Table

 

The following table sets forth information regarding the compensation of our Chief Executive Officer, our Chief Financial Officer, the person who was, at December 31, 2007, one of our most highly compensated executive officers during 2007, and two of our significant employees who were not serving as executive officers at December 31, 2007, collectively referred to as our named executive officers.

 

16



 

 

 

 

 

 

 

Stock

 

Option

 

All Other

 

 

 

Name and Principal Position

 

Year

 

Salary

 

Awards

 

Awards(1)(2)

 

Compensation

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

S. James Miller, Jr.
Chairman of the Board
and Chief Executive
Officer

 

2007

 

$

314,791

 

$

126,119

(3)

$

52,325

 

$

12,244

(4)

$

505,479

 

 

 

2006

 

299,230

 

167,540

(3)

168,648

(5)

12,015

(6)

647,433

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Wayne G. Wetherell
Senior Vice President Administration, Chief
Financial Officer,
Secretary, and
Treasurer

 

2007

 

186,631

 

67,136

(7)

35,588

 

10,019

(8)

299,374

 

 

 

2006

 

177,022

 

75,702

(7)

91,079

(5)

 

343,803

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

William Willis(9)
Executive Vice
President Sales

 

2007

 

225,000

 

 

58,585

 

 

283,585

 

 

 

2006

 

229,917

 

 

100,780

(5)

 

330,697

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Charles AuBuchon
Vice President Business Development

 

2007

 

155,581

 

 

62,439

 

 

218,020

 

 

 

2006

 

152,600

 

 

117,557

(5)

 

270,157

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

David Harding
Vice President and
Chief Technical Officer

 

2007

 

182,132

 

 

48,251

 

 

230,383

 

 

 

2006

 

138,107

 

 

36,052

(5)

 

174,159

 

 


(1)

 

All option awards were granted under the 1999 Plan.

 

 

 

(2)

 

The amounts reflect the dollar amount recognized for financial statement reporting purposes for the fiscal year ended December 31, 2007, in accordance with the provisions of SFAS 123R and thus may include amounts from awards granted prior to 2007. We have elected to use the Black-Scholes option-pricing model, which incorporates various assumptions including volatility, expected life, and interest rates. We are required to make various assumptions in the application of the Black-Scholes option pricing model and have determined that the best measure of expected volatility is based on the historical weekly volatility of our common stock. Historical volatility factors utilized in our Black-Scholes computations range from 82.1% to 98.5%. We have elected to estimate the expected life of an award based upon the SEC approved “simplified method” noted under the provisions of Staff Accounting Bulletin No. 107. Under this formula, the expected term is equal to: ((weighted-average vesting term + original contractual term)/2). The expected term used by us as computed by this method ranges from 3.5 years to 6.1 years. The interest rate used is the risk free interest rate and is based upon U.S. Treasury rates appropriate for the expected term. Interest rates used in our Black-Scholes calculations range from 2.7% to 4.6%. Dividend yield is zero as we do not expect to declare any dividends on our common shares in the foreseeable future. In addition to the key assumptions used in the Black-Scholes model, the estimated forfeiture rate at the time of valuation is a critical assumption. We have estimated an annualized forfeiture rate of 5.7% for corporate officers, 2.4% for members of the Board of Directors and 25% for all other employees. We review the expected forfeiture rate annually to determine if that percent is still reasonable based on historical experience.

 

 

 

(3)

 

Represents the quarterly vesting of 124,162 restricted shares granted on March 30, 2004, and the vesting of 109,700 restricted shares granted on September 27, 2005 for Mr. Miller. The restricted shares granted in September 2005 vest one-third after one year with the remainder vesting ratably on a quarterly basis over two years ending September 27, 2008.

 

 

 

(4)

 

Consists of $9,000 in 401(K) matching contributions, $1,244 in life insurance premiums and $2,000 in club membership.

 

17



 

(5)

 

The amounts reflect the dollar amount recognized for financial statement reporting purposes for the fiscal year ended December 31, 2006, in accordance with the provisions of SFAS 123R and thus may include amounts from awards granted prior to 2006. Assumptions used in the calculation of these amounts are included in Notes to the Consolidated Financial Statements for the fiscal year ended December 31, 2006, included in our annual report on Form 10-K filed with the SEC on April 17, 2007.

 

 

 

(6)

 

Consists of $8,800 in 401(K) matching contributions, $1,215 in life insurance premiums and $2,000 in club membership.

 

 

 

(7)

 

Represents the quarterly vesting of 80,281 restricted shares granted on March 30, 2004 and the vesting of 52,600 restricted shares granted on September 27, 2005. The restricted shares granted in September 2005 vest one-third after one year with the remainder vesting ratably on a quarterly basis over two years ending September 27, 2008.

 

 

 

(8)

 

Consists of $7,221 in 401(K) matching contributions, $798 in life insurance premiums and $2,000 in club membership.

 

 

 

(9)

 

Mr. Willis resigned from the Company on March 31, 2008.

 

2007 Grants of Plan-Based Awards

 

The following table sets forth certain information with respect to each grant of an award made to a named executive officer in 2007 under our plans.

 

 

 

 

 

All Other

 

 

 

 

 

 

 

 

 

Stock

 

Exercise or

 

 

 

 

 

 

 

Awards:

 

Base

 

Grant Date

 

 

 

 

 

Number of

 

Price of

 

Fair Value

 

 

 

 

 

Securities

 

Option

 

of Stock

 

 

 

Grant

 

Underlying

 

Awards

 

and Option

 

Name

 

Date

 

Options(1)

 

($/Sh)(2)

 

Awards(3)

 

 

 

 

 

 

 

 

 

 

 

 

 

S. James Miller, Jr.

 

4/3/2007

 

18,000

 

$

2.49

 

$

37,296

 

 

 

 

 

 

 

 

 

 

 

Wayne Wetherell

 

4/3/2007

 

15,000

 

$

2.49

 

31,080

 

 

 

 

 

 

 

 

 

 

 

Charles AuBuchon

 

4/3/2007

 

10,000

 

$

2.49

 

20,720

 

 

 

 

 

 

 

 

 

 

 

William Willis(4)

 

4/3/2007

 

20,000

 

$

2.49

 

41,440

 

 

 

 

 

 

 

 

 

 

 

David Harding

 

4/3/2007

 

25,000

 

$

2.49

 

51,800

 

 


(1) The shares subject to each option vest over a three year period, with 33 1/3% of the shares subject to each option vesting on each anniversary at the grant date. The options expire ten years from the date of grant.

(2) The exercise price is the closing price of our common stock on the date of grant.

(3) The fair value of our stock options is computed using the Black-Scholes valuation model.

(4) Mr. Willis resigned from the Company on March 31, 2008.

 

Outstanding Equity Awards at Fiscal Year-End

 

The following table sets forth information regarding unexercised options, stock that has not vested and equity incentive awards held by each of the named executive officers outstanding as of December 31, 2007.

 

18



 

 

 

Option Awards

 

Stock Awards

 

 

 

Number of

 

Number of

 

 

 

 

 

 

 

Market

 

 

 

Securities

 

Securities

 

 

 

 

 

Number of

 

Value of

 

 

 

Underlying

 

Underlying

 

 

 

 

 

Shares or

 

Shares or

 

 

 

Unexercised

 

Unexercised

 

 

 

 

 

Units of

 

Units of

 

 

 

Unearned

 

Unearned

 

Option

 

 

 

Stock That

 

Stock That

 

 

 

Options:

 

Options:

 

Exercise

 

Option

 

Have Not

 

Have Not

 

 

 

#

 

#

 

Price

 

Expiration

 

Vested

 

Vested

 

Name

 

Exercisable

 

Unexercisable

 

($)

 

Date

 

(#)

 

($)

 

S. James Miller, Jr.

 

75,000

 

 

$

3.00

 

9/12/2011

 

27,423

(7)

$

41,957

 

 

 

25,000

 

 

$

1.97

 

5/28/2013

 

 

 

 

 

 

 

100,000

 

 

$

2.40

 

10/28/2014

 

 

 

 

 

 

 

75,001

(1)

24,999

 

$      2.62

 

8/16/2015

 

 

 

 

 

 

 

82,277

(2)

27,423

 

$

2.36

 

9/27/2015

 

 

 

 

 

 

 

0

(3)

18,000

 

$      2.49

 

9/12/2017

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Wayne G. Wetherell

 

25,000

 

 

$

3.00

 

9/12/2011

 

13,149

(7)

$

20,118

 

 

 

10,000

 

 

$

1.97

 

5/28/2013

 

 

 

 

 

 

 

50,000

 

 

$      2.40

 

10/28/2014

 

 

 

 

 

 

 

45,000

(1)

15,000

 

$      2.62

 

8/16/2015

 

 

 

 

 

 

 

39,451

(2)

13,149

 

$

2.36

 

9/27/2015

 

 

 

 

 

 

 

0

(3)

15,000

 

$

2.36

 

9/12/2017

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

William Willis(4)

 

67,500

 

 

$

2.65

 

10/1/2013

 

 

 

 

 

 

 

50,000

 

 

$

2.30

 

10/15/2014

 

 

 

 

 

 

 

45,000

(1)

15,000

 

$      2.62

 

8/16/2015

 

 

 

 

 

 

 

35,000

(4)

25,000

 

$

1.99

 

1/13/2016

 

 

 

 

 

 

 

0

(3)

20,000

 

$

2.36

 

9/12/2017

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Charles AuBuchon

 

10,000

 

 

$

3.00

 

12/31/2013

 

 

 

 

 

 

 

40,000

 

 

$

2.30

 

10/15/2014

 

 

 

 

 

 

 

20,000

(5)

10,000

 

$      3.19

 

4/1/2015

 

 

 

 

 

 

 

45,000

(1)

15,000

 

$      2.62

 

8/16/2015

 

 

 

 

 

 

 

35,000

(4)

25,000

 

$

1.99

 

1/13/2016

 

 

 

 

 

 

 

0

(3)

10,000

 

$

2.36

 

9/12/2017

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

David Harding

 

58,375

(6)

41,625

 

$

1.65

 

1/31/2016

 

 

 

 

 

 

 

0

(3)

25,000

 

$      2.36

 

9/12/2017

 

 

 

 

 

 


(1)

 

These options vest over three years with one third vesting 8/16/2006 and the remainder vesting in equal quarterly installments thereafter.

(2)

 

These options vest over three years with one third vesting 9/27/2006 and the remainder vesting in equal quarterly installments thereafter.

(3)

 

These options vest over three years with one third vesting 4/2/2008 and the remainder vesting in equal quarterly installments thereafter.

(4)

 

Mr. Willis resigned from the Company on March 31, 2008.

(5)

 

These options vest over three years with one third vesting 1/13/2007 and the remainder vesting in equal quarterly installments thereafter.

(6)

 

These options vest over three years with one third vesting on each of 4/1/2006, 4/1/2007 and 4/1/2008.

(7)

 

These options vest over three years with one third vesting 1/31/2007 and the remainder vesting in equal quarterly installments thereafter.

(8)

 

These stock grants vest over three years with one third vesting 9/27/2006 and the remainder vesting in equal quarterly installments thereafter.

 

19



 

Options Exercises and Stock Vested

 

The following table sets forth information regarding exercises of stock options and vesting of stock for each of the named executive officers during 2007.

 

 

 

Stock Awards

 

 

 

Number of

 

 

 

 

 

Shares

 

Value

 

 

 

Acquired on

 

Realized

 

Name

 

Vesting

 

on Vesting

 

 

 

 

 

 

 

S. James Miller, Jr.(1)

 

46,909

 

$

126,119

 

 

 

 

 

 

 

Wayne G. Wetherell(2)

 

24,223

 

67,136

 

 


(1)

 

Represents the quarterly vesting of 124,162 restricted shares granted on March 30, 2004 and the vesting of 109,700 restricted shares granted on September 27, 2005. The restricted shares granted in September 2005 vest one-third after one year with the remainder vesting ratably on a quarterly basis over two years ending September 27, 2008.

 

 

 

(2)

 

Represents the quarterly vesting of 80,281 restricted shares granted on March 30, 2004 and the vesting of 52,600 restricted shares granted on September 27, 2005. The restricted shares granted in September 2005 vest one-third after one year with the remainder vesting ratably on a quarterly basis over two years ending September 27, 2008.

 

Employment Contracts

 

Employment Agreement with S. James Miller, Jr. On October 1, 2005, we entered into an employment agreement with Mr. Miller pursuant to which Mr. Miller will serve as President and Chief Executive Officer. This agreement is for a three-year term ending September 30, 2008. This agreement provides for annual base compensation in the amount of $291,048, which amount will be increased based on cost-of-living increases. Under this agreement, we will reimburse Mr. Miller for reasonable expenses incurred in connection with our business. Under the terms of the agreement, Mr. Miller will be entitled to the following severance benefits if we terminate his employment without cause or in the event of an involuntary termination: (i) a lump sum cash payment equal to twenty-four months’ base salary; (ii) continuation of Mr. Miller’s fringe benefits and medical insurance for a period of three years; and (iii) immediate vesting of 50% of Mr. Miller’s outstanding stock options and restricted stock awards. In the event that Mr. Miller’s employment is terminated within six months prior to or thirteen months following a change of control (defined below), Mr. Miller is entitled to the severance benefits described above, except that 100% of Mr. Miller’s outstanding stock options and restricted stock awards will immediately vest.

 

Employment Agreement with Wayne Wetherell. On October 1, 2005, we entered into an amended employment agreement with Mr. Wetherell pursuant to which Mr. Wetherell will serve as our Chief Financial Officer. This agreement is for a three-year term ending September 30, 2008. This agreement provides for annual base compensation in the amount of $174,100, which amount will be increased based on cost-of-living increases and may also be increased based on performance reviews. Under this agreement, we will reimburse Mr. Wetherell for reasonable expenses incurred in connection with our business. Under the terms of the agreement, Mr. Wetherell will be entitled to the following severance benefits if we terminate his employment without cause or in the event of an involuntary termination: (i) a lump sum cash payment equal to twelve months; (ii) continuation of Mr. Wetherell’s fringe benefits and medical insurance for a period of three years; (iii) immediate vesting of 50% of Mr. Wetherell’s outstanding stock options and restricted stock awards. In the event that Mr. Wetherell’s employment is terminated within six months prior to or thirteen months following a change of control (defined below), Mr. Wetherell is entitled to the severance benefits described above, except that 100% of Mr. Wetherell’s outstanding stock options and restricted stock awards will immediately vest.

 

Change of Control and Severance Benefits Agreement with Charles AuBuchon. On October 31, 2005, we entered into a Change of Control and Severance Benefits Agreement with Mr. Charles AuBuchon, our Vice President of Sales. This agreement has a three-year term, commencing on October 31, 2005. Subject to the conditions and other limitations set forth therein, Mr. AuBuchon will be entitled to the following severance benefits if we terminate his employment without cause prior to the closing of any change of control transaction: (i) a lump sum cash payment equal to six months of base salary; and (ii) continuation of Mr. AuBuchon’s health insurance benefits until the earlier of six (6) months following the date of termination, the date on which he is no longer entitled to continuation coverage pursuant to COBRA or the date that he

 

20



 

obtains comparable health insurance coverage. In the event that Mr. AuBuchon’s employment is terminated within the twelve months following a change of control, he is entitled to the severance benefits described above, plus his stock options will immediately vest and become exercisable. Mr. AuBuchon’s eligibility to receive severance payments or other benefits upon his termination is conditioned upon him executing a general release of liability.

 

Change of Control and Severance Benefits Agreement with David Harding. On May 21, 2007, we entered into a Change of Control and Severance Benefits Agreement with Mr. David Harding, our Vice President and Chief Technical Officer. This agreement has a three-year term, commencing on May 21, 2007. Subject to the conditions and other limitations set forth therein, Mr. Harding will be entitled to the following severance benefits if we terminate his employment without cause prior to the closing of any change of control transaction: (i) a lump sum cash payment equal to six months of base salary; and (ii) continuation of Mr. Harding’s health insurance benefits until the earlier of six (6) months following the date of termination, the date on which he is no longer entitled to continuation coverage pursuant to COBRA or the date that he obtains comparable health insurance coverage. In the event that Mr. Harding’s employment is terminated within the twelve months following a change of control, he is entitled to the severance benefits described above, plus his stock options will immediately vest and become exercisable. Mr. Harding’s eligibility to receive severance payments or other benefits upon his termination is conditioned upon him executing a general release of liability.

 

For purposes of each of the above-referenced agreements, termination for “cause” generally means the executive’s commission of an act of fraud or similar conduct which is intended to result in substantial personal enrichment of the executive, conviction or plea of nolo contendere to a felony, gross negligence or breach of fiduciary duty that results in material injury to us, material breach of the executive’s proprietary information agreement that is materially injurious to us, willful and material failure to perform his duties as an officer or employee of ours or material breach of his employment agreement and the failure to cure such breach in a specified period of time or a violation of a material policy of ours that is materially injurious to us. A “change in control” as used in these agreements generally means the occurrence of any of the following events: (i) the acquisition by any person or group of 50% or more of our outstanding voting stock, (ii) the consummation of a merger, consolidation, reorganization, or similar transaction other than a transaction: (1) in which substantially all of the holders of our voting stock hold or receive directly or indirectly 50% or more of the voting stock of the resulting entity or a parent company thereof, in substantially the same proportions as their ownership of the Company immediately prior to the transaction; or (2) in which the holders of our capital stock immediately before such transaction will, immediately after such transaction, hold as a group on a fully diluted basis the ability to elect at least a majority of the directors of the surviving corporation (or a parent company); (iii)  there is consummated a sale, lease, exclusive license, or other disposition of all or substantially all of the consolidated assets of us and our Subsidiaries, other than a sale, lease, license, or other disposition of all or substantially all of the consolidated assets of us and our Subsidiaries to an entity, 50% or more of the combined voting power of the voting securities of which are owned by our stockholders in substantially the same proportions as their ownership of the Company immediately prior to such sale, lease, license, or other disposition; or (iv)  individuals who, on the date the applicable agreement was adopted by the Board, are Directors (the “Incumbent Board”) cease for any reason to constitute at least a majority of the Directors; provided , however , that if the appointment or election (or nomination for election) of any new Director was approved or recommended by a majority vote of the members of the Incumbent Board then still in office, such new member shall, for purposes of the applicable agreement, be considered as a member of the Incumbent Board.

 

Potential Payments Upon Termination or Change in Control

 

The following tables summarize the potential payments to certain of our named executive officers upon a termination of employment or a change in control. The amounts shown in the tables are only estimates and apply the assumption that employment terminated on December 31, 2007. The calculations of payments related to equity reflect the closing price of our common stock on December 31, 2007 on the AMEX. The amounts set forth below do not include accrued obligations such as salary and other amounts payable with respect to days previously worked, accrued vacation time and other accrued amounts that were fully earned and vested as of December 31, 2007, and would be payable in connection with the executive’s employment.

 

21



 

S. James Miller, Jr. The following table describes the potential payments upon termination or a change in control for Mr. Miller, our Chief Executive Officer.

 

 

 

 

 

Involuntary

 

 

 

Executive Benefits and Payments

 

Voluntary

 

Not for Cause

 

Change in

 

Upon Termination(1)

 

Termination

 

Termination

 

Control

 

 

 

 

 

 

 

 

 

Cash

 

$

 

$

623,976

(2)

$

623,976

(2)

Equity

 

$

 

$

20,979

(3)(4)

$

41,957

(3)(4)

Fringe Benefits

 

$

 

$

66,469

(5)

$

66,469

(5)

 


(1)

 

For purposes of this analysis, we assumed Mr. Miller’s compensation is based on his current base salary of $311,988.

 

 

 

(2)

 

Mr. Miller’s cash severance benefit under an involuntary, good reason termination or a termination due to a change in control is equal to two times annual compensation.

 

 

 

(3)

 

Mr. Miller’s equity severance benefit under an involuntary or good reason termination is the immediate vesting of 50% of Mr. Miller’s outstanding stock options and restricted stock awards. In the event that Mr. Miller’s employment is terminated within six months prior to or thirteen months following a change in control, Mr. Miller is entitled to the immediate vesting of 100% of Mr. Miller’s outstanding stock options and restricted stock awards.

 

 

 

(4)

 

This amount was calculated from the unexercised unexercisable stock options and unvested stock awards held by Mr. Miller on December 31, 2007. The stock option award amount was calculated by multiplying the number of securities underlying the unexercised unexercisable options by the difference between the option price and the price per share of common stock on the date of termination. The unvested stock award amount was calculated by multiplying the number of unvested shares of stock by the price per share on the date of termination.

 

 

 

(5)

 

Mr. Miller’s fringe benefits consist of medical and life insurance for a period of three years.

 

Wayne G. Wetherell. The following table describes the potential payments upon termination or a change in control for Mr. Wetherell, our Sr. Vice President Administration, Chief Financial Officer, Secretary and Treasurer.

 

 

 

 

 

Involuntary

 

 

 

Executive Benefits and Payments

 

Voluntary

 

Not for Cause

 

Change in

 

Upon Termination(1)

 

Termination

 

Termination

 

Control

 

 

 

 

 

 

 

 

 

Cash

 

$

 

$

186,660

(2)

$

186,660

(2)

Equity

 

$

 

10,059

(3)(4)

20,118

(3)(4)

Fringe Benefits

 

$

 

$

70,517

(5)

$

70,517

(5)

 


(1)

 

For purposes of this analysis, we assumed Mr. Wetherell’s compensation is based on his current base salary of $186,660.

 

 

 

(2)

 

Mr. Wetherell’s cash severance benefit under an involuntary, good reason termination or a termination due to a change in control is equal to the amount of his annual compensation.

 

 

 

(3)

 

Mr. Wetherell’s equity severance benefit under an involuntary or good reason termination is the immediate vesting of 50% of Mr. Wetherell’s outstanding stock options and restricted stock awards. In the event that Mr. Wetherell’s employment is terminated within six months prior to or thirteen months following a change in control, Mr. Wetherell is entitled to the immediate vesting of 100% of Mr. Wetherell’s outstanding stock options and restricted stock awards.

 

 

 

(4)

 

This amount was calculated from the unexercised unexercisable stock options and unvested stock awards held by Mr. Wetherell on December 31, 2007. The stock option award amount was calculated by multiplying the number of securities underlying the unexercised unexercisable options by the difference between the option price and the price

 

22



 

 

 

per share of common stock on the date of termination. The unvested stock award amount was calculated by multiplying the number of unvested shares of stock by the price per share on the date of termination.

 

 

 

(5)

 

Mr. Wetherell’s fringe benefits consist of medical and life insurance for a period of three years.

 

Charles AuBuchon. The following table describes the potential payments upon termination or a change in control for Mr. AuBuchon, our Vice President Business Development.

 

 

 

 

 

Involuntary

 

 

 

Executive Benefits and Payments

 

Voluntary

 

Not for Cause

 

Change in

 

Upon Termination(1)

 

Termination

 

Termination

 

Control

 

 

 

 

 

 

 

 

 

Cash

 

$

 

$

77,500

(2)

$

77,500

(2)

Equity

 

$

 

$

 

$

 

Fringe Benefits

 

$

 

$

13,868

(3)

$

13,868

(3)

 


(1)

 

For purposes of this analysis, we assumed Mr. AuBuchon’s compensation is based on his current base salary of $155,000.

 

 

 

(2)

 

Mr. AuBuchon’s cash severance benefit under an involuntary, good reason termination or a termination due to a change in control is equal to six months of annual compensation.

 

 

 

(3)

 

Mr. AuBuchon’s fringe benefits consist of medical and life insurance for a period of six months.

 

David Harding. The following table describes the potential payments upon termination or a change in control for Mr. Harding, our Vice President and Chief Technical Officer.

 

 

 

 

 

Involuntary

 

 

 

Executive Benefits and Payments

 

Voluntary

 

Not for Cause

 

Change in

 

Upon Termination(1)

 

Termination

 

Termination

 

Control

 

 

 

 

 

 

 

 

 

Cash

 

$

 

$

92,500

(2)

$

92,500

(2)

Equity

 

$

 

$

 

$

 

Fringe Benefits

 

$

 

$

6,495

(3)

$

6

(3)

 


(1)

 

For purposes of this analysis, we assumed Mr. Harding’s compensation is based on his current base salary of $185,000.

 

 

 

(2)

 

Mr. Harding’s cash severance benefit under an involuntary, good reason termination or a termination due to a change in control is equal to six months of annual compensation.

 

 

 

(3)

 

Mr. Harding’s fringe benefits consist of medical and life insurance for a period of six months.

 

23



 

DIRECTOR COMPENSATION

 

Each of our non-employee directors receives a monthly retainer of $2,000 for serving on the Board. Board members who also serve on the Audit Committee receive additional monthly compensation of $458.33 for the Chairman and $208.33 for the remaining members of the Audit Committee. The members of the Board of Directors are also eligible for reimbursement for their expenses incurred in attending Board meetings in accordance with our policies. For the fiscal year ended December 31, 2007, the total amounts paid to non-employee directors as compensation (excluding reimbursable expenses) was $153,500.

 

Each of our non-employee directors are also eligible to receive stock option grants under the 1999 Plan. Options granted under the 1999 Plan are intended by us not to qualify as incentive stock options under the Code.

 

The term of options granted under the 1999 Plan is 10 years. In the event of a merger of us with or into another corporation or a consolidation, acquisition of assets or other change-in-control transaction involving us, an equivalent option will be substituted by the successor corporation, provided, however, that we may cancel outstanding options upon consummation of the transaction by giving at least thirty (30) days notice.

 

During the last fiscal year, we granted 30,000 options under the 1999 Plan to our non-employee directors. The fair market value of the common stock underlying such options on the date of grant is based on the closing sales price reported on AMEX for the date of each such grant, as detailed in the following table:

 

Name (1) 

 

Option
Awards
(number of
shares)

 

Exercise Price
Per Share

 

Fair Market Value
on Option Grant
Date (2)

 

 

 

 

 

 

 

 

 

John Callan

 

5,000

 

$

2.49

 

$

2.49

 

 

 

 

 

 

 

 

 

Patrick Downs(3)

 

5,000

 

2.49

 

2.49

 

 

 

 

 

 

 

 

 

John Holleran

 

5,000

 

2.49

 

2.49

 

 

 

 

 

 

 

 

 

David Loesch

 

5,000

 

2.49

 

2.49

 

 

 

 

 

 

 

 

 

Guy Steven Hamm

 

5,000

 

2.49

 

2.49

 

 

 

 

 

 

 

 

 

David Carey

 

5,000

 

2.49

 

2.49

 

 


(1)

 

As of December 31, 2007, no options had been exercised by non-employee directors under any plans maintained by us.

 

 

 

(2)

 

The fair market value of the common stock underlying such options on the date of grant is based on the closing sales price reported on AMEX for the date of each such grant.

 

 

 

(3) 

 

Mr. Downs passed away on March 16, 2008.

 

The following table sets forth the compensation of our directors for the 2007 fiscal year.

 

Name and Principal Position

 

Fees
Earned or
Paid in
Cash

 

Option
Awards(1)(2)(3)

 

Total

 

 

 

 

 

 

 

 

 

John Callan

 

$

24,000

 

$

8,114

 

$

32,114

 

 

 

 

 

 

 

 

 

Patrick Downs

 

24,000

 

9,620

 

33,620

 

 

 

 

 

 

 

 

 

John Holleran

 

26,500

 

8,114

 

34,614

 

 

 

 

 

 

 

 

 

David Loesch

 

26,500

 

9,670

 

36,170

 

 

 

 

 

 

 

 

 

Guy Steven Hamm

 

28,500

 

5,828

 

34,328

 

 

 

 

 

 

 

 

 

David Carey

 

24,000

 

7,589

 

31,589

 

 

24



 


(1)

 

The grant date per share fair value of options issued to Messrs. Callan, Downs, Holleran, Loesch, Hamm and Carey in 2007 was $2.07.

 

 

 

(2)

 

The amounts reflect the dollar amount recognized for financial statement reporting purposes for the fiscal year ended December 31, 2007, in accordance with the provisions of SFAS 123R and thus may include amounts from awards granted prior to 2007. We have elected to use the Black-Scholes option-pricing model, which incorporates various assumptions including volatility, expected life, and interest rates. We are required to make various assumptions in the application of the Black-Scholes option pricing model and have determined that the best measure of expected volatility is based on the historical weekly volatility of our common stock. Historical volatility factors utilized in our Black-Scholes computations range from 82.1% to 98.5%. We have elected to estimate the expected life of an award based upon the SEC approved “simplified method” noted under the provisions of Staff Accounting Bulletin No. 107. Under this formula, the expected term is equal to: ((weighted-average vesting term + original contractual term)/2). The expected term used by us as computed by this method ranges from 3.5 years to 6.1 years. The interest rate used is the risk free interest rate and is based upon U.S. Treasury rates appropriate for the expected term. Interest rates used in our Black-Scholes calculations range from 2.7% to 4.6%. Dividend yield is zero as we do not expect to declare any dividends on our common shares in the foreseeable future. In addition to the key assumptions used in the Black-Scholes model, the estimated forfeiture rate at the time of valuation is a critical assumption. We have estimated an annualized forfeiture rate of 5.7% for corporate officers, 2.4% for members of the Board of Directors and 25% for all other employees. We review the expected forfeiture rate annually to determine if that percent is still reasonable based on historical experience.

 

 

 

(3)

 

The aggregate number of stock option awards outstanding at the end of fiscal 2007 for each director were as follows: John Callan (37,535); Patrick Downs (41,261); John Holleran (35,261); David Loesch (42,000); Guy Steven Hamm (22,000); and David Carey (15,000).

 

SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS

 

The following table sets forth additional information as of December 31, 2007, with respect to the shares of common stock that may be issued upon the exercise of options and other rights under our existing equity compensation plans and arrangements. The information includes the number of shares covered by, and the weighted average exercise price of, outstanding options and other rights and the number of shares remaining available for future grants, excluding the shares to be issued upon exercise of outstanding options and other rights.

 

Equity Compensation Plan Information

 

Plan category

 

Number of securities to be issued
upon exercise of outstanding
options, warrants and rights

 

Weighted-
average exercise price of
outstanding options, warrants and
rights

 

Number of securities remaining
available for future issuance
under equity compensation plans
(excluding securities reflected in
column (a))

 

 

 

(a)

 

(b)

 

(c)

 

Equity
compensation
plans approved by security holders:

 

 

 

 

 

 

 

1994 Employee Stock Option
Plan

 

24,250

 

$

2.15

 

 

1999 Stock Award Plan amended
and restated as of June 7, 2005

 

1,378,495

 

$

2.19

 

1,035,208

 

Equity
compensation
plans not
approved by security holders:

 

 

 

 

 

 

 

2001 Equity Incentive Plan

 

345,654

 

$

2.89

 

 

Total

 

1,748,399

 

$

2.33

 

1,035,208

 

 

25



 

Description of Equity Compensation Plans Not Approved by Security Holders.

 

2001 Equity Incentive Plan.

 

On September 12, 2001, our Board of Directors adopted the 2001 Equity Incentive Plan (the “2001 Plan”). Under the terms of the 2001 Plan, we may issue stock awards to our employees, directors and consultants, and such stock awards may be given for non-statutory stock options (options not intended to qualify as an “incentive stock option” within the meaning of Section 422 of the Code), stock bonuses, and rights to acquire restricted stock. The number of options issued and outstanding and the number of options remaining available for future issuance are shown in the table above.

 

The 2001 Plan is administered by the Board of Directors or a Committee of the Board as provided in the 2001 Plan. Options granted under the 2001 Plan shall not be less than 85% of the market value of our common stock on the date of the grant, and, in some cases, may not be less than 110% of such fair market value. The term of options granted under the 2001 Plan as well as their vesting are determined by the Board and to date, options have been granted with a ten-year term and vesting over a three-year period. While the Board may suspend or terminate the 2001 Plan at any time, if not terminated earlier, it will terminate on the day before its tenth anniversary of the date of adoption. The Board has determined not to issue any future awards under the 2001 Plan.

 

RELATED PARTY TRANSACTIONS

 

Transactions with Related Persons

 

On November 14, 2006, we entered into a Securities Purchase Agreement with certain accredited investors (the “Series C Investors”) pursuant to which we issued an aggregate of 2,300 shares of our Series C 8% Convertible Preferred Stock (the “Series C Preferred Stock”) and issued to the Series C Investors warrants to purchase up to an aggregate of 115,000 shares of the Company’s common stock, for aggregate gross proceeds of $2,300,000 (the “Series C Financing”).

 

On March 9, 2007, we entered into a Securities Purchase Agreement with certain accredited investors (the “Series D Investors”) pursuant to which we issued an aggregate of 1,500 shares of our Series D 8% Convertible Preferred Stock (the “Series D Preferred Stock”) and issued to the Series D Investors warrants to purchase up to an aggregate of 59,207 shares of our common stock, for aggregate gross proceeds of $1,500,000 (the “Series D Financing”).

 

On September 25, 2007, we entered into a Securities Purchase Agreement with certain accredited investors (the “Investors”) pursuant to which we sold to the Investors an aggregate of 2,016,666 shares of our common stock, and issued to the Investors warrants (the “September 2007 Investor Warrants”) to purchase up to an aggregate of 1,008,333 shares of our common stock, for aggregate gross proceeds of approximately $3,000,000 (the “September 2007 Private Placement”).

 

On March 12, 2008, we agreed to reduce the price of the September 2007 Investor Warrants, which initially had an exercise price of $1.67 per share, to an exercise price of $1.00 per share, in consideration for their immediate exercise (the “Warrant Repricing”) by the Investors who participated in the Warrant Repricing (the “Participating Investors”).  In addition, we also issued to the Participating Investors new warrants to purchase up to an aggregate of 270,833 shares of our common stock.  We received aggregate gross proceeds of $541,666 from the Warrant Repricing.

 

Gruber & McBaine Capital Management, LLC and its affiliates, which include Lagunitas Partners, LP and Gruber & McBaine International, beneficially own more than 10% of our issued and outstanding common stock. J. Patterson McBaine, together with Jon D. Gruber, exercises voting and investment control over the shares held by Gruber & McBaine Capital Management, LLC, Lagunitas Partners, LP, and Gruber & McBaine International.

 

Gruber & McBaine International purchased 400 shares of Series C Preferred Stock and warrants to purchase 20,000 shares of common stock in the Series C Financing; 135 shares of Series D Preferred Stock and warrants to purchase 5,328 shares of common stock in the Series D Financing; and 60,000 shares of common stock and warrants to purchase 30,000 shares of common stock in the September 2007 Private Placement.

 

Lagunitas Partners LP purchased 1,200 shares of Series C Preferred Stock and warrants to purchase 60,000 shares of common stock in the Series C Financing; 440 shares of Series D Preferred Stock and warrants to purchase 17,368 shares of

 

26



 

common stock in the Series D Financing; and 240,000 shares of common stock and warrants to purchase 120,000 shares of common stock in the September 2007 Private Placement.

 

J. Patterson McBaine purchased 400 shares of Series C Preferred Stock and warrants to purchase 20,000 shares of common stock in the Series C Financing; 100 shares of Series D Preferred Stock and warrants to purchase 3,947 shares of common stock in the Series D Financing; and 50,000 shares of common stock and warrants to purchase 25,000 shares of common stock in the September 2007 Private Placement.

 

In addition to the employment agreements with Messrs. Miller and Wetherell and the Change of Control and Severance Benefits Agreements with Messrs. AuBuchon and Harding, we have entered into indemnity agreements with certain officers and directors that provide, among other things, that we will indemnify such officer or director, under the circumstances and to the extent provided for therein, for expenses, damages, judgments, fines and settlements he or she may be required to pay in actions or proceedings which he or she is or may be made a party by reason of his or her position as a director, officer or other agent of ours, and otherwise to the fullest extent permitted under Delaware law and our Bylaws.

 

Review, Approval or Ratification of Transactions with Related Persons

 

As provided in the charter of our Audit Committee, it is our policy that we will not enter into any transactions required to be disclosed under Item 404 of the SEC’s Regulation S-K unless the Audit Committee or another independent body of our Board of Directors first reviews and approves the transactions.

 

In addition, pursuant to our Code of Ethical Conduct and Business Practices, all employees, officers and directors of ours and our subsidiaries are prohibited from engaging in any relationship or financial interest that is an actual or potential conflict of interest with us without approval. Employees, officers and directors are required to provide written disclosure to the Chief Executive Officer as soon as they have any knowledge of a transaction or proposed transaction with an outside individual, business or other organization that would create a conflict of interest or the appearance of one.

 

DIRECTOR INDEPENDENCE

 

Our Board of Directors has the responsibility for establishing corporate policies and for our overall performance, although it is not involved in day-to-day operations. As required under the listing standards of AMEX, a majority of the members of a listed company’s board of directors must qualify as “independent,” as affirmatively determined by the Board. Consistent with these considerations, after review of all relevant transactions or relationships between each director, or any of his family members, and ImageWare, our senior management and our independent auditors, our Board of Directors has affirmatively determined that all of our directors are independent directors within the meaning of the applicable AMEX listing standards, except for Mr. Miller, our Chairman of the Board and Chief Executive Officer.

 

COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION

 

The Compensation Committee of our Board of Directors consisted of Messrs. Callan, Downs and Holleran during the fiscal year ended December 31, 2007. No member of the Compensation Committee was at any time during or prior to the fiscal year ended December 31, 2007, an officer or employee of ImageWare. No interlocking relationship existed between Mr. Callan, Mr. Downs or Mr. Holleran and any member of any other company’s board of directors, board of trustees or Compensation Committee during that period.

 

LEGAL PROCEEDINGS

 

We are periodically engaged in litigation in the ordinary course of business and do not believe that any of such litigation is material to our ongoing operations.

 

27



 

MARKET PRICE INFORMATION

 

Market Information.

 

Our common stock trades under the symbol “IW” on AMEX.

 

The following table sets forth the high and low sales prices per share for our common stock as reported by AMEX for each quarter in 2006 and 2007:

 

2006 Fiscal Quarters

 

High

 

Low

 

First Quarter

 

$

2.540

 

$

1.350

 

Second Quarter

 

$

2.560

 

$

1.580

 

Third Quarter

 

$

2.300

 

$

1.110

 

Fourth Quarter

 

$

2.250

 

$

1.200

 

 

2007 Fiscal Quarters

 

High

 

Low

 

First Quarter

 

$

2.810

 

$

1.450

 

Second Quarter

 

$

2.740

 

$

1.450

 

Third Quarter

 

$

2.210

 

$

1.400

 

Fourth Quarter

 

$

2.000

 

$

1.400

 

 

There is no public trading market for our preferred stock.

 

Holders.

 

As of April 9, 2008, the last reported sale price on AMEX for our common stock was $ 1.12 per share. As of March 25, 2008, there were approximately 1,600 holders of record of our common stock.

 

Dividends.

 

We have never declared or paid dividends on our common stock and do not anticipate paying any cash dividends on our shares of common stock in the foreseeable future. We are obligated to pay cumulative cash dividends on shares of Series B Preferred Stock from legally available funds at the annual rate of $0.2125 per share, payable in two semi-annual installments of $0.10625 each, which cumulative dividends must be paid prior to payment of any dividend on our common stock. The holders of our Series C Preferred Stock are entitled to receive cumulative dividends, at the option of the Company, payable (i) in common stock upon conversion of the Series C Preferred Stock, or (ii) in cash after the payment of cash dividends to the holders of our Series B Preferred Stock at the rate of 8% per annum (as a percentage of stated value per share). Our Series D Preferred Stock accrues cumulative dividends at the rate of 8.0% of the stated value per share per annum. At the option of the Company, the dividend payment may be made in the form of cash, after the payment of cash dividends to the holders of Series B and Series C Preferred Stock, or common stock issuable upon conversion of the Series D Preferred Stock. As of December 31, 2007, we had cumulative undeclared dividends on the Series B Preferred Stock of approximately $9,000. As of December 31, 2007, we had cumulative undeclared dividends on the Series C Preferred Stock of approximately $234,000. As of December 31, 2007, we had cumulative undeclared dividends on the Series D Preferred Stock of approximately $98,000.

 

Repurchases.

 

We did not repurchase any shares of our common stock during fiscal 2007.

 

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Foreign Currency Exchange Risk

 

Market risk is the potential loss arising from adverse changes in market rates and prices, such as interest rates and foreign currency exchange rates. Changes in foreign currency exchange rates have an impact on our results of operations. Our exposure to adverse movements in foreign currency exchange rates is primarily related to our subsidiaries operating expense, primarily in Canada and Germany, denominated in the respective local currency. We currently do not enter into forward exchange contracts to hedge exposures denominated in foreign currencies and do not use derivative financial instruments for trading or speculative purposes. The effect of an immediate 10% change in foreign currency exchange rates should not have a

 

28



 

material effect on our future operating results or cash flows; however, a long term change in foreign currency rates would likely result in increased technical support and engineering expenses. The vast majority of our sales are transacted in U.S. dollars.

 

THE SELLING STOCKHOLDERS

 

The shares of common stock covered by this prospectus consist of 17,151,664 shares of our common stock that we issued to the selling stockholders under the terms of certain private placements and debt financings in several private placements and debt financings that took place between May 2002 and September 2007, all as more fully described below.

 

The term “selling stockholders” includes the stockholders listed in the tables below and their transferees, pledgees, donees or other successors. The tables below assume that the selling stockholders will sell all of the shares offered under this prospectus. However, because the selling stockholders may offer from time to time all or some of their shares under this prospectus, or in another permitted manner, no assurances can be given as to the actual number of shares that will be sold by the selling stockholders or that will be held by the selling stockholders after completion of the sales.  Information about the selling stockholders may change over time.

 

The applicable percentages of ownership shown in the tables below are based on an aggregate of 18,332,788 shares of our common stock issued and outstanding on March 31, 2008.

 

2003 Financings

 

In June 2003, we completed a convertible debt financing (the “June 2003 Financing”) with certain lenders pursuant to which we issued the lenders warrants (the “June 2003 Warrants”) to purchase up to an aggregate of 1,600,000 shares of our common stock, par value $0.01 per share (“Common Stock”).  The June 2003 Warrants had an initial exercise price of $2.11 per share.  In connection with the June 2003 Financing, we entered into a registration rights agreement with the lenders pursuant to which we agreed to prepare and file with the SEC a registration statement covering the resale of all of the Common Stock issuable upon exercise of the June 2003 Warrants.

 

In November 2003, we completed a private placement financing pursuant to which we sold to certain accredited investors (the “November 2003 Investors”) an aggregate of 4,069,484 shares (the “November 2003 Shares”) of Common Stock, for aggregate gross proceeds of $6,999,512, and issued to the November 2003 Investors warrants (the “November 2003 Warrants”) to purchase up to an aggregate of 813,897 shares of Common Stock (the “November 2003 Financing” and together with the June 2003 Financing, the “2003 Financings”).  The November 2003 Warrants had an initial exercise price of $2.58 per share.  In connection with the November 2003 Financing, we entered into a registration rights agreement with the November 2003 Investors pursuant to which we agreed to prepare and file with the SEC a registration statement covering the resale of all of the November 2003 Shares and all of the shares of Common Stock issuable upon exercise of the November 2003 Warrants.

 

In connection the November 2003 Financing, we also issued to the placement agents warrants to purchase up to an aggregate of 406,948 shares of Common Stock, in a form substantially similar to the November 2003 Warrants. In connection with the November 2003 Financing, AMEX granted our request for an exception to its shareholder approval requirements. We sent a letter to our shareholders describing these transactions and the circumstances surrounding the exception. A copy of the letter was filed with our Current Report on Form 8-K filed with the SEC on November 17, 2003.

 

The table below presents information regarding the selling stockholders in the 2003 Financings and the shares of Common Stock that they may offer and sell under this prospectus.

 

 

 

NUMBER OF
SHARES
BENEFICIALLY
OWNED BEFORE

 

SHARES OF
COMMON
STOCK BEING

 

SHARES
BENEFICIALLY
OWNED AFTER
OFFERING

 

SELLING STOCKHOLDERS (1)

 

OFFERING

 

OFFERED

 

NUMBER

 

%

 

 

 

 

 

 

 

 

 

 

 

Alfred Abiouness (2)

 

87,600

 

87,600

 

0

 

*

 

Marian L Acree (3)

 

27,600

 

27,600

 

0

 

*

 

 

29



 

 

 

NUMBER OF
SHARES
BENEFICIALLY
OWNED BEFORE

 

SHARES OF
COMMON
STOCK BEING

 

SHARES
BENEFICIALLY
OWNED AFTER
OFFERING

 

SELLING STOCKHOLDERS (1)

 

OFFERING

 

OFFERED

 

NUMBER

 

%

 

Ardmore Blouses, Inc. Retirement Plan, Alan Wolf and Michael Wolf, Trustees (4)

 

17,400

 

17,400

 

0

 

*

 

William C. Bartholomay (5)

 

51,600

 

51,600

 

0

 

*

 

Richard Bergum (6)

 

6,960

 

6,960

 

0

 

*

 

IRA FBO Paul Berman (7)

 

18,000

 

18,000

 

0

 

*

 

Fiserv Securities Inc. A/C/F Hartley Bernstein (8)

 

34,800

 

34,800

 

0

 

*

 

Joseph Bianco SEP IRA (9)

 

18,000

 

18,000

 

0

 

*

 

Edwin R. Bindseil (10)

 

6,960

 

6,960

 

0

 

*

 

Russel F. Bonasso (11)

 

6,960

 

6,960

 

0

 

*

 

Timothy Borne (12)

 

10,440

 

10,440

 

0

 

*

 

Broadway Partners LLC (13)

 

24,000

 

24,000

 

0

 

*

 

Bru Holding Co. LLC (14)

 

207,600

 

207,600

 

0

 

*

 

Warren G. Bulman (15)

 

10,440

 

10,440

 

0

 

*

 

Carcap Co. LLC (16)

 

108,000

 

108,000

 

0

 

*

 

CCJ TR ST Vincent TR SVC Ltd TTEE DTD 1/27/93 (17)

 

62,400

 

62,400

 

0

 

*

 

Chann-Zai LLC (18)

 

6,960

 

6,960

 

0

 

*

 

M. Robert Ching, Trustee of the M. Robert Ching & Phyllis Ching Living Trust U/A/D 6/15/95 (19)

 

69,600

 

69,600

 

0

 

*

 

Marc Cohen (20)

 

10,440

 

10,440

 

0

 

*

 

Corman Foundation, Inc. (21)

 

42,000

 

42,000

 

0

 

*

 

Scott Crowther, Sr. (22)

 

19,200

 

19,200

 

0

 

*

 

George R. Dick & JoAnn L. Dick (23)

 

18,000

 

18,000

 

0

 

*

 

Donald Ekman (24)

 

62,400

 

62,400

 

0

 

*

 

Glen Emig (25)

 

13,200

 

13,200

 

0

 

*

 

Hargreave-Hale Nominees Ltd. (26)

 

34,800

 

34,800

 

0

 

*

 

Jorge Gardyn and Catherine M. Gardyn JT WROS (27)

 

14,400

 

14,400

 

0

 

*

 

Gilcy Partners Inc. (28)

 

17,400

 

17,400

 

0

 

*

 

 

30



 

 

 

NUMBER OF
SHARES
BENEFICIALLY
OWNED BEFORE

 

SHARES OF
COMMON
STOCK BEING

 

SHARES
BENEFICIALLY
OWNED AFTER
OFFERING

 

SELLING STOCKHOLDERS (1)

 

OFFERING

 

OFFERED

 

NUMBER

 

%

 

Bonnie Goldberg & Daniel Goldberg JTTEN WROS (29)

 

6,960

 

6,960

 

0

 

*

 

Stanley Goldberg, Trustee & Lynn G. Intrater, Trustee, Stanley Goldberg Revocable Trust (30)

 

45,360

 

45,360

 

0

 

*

 

Marvin Goldstein and Sheryl Goldstein JTTEN WROS (31)

 

10,440

 

10,440

 

0

 

*

 

NOW Electronics Inc. 401(k) P/S/P FBO Aaron Goodridge (32)

 

17,400

 

17,400

 

0

 

*

 

Sean Greene (33)

 

24,000

 

24,000

 

0

 

*

 

Harvey Greenfield (34)

 

27,600

 

27,600

 

0

 

*

 

John J. Harte, Trustee (35)

 

17,400

 

17,400

 

0

 

*

 

J.E. Deck, LLC (36)

 

17,400

 

17,400

 

0

 

*

 

JR Squared, LLC (37)

 

210,000

 

210,000

 

0

 

*

 

James Jacobs (38)

 

6,960

 

6,960

 

0

 

*

 

Jaor Inc. (39)

 

6,960

 

6,960

 

0

 

*

 

Fiserv Securities Inc A/C/F Joseph S. Kashi CON IRA (40)

 

6,960

 

6,960

 

0

 

*

 

Harvey Kohn SEP IRA (41)

 

62,400

 

62,400

 

0

 

*

 

Steven A. Kohn & Karen J. Kohn, Trustees of the Kohn Family Revocable Trust (42)

 

10,440

 

10,440

 

0

 

*

 

David Krathen and Fran Krathen JT WROS (43)

 

17,400

 

17,400

 

0

 

*

 

Ronald M. Krinick (44)

 

34,800

 

34,800

 

0

 

*

 

Little Bear Investments LLC (45)

 

20,000

 

20,000

 

0

 

*

 

L.W. Marjac LLC (46)

 

24,000

 

24,000

 

0

 

*

 

Joseph N. Lowe and Beva Lowe JT WROS (47)

 

20,400

 

20,400

 

0

 

*

 

William J. Mannion (48)

 

13,800

 

13,800

 

0

 

*

 

Ted Marcucilli and Judy Marcucilli JT WROS (49)

 

18,000

 

18,000

 

0

 

*

 

John C. McNabney & Joyce L. McNabney  JT WROS (50)

 

16,080

 

16,080

 

0

 

*

 

 

31



 

 

 

NUMBER OF
SHARES
BENEFICIALLY
OWNED BEFORE

 

SHARES OF
COMMON
STOCK BEING

 

SHARES
BENEFICIALLY
OWNED AFTER
OFFERING

 

SELLING STOCKHOLDERS (1)

 

OFFERING

 

OFFERED

 

NUMBER

 

%

 

Robert J. Molleur (51)

 

20,400

 

20,400

 

0

 

*

 

Joan Morris (52)

 

10,440

 

10,440

 

0

 

*

 

Gayle Mosenson (53)

 

13,800

 

13,800

 

0

 

*

 

David M. Muffet (54)

 

12,000

 

12,000

 

0

 

*

 

Kay Murcer (55)

 

4,800

 

4,800

 

0

 

*

 

John O’Mahoney (56)

 

24,000

 

24,000

 

0

 

*

 

Dennis Pudvah and Emma Pudvah JTTEN (57)

 

12,000

 

12,000

 

0

 

*

 

Dave Roush (58)

 

36,000

 

36,000

 

0

 

*

 

Alan Rubin (59)

 

69,600

 

69,600

 

0

 

*

 

Richard Santulli (60)

 

27,600

 

27,600

 

0

 

*

 

David Schlotterback, Trustee, David Schlotterback Trust U/A Dtd 4/9/93  (61)

 

10,440

 

10,440

 

0

 

*

 

Fiserv Securities Inc. A/C/F Joel M. Schoenfeld CON IRA (62)

 

18,000

 

18,000

 

0

 

*

 

Shadow Capital LLC (63)

 

17,400

 

17,400

 

0

 

*

 

Ronald Shapiro & Susan Shapiro (64)

 

6,960

 

6,960

 

0

 

*

 

Jerome Silverstein (65)

 

20,400

 

20,400

 

0

 

*

 

Robert Spira (66)

 

17,400

 

17,400

 

0

 

*

 

George Steller, TTEE NOW Electronics Inc 401(k) P/S/P FBO George Steller (67)

 

13,800

 

13,800

 

0

 

*

 

Fiserv Securities Inc. A/C/F Cary W. Sucoff CON IRA (68)

 

18,000

 

18,000

 

0

 

*

 

Jeffrey Sucoff (69)

 

17,400

 

17,400

 

0

 

*

 

Fiserv Securities Inc. C/F John R. Swingle (70)

 

11,160

 

11,160

 

0

 

*

 

Trude Taylor (71)

 

34,800

 

34,800

 

0

 

*

 

Valkyrie Leasing LLC (72)

 

139,200

 

139,200

 

0

 

*

 

Vertical Ventures LLC (73)

 

120,000

 

120,000

 

0

 

*

 

 

32



 

 

 

NUMBER OF
SHARES
BENEFICIALLY
OWNED BEFORE

 

SHARES OF
COMMON
STOCK BEING

 

SHARES
BENEFICIALLY
OWNED AFTER
OFFERING

 

SELLING STOCKHOLDERS (1)

 

OFFERING

 

OFFERED

 

NUMBER

 

%

 

Donald White and Joan White JT WROS (74)

 

24,000

 

24,000

 

0

 

*

 

Bristol Investment Fund, Ltd. (75)

 

174,419

 

174,419

 

0

 

*

 

CD Investment Partners, Ltd. (76)

 

174,419

 

174,419

 

0

 

*

 

Core Fund, L.P. (77)

 

208,096

 

208,096

 

0

 

*

 

Crestview Capital Fund II, L.P. (78)

 

422,257

 

345,565

 

76,692

 

*

 

Gruber & McBaine International (79)

 

224,740

 

224,740

 

0

 

*

 

J. Patterson McBaine (80)

 

116,532

 

116,532

 

0

 

*

 

Jon D. Gruber & Linda W. Gruber  (81)

 

116,532

 

116,532

 

0

 

*

 

Lagunitas Partners LP (82)

 

707,518

 

707,518

 

0

 

*

 

Mark Lamb (83)(84)

 

3,377

 

3,377

 

0

 

*

 

William Corbett (83)(85)

 

21,621

 

21,621

 

0

 

*

 

Gary Shemano (83)(86)

 

89,023

 

89,023

 

0

 

*

 

Reed Freyermuth (83)(87)

 

6,225

 

6,225

 

0

 

*

 

David Baker (83)(88)

 

2,625

 

2,625

 

0

 

*

 

Scott Cacchione (83)(89)

 

3,377

 

3,377

 

0

 

*

 

Michael Jacks (83)(90)

 

177,240

 

177,240

 

0

 

*

 

Ronit Sucoff (91)

 

134,486

 

134,486

 

0

 

*

 

Helen Kohn (92)

 

245,329

 

245,329

 

0

 

*

 

Lisa Sucoff (93)

 

24,500

 

24,500

 

0

 

*

 

Diana Anderson (94)

 

4,500

 

4,500

 

0

 

*

 

Mary Ellen Spedale (95)

 

3,744

 

3,744

 

0

 

*

 

Howard Sterling (96)

 

10,174

 

10,174

 

0

 

*

 

Loius Trust (97)

 

45,785

 

45,785

 

0

 

*

 

 

33



 

 

 

NUMBER OF
SHARES
BENEFICIALLY
OWNED BEFORE

 

SHARES OF
COMMON
STOCK BEING

 

SHARES
BENEFICIALLY
OWNED AFTER
OFFERING

 

SELLING STOCKHOLDERS (1)

 

OFFERING

 

OFFERED

 

NUMBER

 

%

 

Targhee (98)

 

45,785

 

45,785

 

0

 

*

 

Alan Shapiro & Judy Shapiro Trustees t/v/a/ Judy Shapiro d/t/d 5/15/2001 (99)

 

100,000

 

100,000

 

0

 

*

 

Ira Gerald Bassin Trustee g/b/b Ira Bassin Revocable Living Trust u/a/d 07/14/2004 (100)

 

100,000

 

100,000

 

0

 

*

 

Laurus Master Fund (101)

 

578,313

 

578,313

 

0

 

*

 

 


 * Represents beneficial ownership of less than 1%

 

(1)

 

The information related to voting and investment control and, if applicable, the selling stockholder’s status as an affiliate of a registered broker-dealer, is based on information provided to the Company by the selling stockholders as of November 24, 2003.

 

 

 

(2)

 

Comprised of 73,000 shares of common stock held directly and 14,600 shares of common stock issuable upon exercise of warrants.

 

 

 

(3)

 

Comprised of 23,000 shares of common stock held directly and 4,600 shares of common stock issuable upon exercise of warrants.

 

 

 

(4)

 

Comprised of 14,500 shares of common stock held directly and 2,900 shares of common stock issuable upon exercise of warrants.

 

 

 

(5)

 

Comprised of 43,000 shares of common stock held directly and 8,600 shares of common stock issuable upon exercise of warrants.

 

 

 

(6)

 

Comprised of 5,800 shares of common stock held directly and 1,160 shares of common stock issuable upon exercise of warrants.

 

 

 

(7)

 

Comprised of 15,000 shares of common stock held directly and 3,000 shares of common stock issuable upon exercise of warrants.

 

 

 

(8)

 

Comprised of 29,000 shares of common stock held directly and 5,800 shares of common stock issuable upon exercise of warrants.

 

 

 

(9)

 

Comprised of 15,000 shares of common stock held directly and 3,000 shares of common stock issuable upon exercise of warrants.

 

 

 

(10)

 

Comprised of 5,800 shares of common stock held directly and 1,160 shares of common stock issuable upon exercise of warrants.

 

 

 

(11)

 

Comprised of 5,800 shares of common stock held directly and 1,160 shares of common stock issuable upon exercise of warrants.

 

 

 

(12)

 

Comprised of 8,700 shares of common stock held directly and 1,740 shares of common stock issuable upon exercise of warrants.

 

 

 

(13)

 

Comprised of 20,000 shares of common stock held directly and 4,000 shares of common stock issuable upon exercise of warrants. Jeffrey Cohen, Stephanie Cohen Rubin, Allyson Cohen Shapiro, Gabrielle Cohen and Jaclyn Cohen have voting and investment control over these shares.

 

 

 

(14)

 

Comprised of 173,000 shares of common stock held directly and 34,600 shares of common stock issuable upon exercise of warrants. Bruce E. Toll has voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder table for the 2006

 

34



 

 

 

Financings beginning on page 49 of this prospectus.

 

 

 

(15)

 

Comprised of 8,700 shares of common stock held directly and 1,740 shares of common stock issuable upon exercise of warrants.

 

 

 

(16)

 

Comprised of 90,000 shares of common stock held directly and 18,000 shares of common stock issuable upon exercise of warrants. Richard P. Carney and Jean M. Carney have voting and investment control over these shares.

 

 

 

(17)

 

Comprised of 52,000 shares of common stock held directly and 10,400 shares of common stock issuable upon exercise of warrants.

 

 

 

(18)

 

Comprised of 5,800 shares of common stock held directly and 1,160 shares of common stock issuable upon exercise of warrants. Dean M. Willard has voting and investment control over these shares.

 

 

 

(19)

 

Comprised of 58,000 shares of common stock held directly and 11,600 shares of common stock issuable upon exercise of warrants.

 

 

 

(20)

 

Comprised of 8,700 shares of common stock held directly and 1,740 shares of common stock issuable upon exercise of warrants.

 

 

 

(21)

 

Comprised of 35,000 shares of common stock held directly and 7,000 shares of common stock issuable upon exercise of warrants. James F. Corman, Chuck Dettling and Jane D. Corman have voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder tables for the 2006 Financings and September 2007 Financing beginning on page 49 and 55 of this prospectus, respectively.

 

 

 

(22)

 

Comprised of 16,000 shares of common stock held directly and 3,200 shares of common stock issuable upon exercise of warrants.

 

 

 

(23)

 

Comprised of 15,000 shares of common stock held directly and 3,000 shares of common stock issuable upon exercise of warrants.

 

 

 

(24)

 

Comprised of 52,000 shares of common stock held directly and 10,400 shares of common stock issuable upon exercise of warrants.

 

 

 

(25)

 

Comprised of 11,000 shares of common stock held directly and 2,200 shares of common stock issuable upon exercise of warrants.

 

 

 

(26)

 

Comprised of 29,000 shares of common stock held directly and 5,800 shares of common stock issuable upon exercise of warrants. Michael Withers has voting and investment control over these shares.

 

 

 

(27)

 

Comprised of 12,000 shares of common stock held directly and 2,400 shares of common stock issuable upon exercise of warrants.

 

 

 

(28)

 

Comprised of 14,500 shares of common stock held directly and 2,900 shares of common stock issuable upon exercise of warrants. Aaron Cohen has voting and investment control over these shares.

 

 

 

(29)

 

Comprised of 5,800 shares of common stock held directly and 1,160 shares of common stock issuable upon exercise of warrants.

 

 

 

(30)

 

Comprised of 37,800 shares of common stock held directly and 7,560 shares of common stock issuable upon exercise of warrants.

 

 

 

(31)

 

Comprised of 8,700 shares of common stock held directly and 1,740 shares of common stock issuable upon exercise of warrants.

 

 

 

(32)

 

Comprised of 14,500 shares of common stock held directly and 2,900 shares of common stock issuable upon exercise of warrants.

 

 

 

(33)

 

Comprised of 20,000 shares of common stock held directly and 4,000 shares of common stock issuable upon exercise of warrants. The selling stockholder is also the beneficial owner of the securities set forth under his name in the selling stockholder tables for the 2006 Financings and September 2007 Financing beginning on page 49 and 55 of this prospectus, respectively.

 

 

 

(34)

 

Comprised of 23,000 shares of common stock held directly and 4,600 shares of common stock issuable upon exercise of warrants.

 

35



 

(35)

 

Comprised of 14,500 shares of common stock held directly and 2,900 shares of common stock issuable upon exercise of warrants.

 

 

 

(36)

 

Comprised of 14,500 shares of common stock held directly and 2,900 shares of common stock issuable upon exercise of warrants. Philip Collins has voting and investment control over these shares.

 

 

 

(37)

 

Comprised of 175,000 shares of common stock held directly and 35,000 shares of common stock issuable upon exercise of warrants. Jeffrey Markowitz and Richard Friedman have voting and investment control over these shares.

 

 

 

(38)

 

Comprised of 5,800 shares of common stock held directly and 1,160 shares of common stock issuable upon exercise of warrants.

 

 

 

(39)

 

Comprised of 5,800 shares of common stock held directly and 1,160 shares of common stock issuable upon exercise of warrants. Jim Jacobs and David Orlinsky have voting and investment control over these shares.

 

 

 

(40)

 

Comprised of 5,800 shares of common stock held directly and 1,160 shares of common stock issuable upon exercise of warrants.

 

 

 

(41)

 

Comprised of 52,000 shares of common stock held directly and 10,400 shares of common stock issuable upon exercise of warrants.

 

 

 

(42)

 

Comprised of 8,700 shares of common stock held directly and 1,740 shares of common stock issuable upon exercise of warrants.

 

 

 

(43)

 

Comprised of 14,500 shares of common stock held directly and 2,900 shares of common stock issuable upon exercise of warrants.

 

 

 

(44)

 

Comprised of 29,000 shares of common stock held directly and 5,800 shares of common stock issuable upon exercise of warrants.

 

 

 

(45)

 

Comprised of 20,000 shares of common stock issuable upon exercise of warrants. Based on information provided to the Company on March 18, 2008. Zachary Prensky and Jeffrey Mann have voting and investment control over these shares. In connection with the November 2003 Financing, the selling stockholder purchased 100,000 shares of common stock and such shares were resold, prior to the date of this prospectus, pursuant to that certain Form SB-2 Registration Statement (Reg. No. 333-111842) filed with the SEC on January 12, 2004, as amended. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder tables for the July 2005 Financing, 2006 Financings, and September 2007 Financing beginning on page 44, 49, and 55 of this prospectus, respectively.

 

 

 

(46)

 

Comprised of 20,000 shares of common stock held directly and 4,000 shares of common stock issuable upon exercise of warrants. Alan Zunamon has voting and investment control over these shares.

 

 

 

(47)

 

Comprised of 17,000 shares of common stock held directly and 3,400 shares of common stock issuable upon exercise of warrants.

 

 

 

(48)

 

Comprised of 11,500 shares of common stock held directly and 2,300 shares of common stock issuable upon exercise of warrants.

 

 

 

(49)

 

Comprised of 15,000 shares of common stock held directly and 3,000 shares of common stock issuable upon exercise of warrants.

 

 

 

(50)

 

Comprised of 13,400 shares of common stock held directly and 2,680 shares of common stock issuable upon exercise of warrants.

 

 

 

(51)

 

Comprised of 17,000 shares of common stock held directly and 3,400 shares of common stock issuable upon exercise of warrants.

 

 

 

(52)

 

Comprised of 8,700 shares of common stock held directly and 1,740 shares of common stock issuable upon exercise of warrants.

 

 

 

(53)

 

Comprised of 11,500 shares of common stock held directly and 2,300 shares of common stock issuable upon exercise of warrants.

 

 

 

(54)

 

Comprised of 10,000 shares of common stock held directly and 2,000 shares of common stock issuable upon exercise of warrants.

 

36



 

(55)

 

Comprised of 4,000 shares of common stock held directly and 800 shares of common stock issuable upon exercise of warrants.

 

 

 

(56)

 

Comprised of 20,000 shares of common stock held directly and 4,000 shares of common stock issuable upon exercise of warrants.

 

 

 

(57)

 

Comprised of 10,000 shares of common stock held directly and 2,000 shares of common stock issuable upon exercise of warrants.

 

 

 

(58)

 

Comprised of 30,000 shares of common stock held directly and 6,000 shares of common stock issuable upon exercise of warrants.

 

 

 

(59)

 

Comprised of 58,000 shares of common stock held directly and 11,600 shares of common stock issuable upon exercise of warrants.

 

 

 

(60)

 

Comprised of 23,000 shares of common stock held directly and 4,600 shares of common stock issuable upon exercise of warrants.

 

 

 

(61)

 

Comprised of 8,700 shares of common stock held directly and 1,740 shares of common stock issuable upon exercise of warrants.

 

 

 

(62)

 

Comprised of 15,000 shares of common stock held directly and 3,000 shares of common stock issuable upon exercise of warrants.

 

 

 

(63)

 

Comprised of 14,500 shares of common stock held directly and 2,900 shares of common stock issuable upon exercise of warrants. B. Kent Garlinghouse has voting and investment control over these shares.

 

 

 

(64)

 

Comprised of 5,800 shares of common stock held directly and 1,160 shares of common stock issuable upon exercise of warrants.

 

 

 

(65)

 

Comprised of 17,000 shares of common stock held directly and 3,400 shares of common stock issuable upon exercise of warrants.

 

 

 

(66)

 

Comprised of 14,500 shares of common stock held directly and 2,900 shares of common stock issuable upon exercise of warrants.

 

 

 

(67)

 

Comprised of 11,500 shares of common stock held directly and 2,300 shares of common stock issuable upon exercise of warrants.

 

 

 

(68)

 

Comprised of 15,000 shares of common stock held directly and 3,000 shares of common stock issuable upon exercise of warrants. Fiserv Securities Inc. A/C/F Cary W. Sucoff CON IRA is or may be an affiliate of a registered broker-dealer. We have been informed by Fiserv Securities Inc. A/C/F Cary W. Sucoff CON IRA that it acquired the securities offered by this prospectus for its own account in the ordinary course of business, and that, at the time it acquired such securities, it had no agreement or understanding, direct or indirect, with any person to distribute such securities.

 

 

 

(69)

 

Comprised of 14,500 shares of common stock held directly and 2,900 shares of common stock issuable upon exercise of warrants.

 

 

 

(70)

 

Comprised of 9,300 shares of common stock held directly and 1,860 shares of common stock issuable upon exercise of warrants.

 

 

 

(71)

 

Comprised of 29,000 shares of common stock held directly and 5,800 shares of common stock issuable upon exercise of warrants.

 

 

 

(72)

 

Comprised of 116,000 shares of common stock held directly and 23,200 shares of common stock issuable upon exercise of warrants. Charles Simonyi has voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder tables for the 2006 Financings and September 2007 Financing beginning on page 49 and 55 of this prospectus, respectively.

 

 

 

(73)

 

Comprised of 100,000 shares of common stock held directly and 20,000 shares of common stock issuable upon exercise of warrants. Joshua Silverman has voting and investment control over these shares.

 

 

 

(74)

 

Comprised of 20,000 shares of common stock held directly and 4,000 shares of common stock issuable upon exercise of warrants.

 

37



 

(75)

 

Comprised of 145,349 shares of common stock held directly and 29,070 shares of common stock issuable upon exercise of warrants. Paul Kessler has voting and investment control of the securities held by Bristol Investment Fund, Ltd.

 

 

 

(76)

 

Comprised of 145,349 shares of common stock held directly and 29,070 shares of common stock issuable upon exercise of warrants. CD Capital Management LLC, as the investment manager of CD Investment Partners, Ltd., and John D. Ziegelman, president of CD Capital Management LLC, each may be deemed to have beneficial ownership of the registered shares.

 

 

 

(77)

 

Comprised of 145,349 shares of common stock held directly and 62,747 shares of common stock issuable upon exercise of warrants. Core Fund, L.P. is or may be an affiliate of a registered broker-dealer. We have been informed by Core Fund, L.P. that it acquired the securities offered by this prospectus for its own account in the ordinary course of business, and that, at the time it acquired such securities, it had no agreement or understanding, direct or indirect, with any person to distribute such securities. David Baker has voting and investment control over these shares.

 

 

 

(78)

 

Comprised of 422,257 shares of common stock issuable upon exercise of warrants. Stewart Flink, Robert Hoyt & Daniel Warsh have voting and investment control over these shares. Based on information provided to the Company by the selling stockholder on March 19, 2008. In connection with the November 2003 Financing, the selling stockholder purchased 784,884 shares of common stock and such shares were resold, prior to the date of this prospectus, pursuant to that certain Form SB-2 Registration Statement (Reg. No. 333-111842) filed with the SEC on January 12, 2004, as amended.

 

 

 

(79)

 

Comprised of 156,977 shares of common stock held directly and 67,763 shares of common stock issuable upon exercise of warrants. Gruber & McBaine Capital Management is the financial advisor for Gruber & McBaine International and has full voting and dispositive power over investments. Jon D. Gruber and J. Patterson McBaine are managers of Gruber & McBaine Capital Management and oversee investment activity. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder tables for the July 2005 Financing, 2006 Financings, March 2007 Financing, and September 2007 Financing beginning on page 44, 49, 53, and 55 of this prospectus, respectively.

 

 

 

(80)

 

Comprised of 81,395 shares of common stock held directly and 35,137 shares of common stock issuable upon exercise of warrants. The selling stockholder is also the beneficial owner of the securities set forth under his name in the selling stockholder tables for the July 2005 Financing, 2006 Financings, March 2007 Financing, and September 2007 Financing beginning on page 44, 49, 53, and 55 of this prospectus, respectively.

 

 

 

(81)

 

Comprised of 81,395 shares of common stock held directly and 35,137 shares of common stock issuable upon exercise of warrants.

 

 

 

(82)

 

Comprised of 494,186 shares of common stock held directly and 213,332 shares of common stock issuable upon exercise of warrants. Gruber & McBaine Capital Management is the financial advisor for Lagunitas Partners LP and has full voting and dispositive power over investments. Jon D. Gruber and J. Patterson McBaine are managers of Gruber & McBaine Capital Management and oversee investment activity. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder tables for the July 2005 Financing, 2006 Financings, March 2007 Financing, and September 2007 Financing beginning on page 44, 49, 53, and 55 of this prospectus, respectively.

 

 

 

(83)

 

The selling security holder is or may be an affiliate of a registered broker-dealer. We have been informed by each selling security holder that such selling security holder acquired the securities offered by this prospectus for its own account in the ordinary course of business, and that, at the time it acquired the securities, it had no agreement or understanding, direct or indirect, with any person to distribute such securities.

 

 

 

(84)

 

Comprised of 3,377 shares of common stock issuable upon exercise of warrants. The selling stockholder is also the beneficial owner of the securities set forth under his name in the selling stockholder table for the January 2004 Financing beginning on page 39 of this prospectus.

 

 

 

(85)

 

Comprised of 21,621 shares of common stock issuable upon exercise of warrants. The selling stockholder is also the beneficial owner of the securities set forth under his name in the selling stockholder tables for the January 2004 Financing, July 2005 Financing, 2006 Financings, and September 2007 Financing beginning on page 39, 44, 49, and 55 of this prospectus, respectively.

 

 

 

(86)

 

Comprised of 89,023 shares of common stock issuable upon exercise of warrants. The selling stockholder is also the beneficial owner of the securities set forth under his name in the selling stockholder tables for the January 2004

 

38



 

 

 

Financing and July 2005 Financing beginning on page 39 and 44 of this prospectus, respectively.

 

 

 

(87)

 

Comprised of 6,225 shares of common stock issuable upon exercise of warrants. The selling stockholder is also the beneficial owner of the securities set forth under his name in the selling stockholder table for the January 2004 Financing beginning on page 39 of this prospectus.

 

 

 

(88)

 

Comprised of 2,625 shares of common stock issuable upon exercise of warrants. The selling stockholder is also the beneficial owner of the securities set forth under his name in the selling stockholder table for the January 2004 Financing beginning on page 39 of this prospectus.

 

 

 

(89)

 

Comprised of 3,377 shares of common stock issuable upon exercise of warrants. The selling stockholder is also the beneficial owner of the securities set forth under his name in the selling stockholder table for the January 2004 Financing beginning on page 39 of this prospectus.

 

 

 

(90)

 

Comprised of 177,240 shares of common stock issuable upon exercise of warrants. The selling stockholder is also the beneficial owner of the securities set forth under his name in the selling stockholder tables for the January 2004 Financing, July 2005 Financing, 2006 Financings, and September 2007 Financing beginning on page 39, 44, 49, and 55 of this prospectus, respectively.

 

 

 

(91)

 

Comprised of 134,486 shares of common stock issuable upon exercise of warrants. The selling stockholder is also the beneficial owner of the securities set forth under her name in the selling stockholder table for the July 2005 Financing beginning on page 44 of this prospectus.

 

 

 

(92)

 

Comprised of 245,329 shares of common stock issuable upon exercise of warrants. The selling stockholder is also the beneficial owner of the securities set forth under her name in the selling stockholder table for the July 2005 Financing beginning on page 44 of this prospectus.

 

 

 

(93)

 

Comprised of 24,500 shares of common stock issuable upon exercise of warrants.

 

 

 

(94)

 

Comprised of 4,500 shares of common stock issuable upon exercise of warrants.

 

 

 

(95)

 

Comprised of 3,744 shares of common stock issuable upon exercise of warrants.

 

 

 

(96)

 

Comprised of 10,174 shares of common stock issuable upon exercise of warrants.

 

 

 

(97)

 

Comprised of 45,785 shares of common stock issuable upon exercise of warrants.

 

 

 

(98)

 

Comprised of 45,785 shares of common stock issuable upon exercise of warrants. Kim Sands, trustee, has voting and investment control over these shares.

 

 

 

(99)

 

Comprised of 100,000 shares of common stock issuable upon exercise of warrants.

 

 

 

(100)

 

Comprised of 100,000 shares of common stock issuable upon exercise of warrants.

 

 

 

(101)

 

Comprised of 578,313 shares of common stock issuable upon exercise of warrants. David Grin has voting and investment control over these shares.

 

January 2004 Financing

 

In January 2004, we completed a private placement financing pursuant to which we sold to certain accredited investors an aggregate of 1,818,332 shares (the “January 2004 Shares”) of Common Stock, for aggregate gross proceeds of $6,635,936, and issued such investors warrants (the “January 2004 Warrants”) to purchase up to an aggregate of 363,660 shares of Common Stock (the “January 2004 Financing”).  The January 2004 Warrants have a five-year term and had an initial exercise price of $5.48 per share.  In connection with the January 2004 Financing, we entered into a registration rights agreement with the investors, pursuant to which we agreed to prepare and file with the SEC a registration statement covering the resale of all of the January 2004 Shares and all of the shares of Common Stock issuable upon exercise of the January 2004 Warrants.

 

In connection with the January 2004 Financing, we also issued to the placement agents warrants to purchase up to an aggregate of 99,108 shares of Common Stock, in a form substantially identical to the January 2004 Warrants.

 

39



 

The following table presents information regarding the selling stockholders in the January 2004 Financing and the shares of Common Stock that they may offer and sell under this prospectus.

 

 

 

NUMBER OF 

 

 

 

SHARES 

 

 

 

SHARES 

 

SHARES OF 

 

BENEFICIALLY 

 

 

 

BENEFICIALLY 

 

COMMON 

 

OWNED AFTER 

 

 

 

OWNED BEFORE 

 

STOCK BEING 

 

OFFERING

 

SELLING STOCKHOLDERS(1)

 

OFFERING

 

OFFERED

 

NUMBER

 

%

 

 

 

 

 

 

 

 

 

 

 

Adams Market Neutral Fund, LP (2)(3)

 

52,603

 

52,603

 

0

 

*

 

Adams Select Fund, LP (2)(4)

 

26,400

 

26,400

 

0

 

*

 

Adams Technology Fund, LLLP (2)(5)

 

13,200

 

13,200

 

0

 

*

 

Alexandra Global Master Fund Ltd. (2)(6)

 

330,000

 

330,000

 

0

 

*

 

Chilmark Partners LP (2)(7)

 

82,191

 

82,191

 

0

 

*

 

Choice Long-Short Fund (2)(8)

 

49,320

 

49,320

 

0

 

*

 

Choice Market Neutral Fund (2)(9)

 

36,164

 

36,164

 

0

 

*

 

Conestoga Partners, LP (2)(10)

 

13,200

 

13,200

 

0

 

*

 

Cranshire Capital, L.P. (2)(11)

 

82,191

 

82,191

 

0

 

*

 

Edward & Edna Elbaor Family LP #2 (2)(12)

 

13,200

 

13,200

 

0

 

*

 

Elliot Associates, L.P. (13)

 

65,752

 

65,752

 

0

 

*

 

Elliot International, L.P. (14)

 

98,630

 

98,630

 

0

 

*

 

Enable Growth Partners (2)(15)

 

32,876

 

32,876

 

0

 

*

 

Glenbrook Capital L.P. (16)

 

32,876

 

32,876

 

0

 

*

 

MicroCapital Fund LP (17)

 

115,068

 

115,068

 

0

 

*

 

MicroCapital Fund Ltd. (18)

 

49,314

 

49,314

 

0

 

*

 

Omicron Master Trust (19)

 

155,705

 

155,705

 

0

 

*

 

Palisades Master Fund, LP (20)

 

230,136

 

230,136

 

0

 

*

 

Porter Partners, L.P. (21)

 

60,000

 

60,000

 

0

 

*

 

Portside Growth and Opportunity Fund (2)(22)

 

32,876

 

32,876

 

0

 

*

 

Potrero Capital Research (23)

 

32,876

 

32,876

 

0

 

*

 

 

40



 

 

 

NUMBER OF 

 

 

 

SHARES 

 

 

 

SHARES 

 

SHARES OF 

 

BENEFICIALLY 

 

 

 

BENEFICIALLY 

 

COMMON 

 

OWNED AFTER 

 

 

 

OWNED BEFORE 

 

STOCK BEING 

 

OFFERING

 

SELLING STOCKHOLDERS(1)

 

OFFERING

 

OFFERED

 

NUMBER

 

%

 

SF Capital Partners Ltd. (2)(24)

 

328,756

 

328,756

 

0

 

*

 

Spectrum Galaxy Fund Re: CM Market Neutral Fund (2)(25)

 

42,720

 

42,720

 

0

 

*

 

TCMP3 Partners (26)

 

32,880

 

32,880

 

0

 

*

 

Vulcan Properties (27)

 

49,314

 

49,314

 

0

 

*

 

AS Capital Partners, LLC (28)

 

32,876

 

32,876

 

0

 

*

 

PAS Stock Purchase Account (29)

 

32,876

 

32,876

 

0

 

*

 

Lyons Community Property Trust (30)

 

49,314

 

49,314

 

0

 

*

 

Gary Shemano (31)

 

86,644

 

86,644

 

0

 

*

 

Michael Jacks (32)

 

75,239

 

75,239

 

0

 

*

 

William Corbett (33)

 

21,621

 

21,621

 

0

 

*

 

Reed Freyermuth (34)

 

6,225

 

6,225

 

0

 

*

 

David Baker (35)

 

2,625

 

2,625

 

0

 

*

 

Mark Lamb (36)

 

3,377

 

3,377

 

0

 

*

 

Scott Cacchione (37)

 

3,377

 

3,377

 

0

 

*

 

Rockmore Investment Master Fund (38)

 

8,678

 

8,678

 

0

 

*

 

 


 * Represents beneficial ownership of less than 1%

 

(1)

 

The information related to voting and investment control and, if applicable, the selling stockholder’s status as an affiliate of a registered broker-dealer, is based on information provided to the Company by the selling stockholders as of February 9, 2004.

 

 

 

(2)

 

The selling stockholder is or may be an affiliate of a registered broker-dealer. We have been informed by the selling stockholder that such selling stockholder acquired the securities offered by this prospectus for its own account in the ordinary course of business, and that, at the time it acquired the securities, it had no agreement or understanding, direct or indirect, with any person to distribute such securities.

 

 

 

(3)

 

Comprised of 43,836 shares of common stock and 8,767 shares of common stock issuable upon exercise of warrants. Patrick Adams, CFA, managing member and portfolio manager, has voting and investment control over these shares.

 

 

 

(4)

 

Comprised of 22,000 shares of common stock and 4,400 shares of common stock issuable upon exercise of warrants. Patrick Adams, CFA, managing member and portfolio manager, has voting and investment control over these shares.

 

41



 

(5)

 

Comprised of 11,000 shares of common stock and 2,200 shares of common stock issuable upon exercise of warrants. Patrick Adams, CFA, managing member and portfolio manager, has voting and investment control over these shares.

 

 

 

(6)

 

Comprised of 275,000 shares of common stock and 55,000 shares of common stock issuable upon exercise of warrants. Alexandra Investment Management, LLC, a Delaware limited liability company (“Alexandra”), serves as investment adviser to Alexandra Global Master Fund Ltd., a British Virgin Islands company (“Master Fund”). By reason of such relationship, Alexandra may be deemed to share dispositive power over the shares of common stock stated as beneficially owned by Master Fund. Alexandra disclaims beneficial ownership of such shares of common stock. Messrs. Mikhail A. Filimonov (“Filimonov”) and Dimitri Sogoloff (“Sogoloff”) are managing members of Alexandra. By reason of such relationships, Filimonov and Sogoloff may be deemed to share dispositive power over the shares of common stock stated as beneficially owned by Master Fund. Filimonov and Sogoloff disclaim beneficial ownership of such shares of common stock.

 

 

 

(7)

 

Comprised of 68,493 shares of common stock and 13,698 shares of common stock issuable upon exercise of warrants. Mitchell Peters and David Fried have voting and investment control over these shares.

 

 

 

(8)

 

Comprised of 41,100 shares of common stock and 8,220 shares of common stock issuable upon exercise of warrants. Patrick Adams, CFA, managing member and portfolio manager, has voting and investment control over these shares.

 

 

 

(9)

 

Comprised of 30,137 shares of common stock and 6,027 shares of common stock issuable upon exercise of warrants. Patrick Adams, CFA, managing member and portfolio manager, has voting and investment control over these shares.

 

 

 

(10)

 

Comprised of 11,000 shares of common stock and 2,200 shares of common stock issuable upon exercise of warrants. Patrick Adams, CFA, managing member and portfolio manager, has voting and investment control over these shares.

 

 

 

(11)

 

Comprised of 68,493 shares of common stock and 13,698 shares of common stock issuable upon exercise of warrants. Mitchell Kopin, president of Downsview Capital, Inc., the general partner of Cranshire Capital, L.P., has sole voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder tables for the 2006 Financings and September 2007 Financing beginning on page 49 and 55 of this prospectus, respectively.

 

 

 

(12)

 

Comprised of 11,000 shares of common stock and 2,200 shares of common stock issuable upon exercise of warrants.

 

 

 

(13)

 

Comprised of 54,794 shares of common stock and 10,958 shares of common stock issuable upon exercise of warrants. Paul Singer has voting and investment control over these shares.

 

 

 

(14)

 

Comprised of 82,192 shares of common stock and 16,438 shares of common stock issuable upon exercise of warrants. Paul Singer has voting and investment control over these shares.

 

 

 

(15)

 

Comprised of 27,397 shares of common stock and 5,479 shares of common stock issuable upon exercise of warrants. Mitch Levine has voting and investment control over these shares.

 

 

 

(16)

 

Comprised of 27,397 shares of common stock and 5,479 shares of common stock issuable upon exercise of warrants. Robert Lishman has voting and investment control over these shares.

 

 

 

(17)

 

Comprised of 95,890 shares of common stock and 19,178 shares of common stock issuable upon exercise of warrants. Ian P. Ellis has voting and investment control over these shares.

 

 

 

(18)

 

Comprised of 41,095 shares of common stock and 8,219 shares of common stock issuable upon exercise of warrants. Ian P. Ellis has voting and investment control over these shares.

 

 

 

(19)

 

Comprised of 136,986 shares of common stock and 18,719 shares of common stock issuable upon exercise of warrants. Based on certain records of the Company. Omicron Capital, L.P., a Delaware limited partnership (“Omicron Capital”), serves as investment manager to Omicron Master Trust, a trust formed under the laws of Bermuda (“Omicron”), Omicron Capital, Inc., a Delaware corporation (“OCI”), serves as general partner of Omicron Capital and Winchester Global Trust Company Limited (“Winchester”) serves as the trustee of Omicron. By reason of such relationships, Omicron Capital and OCI may be deemed to share dispositive power over the shares of our common stock owned by Omicron, and Winchester may be deemed to share voting and dispositive power over the shares of our common stock owned by Omicron. Omicron Capital, OCI and Winchester disclaim beneficial ownership of such shares of our common stock. Omicron Capital has delegated authority from the board of directors of Winchester regarding the portfolio management decisions with respect to the shares of common stock owned by Omicron and, as of April 21, 2003, Mr. Oliver H. Morali and Mr. Bruce T. Bernstein, officers of OCI, have delegated authority from the board of directors of OCI regarding the portfolio management decisions of Omicron Capital with respect to the shares of common stock owned by Omicron. By reason of such delegated authority, Messrs. Morali and Bernstein may be deemed to share dispositive power over the shares of our common stock owned by Omicron.

 

42



 

 

 

Messrs. Morali and Bernstein disclaim beneficial ownership of such shares of our common stock and neither of such persons has any legal right to maintain such delegated authority. No other person has sole or shares voting or dispositive power with respect to the shares of our common stock being offered by Omicron, as those terms are used for purposes under Regulation 13D-G of the Securities Exchange Act of 1934, as amended. Omicron and Winchester are not “affiliates” of one another, as that term is used for purposes of the Securities Exchange Act of 1934, as amended, or of any other person named in this prospectus as a selling stockholder. No person or “group” (as that term is used in Section 13(d) of the Securities Exchange Act of 1934, as amended, or the SEC’s Regulation 13D-G controls Omicron and Winchester. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder table for the July 2005 Financing beginning on page 44 of this prospectus.

 

 

 

(20)

 

Comprised of 191,780 shares of common stock and 38,356 shares of common stock issuable upon exercise of warrants. Murray Todd and Leslie Elliott, signing on behalf of Discovery Management Ltd., have voting and investment control over these shares.

 

 

 

(21)

 

Comprised of 50,000 shares of common stock and 10,000 shares of common stock issuable upon exercise of warrants. Jeffrey H. Porter has voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder table for the September 2007 Financing beginning on page 55 of this prospectus.

 

 

 

(22)

 

Comprised of 27,397 shares of common stock and 5,479 shares of common stock issuable upon exercise of warrants. The investment advisor to Portside Growth and Opportunity Fund is Ramius Capital Group, LLC. The managing member of Ramius Capital Group, LLC is CAS & Co., the managing members of which are Peter Cohen, Morgan Stark, Thomas Strauss and Jeffrey Solomon. As such, Messrs. Cohen, Stark, Strauss and Solomon may be deemed beneficial owners of the shares. Messrs. Cohen, Stark, Strauss and Solomon therefore disclaim beneficial ownership of such shares.

 

 

 

(23)

 

Comprised of 27,397 shares of common stock and 5,479 shares of common stock issuable upon exercise of warrants. Jack R. Ripsteen has voting and investment control over these shares.

 

 

 

(24)

 

Comprised of 273,964 shares of common stock and 54,792 shares of common stock issuable upon exercise of warrants. Michael A. Roth and Brian J. Stark are the founding members and direct the management of Staro Asset Management, L.L.C., a Wisconsin limited liability company (“Staro”), which acts as investment manager and has sole power to direct the management of SF Capital Partners Ltd. Through Staro, Messrs. Roth and Stark possess sole voting and dispositive power over all the shares owned by SF Capital Partners Ltd.

 

 

 

(25)

 

Comprised of 35,600 shares of common stock and 7,120 shares of common stock issuable upon exercise of warrants. Patrick Adams, CFA, managing member and portfolio manager, has voting and investment control over these shares.

 

 

 

(26)

 

Comprised of 27,400 shares of common stock and 5,480 shares of common stock issuable upon exercise of warrants. Steven Slawson and Walter Schenker have voting and investment control over these shares.

 

 

 

(27)

 

Comprised of 41,095 shares of common stock and 8,219 shares of common stock issuable upon exercise of warrants. Karen B. Cohen has voting and investment control over these shares.

 

 

 

(28)

 

Comprised of 27,397 shares of common stock and 5,479 shares of common stock issuable upon exercise of warrants. Michael Coughlin has voting and investment control over these shares.

 

 

 

(29)

 

Comprised of 27,397 shares of common stock and 5,479 shares of common stock issuable upon exercise of warrants. Lonnie M. Garber, president of Personal Asset Strategies, Inc., has voting and investment control over these shares.

 

 

 

(30)

 

Comprised of 41,095 shares of common stock and 8,219 shares of common stock issuable upon exercise of warrants. Phillip N. Lyons, Trustee, has voting and investment control over these shares.

 

 

 

(31)

 

Comprised of 75,239 shares of common stock issuable upon exercise of warrants. The selling stockholder is also the beneficial owner of the securities set forth under his name in the selling stockholder tables for the 2003 Financings and July 2005 Financing beginning on page 29 and 44 of this prospectus, respectively.

 

 

 

(32)

 

Comprised of 72,239 shares of common stock issuable upon exercise of warrants. The selling stockholder is also the beneficial owner of the securities set forth under his name in the selling stockholder tables for the 2003 Financings, July 2005 Financing, 2006 Financings, and September 2007 Financing beginning on page 29, 44, 49, and 55 of this prospectus, respectively.

 

43



 

(33)

 

Comprised of 26,621 shares of common stock issuable upon exercise of warrants. The selling stockholder is also the beneficial owner of the securities set forth under his name in the selling stockholder tables for the 2003 Financings, July 2005 Financing, 2006 Financings, and September 2007 Financing beginning on page 29, 44, 49, and 55 of this prospectus, respectively.

 

 

 

(34)

 

Comprised of 6,225 shares of common stock issuable upon exercise of warrants. The selling stockholder is also the beneficial owner of the securities set forth under his name in the selling stockholder table for the 2003 Financings beginning on page 29 of this prospectus.

 

 

 

(35)

 

Comprised of 2,625 shares of common stock issuable upon exercise of warrants. The selling stockholder is also the beneficial owner of the securities set forth under his name in the selling stockholder table for the 2003 Financings beginning on page 29 of this prospectus.

 

 

 

(36)

 

Comprised of 3,377 shares of common stock issuable upon exercise of warrants. The selling stockholder is also the beneficial owner of the securities set forth under his name in the selling stockholder table for the 2003 Financings beginning on page 29 of this prospectus.

 

 

 

(37)

 

Comprised of 3,377 shares of common stock issuable upon exercise of warrants. The selling stockholder is also the beneficial owner of the securities set forth under his name in the selling stockholder table for the 2003 Financings beginning on page 29 of this prospectus.

 

 

 

(38)

 

Comprised of 8,678 shares of common stock issuable upon exercise of warrants. Based on information provided to the Company by the selling stockholder on March 19, 2008. Rockmore Capital, LLC (“Rockmore Capital”) and Rockmore Partners, LLC (“Rockmore Partners”), each a limited liability company formed under the laws of the State of Delaware, serve as the investment manager and general partner, respectively, to Rockmore Investments (US) LP, a Delaware limited partnership, which invests all of its assets through Rockmore Investment Master Fund Ltd., an exempted company formed under the laws of Bermuda (“Rockmore Master Fund”). By reason of such relationships, Rockmore Capital and Rockmore Partners may be deemed to share dispositive power over the shares of our common stock owned by Rockmore Master Fund. Rockmore Capital and Rockmore Partners disclaim beneficial ownership of such shares of our common stock. Rockmore Partners has delegated authority to Rockmore Capital regarding the portfolio management decisions with respect to the shares of common stock owned by Rockmore Master Fund and, as of April 15, 2008, Mr. Bruce T. Bernstein and Mr. Brian Daly, as officers of Rockmore Capital, are responsible for the portfolio management decisions of the shares of common stock owned by Rockmore Master Fund. By reason of such authority, Messrs. Bernstein and Daly may be deemed to share dispositive power over the shares of our common stock owned by Rockmore Master Fund. Messrs. Bernstein and Daly disclaim beneficial ownership of such shares of our common stock and neither of such persons has any legal right to maintain such authority. No other person has sole or shared voting or dispositive power with respect to the shares of our common stock as those terms are used for purposes under Regulation 13D-G of the Securities Exchange Act of 1934, as amended. No person or “group” (as that term is used in Section 13(d) of the Securities Exchange Act of 1934, as amended, or the SEC’s Regulation 13D-G) controls Rockmore Master Fund.

 

July 2005 Financing

 

In July 2005, we completed a private placement financing pursuant to which we sold to certain accredited investors an aggregate of 1,397,287 shares (the “July 2005 Shares”) of Common Stock and issued such investors warrants (the “July 2005 Warrants”) to purchase up to an aggregate of 635,767 shares of Common Stock (the “July 2005 Financing”).  The July 2005 Warrants have a five-year term and had an initial exercise price of $3.45 per share.  In connection with the July 2005 Financing, we agreed to prepare and file with the SEC a registration statement covering the resale of the July 2005 Shares and the shares of Common Stock issuable upon exercise of the July 2005 Warrants.  Of the 2,033,054 shares of Common Stock being offered by the selling stockholders set forth in the table below, 90,262 shares are issuable upon the exercise of warrants issued to Laidlaw & Company (UK), Ltd., and five of its affiliates, as partial compensation for acting as placement agents in the July 2005 Financing.

 

The table below presents information regarding the selling stockholders in the July 2005 Financing and shares of Common Stock that they may offer and sell under this prospectus.

 

44



 

 

 

NUMBER OF 

 

SHARES OF 

 

SHARES 

 

 

 

SHARES 

 

COMMON 

 

BENEFICIALLY 

 

 

 

BENEFICIALLY 

 

STOCK

 

OWNED AFTER 

 

 

 

OWNED BEFORE 

 

BEING 

 

OFFERING

 

SELLING STOCKHOLDERS(1)

 

OFFERING

 

OFFERED

 

NUMBER

 

%

 

 

 

 

 

 

 

 

 

 

 

Iroquois Master Fund Ltd. (2)

 

534,884

 

534,884

 

0

 

*

 

Omicron Master Trust (3)

 

122,057

 

122,057

 

0

 

*

 

Smithfield Fiduciary, LLC (4)

 

133,721

 

133,721

 

0

 

*

 

Haystack Capital (5)

 

267,441

 

267,441

 

0

 

*

 

Jeffrey Glassman (6)

 

13,372

 

13,372

 

0

 

*

 

Helen Kohn (7)

 

53,489

 

53,489

 

0

 

*

 

Ronit Sucoff (8)

 

53,489

 

53,489

 

0

 

*

 

Little Bear Investments LLC (9)

 

16,202

 

16,202

 

0

 

*

 

Zachary Prensky (10)

 

267,441

 

267,441

 

0

 

*

 

Wolf Prensky (11)

 

53,489

 

53,489

 

0

 

*

 

Martha Lipton (12)

 

5,349

 

5,349

 

0

 

*

 

Danny Aharon (13)

 

5,349

 

5,349

 

0

 

*

 

A1-Kim Profit Sharing Plan (14)

 

26,744

 

26,744

 

0

 

*

 

Dean Willard (15)

 

53,489

 

53,489

 

0

 

*

 

Laidlaw & Company (UK) Ltd. (16)

 

20,000

 

20,000

 

0

 

*

 

Lagunitas Partners LP (17)

 

160,466

 

160,466

 

0

 

*

 

Gruber & McBaine International (18)

 

53,489

 

53,489

 

0

 

*

 

J. Patterson McBaine (19)

 

26,743

 

26,743

 

0

 

*

 

Jon D. and Linda W. Gruber Trust (20)

 

26,743

 

26,743

 

0

 

*

 

Gary Shemano (21)

 

7,267

 

7,267

 

0

 

*

 

Michael Jacks (22)

 

3,634

 

3,634

 

0

 

*

 

William Corbett (23)

 

3,634

 

3,634

 

0

 

*

 

 

45



 

 

 

NUMBER OF 

 

SHARES OF 

 

SHARES 

 

 

 

SHARES 

 

COMMON 

 

BENEFICIALLY 

 

 

 

BENEFICIALLY 

 

STOCK

 

OWNED AFTER 

 

 

 

OWNED BEFORE 

 

BEING 

 

OFFERING

 

SELLING STOCKHOLDERS(1)

 

OFFERING

 

OFFERED

 

NUMBER

 

%

 

 

 

 

 

 

 

 

 

 

 

Cary Sucoff (24)(25)

 

23,131

 

23,131

 

0

 

*

 

Harvey Kohn (24)(26)

 

20,000

 

20,000

 

0

 

*

 

Lewis Mason (24)(27)

 

12,000

 

12,000

 

0

 

*

 

Scott Sucoff (24)(29)

 

12,000

 

12,000

 

0

 

*

 

Francis Anderson (24)(29)

 

3,131

 

3,131

 

0

 

*

 

Rockmore Investment Master Fund Ltd. (30)

 

11,664

 

11,664

 

0

 

*

 

 


 * Represents beneficial ownership of less than 1%

 

(1)

 

The information related to voting and investment control and, if applicable, the Selling Stockholder’s status as an affiliate of a registered broker-dealer, is based on information provided to the Company by the Selling Stockholders as of November 8, 2005.

 

 

 

(2)

 

Comprised of 387,597 shares of common stock and 147,287 shares of common stock issuable upon exercise of warrants. Joshua Silverman exercises sole voting and investment control over these shares.  Mr. Silverman disclaims beneficial ownership of these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder tables for the 2006 Financings and September 2007 Financing beginning on page 49 and 55 of this prospectus, respectively.

 

 

 

(3)

 

Comprised of 96,899 shares of common stock and 25,158 shares of common stock issuable upon exercise of warrants. Based on certain records of the Company. Omicron Capital, L.P., a Delaware limited partnership (“Omicron Capital”), serves as investment manager to Omicron Master Trust, a trust formed under the laws of Bermuda (“Omicron”), Omicron Capital, Inc., a Delaware corporation (“OCI”), serves as general partner of Omicron Capital, and Winchester Global Trust Company Limited (“Winchester”) serves as the trustee of Omicron.  By reason of such relationships, Omicron Capital and OCI may be deemed to share dispositive power over the shares of our common stock owned by Omicron, and Winchester may be deemed to share voting and dispositive power over the shares of our common stock owned by Omicron.  Omicron Capital, OCI and Winchester disclaim beneficial ownership of such shares of our common stock.  Omicron Capital has delegated authority from the board of directors of Winchester regarding the portfolio management decisions with respect to the shares of common stock owned by Omicron and, as of October 3, 2005, Mr. Olivier H. Morali and Mr. Bruce T. Bernstein, officers of OCI, have delegated authority from the board of directors of OCI regarding the portfolio management decisions of Omicron Capital with respect to the shares of common stock owned by Omicron.  By reason of such delegated authority, Messrs. Morali and Bernstein exercise voting and dispositive power over the shares of our common stock owned by Omicron.  Messrs. Morali and Bernstein disclaim beneficial ownership of such shares of our common stock and neither of such persons has any legal right to maintain such delegated authority.  No other person has sole or shared voting or dispositive power with respect to the shares of our common stock being offered by Omicron, as those terms are used for purposes under Regulation 13-D-G of the Securities and Exchange Act of 1934, as amended.  Omicron and Winchester are not “affiliates” of one another, as that term is used for purposes of the Securities Exchange Act of 1934, as amended, or of any other person named in this prospectus as a selling shareholder.  No person or “group” (as that term is used in Section 13(d) of the Securities Exchange Act of 1934, as amended, or the SEC’s Regulation 13D-G) controls Omicron and Winchester. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder table for the January 2004 Financing beginning on page 39 of this prospectus.

 

46



 

(4)

 

Comprised of 96,899 shares of common stock and 36,822 shares of common stock issuable upon exercise of warrants. Highbridge Capital Management, LLC is the trading manager of Smithfield Fiduciary LLC and exercises voting control and investment discretion over securities these shares.  Glenn Dubin and Henry Swieca control Highbridge Capital Management, LLC and as such, exercise voting and investment control over these shares.  Each of Highbridge Capital Management, LLC, Glenn Dubin and Henry Swieca disclaims beneficial ownership of these shares.

 

 

 

(5)

 

Comprised of 193,798 shares of common stock and 73,643 shares of common stock issuable upon exercise of warrants. Judith Finger and Douglas Topkis exercise voting and investment control over these shares.

 

 

 

(6)

 

Comprised of 9,690 shares of common stock held directly and 3,682 shares of common stock issuable upon exercise of warrants.

 

 

 

(7)

 

Comprised of 38,760 shares of common stock held directly and 14,729 shares of common stock issuable upon exercise of warrants. The selling stockholder is also the beneficial owner of the securities set forth under her name in the selling stockholder table for the 2003 Financings beginning on page 29 of this prospectus.

 

 

 

(8)

 

Comprised of 38,760 shares of common stock held directly and 14,729 shares of common stock issuable upon exercise of warrants. The selling stockholder is also the beneficial owner of the securities set forth under her name in the selling stockholder table for the 2003 Financings beginning on page 29 of this prospectus.

 

 

 

(9)

 

Comprised of 16,202 shares of common stock issuable upon exercise of warrants. Based on information provided to the Company by the Selling Stockholder on March 19, 2008. Zachary Prensky and Jeffrey Mann exercise voting and investment control over these shares.  Zachary Prensky owns 50% of Little Bear Investments LLC, and is therefore deemed an affiliate of Little Bear Investments LLC. In connection with the November 2003 Financing, the selling stockholder purchased 42,636 shares of common stock and such shares were resold, prior to the date of this prospectus, pursuant to that certain Form S-3 Registration Statement (Reg. No. 333-127829) filed with the SEC on August 25, 2005, as amended. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder tables for the 2003 Financings, 2006 Financings, and September 2007 Financing beginning on page 29, 49, and 55 of this prospectus, respectively.

 

 

 

(10)

 

Comprised of 193,798 shares of common stock held directly and 73,643 shares of common stock issuable upon exercise of warrants. Zachary Prensky and Jeffrey Mann exercise voting and investment control over these shares.  Zachary Prensky owns 50% of Little Bear Investments LLC, and is therefore deemed an affiliate of Little Bear Investments LLC. The selling stockholder is also the beneficial owner of the securities set forth under his name in the selling stockholder tables for the 2006 Financings and September 2007 Financing beginning on page 49 and 55 of this prospectus, respectively.

 

 

 

(11)

 

Comprised of 38,760 shares of common stock held directly and 14,729 shares of common stock issuable upon exercise of warrants.

 

 

 

(12)

 

Comprised of 3,876 shares of common stock held directly and 1,473 shares of common stock issuable upon exercise of warrants.

 

 

 

(13)

 

Comprised of 3,876 shares of common stock held directly and 1,473 shares of common stock issuable upon exercise of warrants.

 

 

 

(14)

 

Comprised of 19,380 shares of common stock held directly and 7,364 shares of common stock issuable upon exercise of warrants. Joshua Kanter is the trustee of the A1-Kim Profit Sharing Plan and exercises voting and investment control over these shares.

 

 

 

(15)

 

Comprised of 38,760 shares of common stock held directly and 14,729 shares of common stock issuable upon exercise of warrants. The selling stockholder is also the beneficial owner of the securities set forth under his name in the selling stockholder table for the 2006 Financings beginning on page 49 of this prospectus.

 

 

 

(16)

 

Comprised of 20,000 shares of common stock issuable upon exercise of warrants. Robert Bonaventura, President, exercises voting and investment control over these shares.  Consists of shares that could be purchased on exercise of warrants issued in connection with our private placement in July 2005.  Laidlaw & Company (UK) Ltd. (“Laidlaw”)

 

47



 

 

 

is a registered broker-dealer.  We issued these warrants to Laidlaw as partial compensation for Laidlaw’s services as placement agent in connection with our private placement in July 2005.  Laidlaw represents that it acquired these warrants in the ordinary course of business and at the time of receiving the securities had no agreements or understandings, directly or indirectly, with any person to distribute them.  These shares are subject to a 180 day lock-up agreement in accordance with the requirements of NASD Rule 2710(g)(1).

 

 

 

(17)

 

Comprised of 116,280 shares of common stock held directly and 44,186 shares of common stock issuable upon exercise of warrants. Jon D. Gruber and J. Patterson McBaine are affiliates of Lagunitas Partners LP and Gruber & McBaine International.  The number of shares being sold for these affiliates are noted separately in this table.  Jon D. Gruber and J. Patterson McBaine exercise voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder tables for the 2003 Financings, 2006 Financings, March 2007 Financing, and September 2007 Financing beginning on page 29, 49, 53, and 55 of this prospectus, respectively.

 

 

 

(18)

 

Comprised of 38,760 shares of common stock held directly and 14,729 shares of common stock issuable upon exercise of warrants. Jon D. Gruber and J. Patterson McBaine are affiliates of Lagunitas Partners LP and Gruber & McBaine International.  The number of shares being sold for these affiliates are noted separately in this table.  Jon D. Gruber and J. Patterson McBaine exercise voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder tables for the 2003 Financings, 2006 Financings, March 2007 Financing, and September 2007 Financing beginning on page 29, 49, 53, and 55 of this prospectus, respectively.

 

 

 

(19)

 

Comprised of 19,379 shares of common stock held directly and 7,364 shares of common stock issuable upon exercise of warrants. Jon D. and Linda W. Gruber Trust and J. Patterson McBaine are affiliates of one another.  The number of shares being sold for these affiliates are noted separately in this table.  Jon D. Gruber exercises voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under his name in the selling stockholder tables for the 2003 Financings, 2006 Financings, March 2007 Financing, and September 2007 Financing beginning on page 29, 49, 53, and 55 of this prospectus, respectively.

 

 

 

(20)

 

Comprised of 19,379 shares of common stock held directly and 7,364 shares of common stock issuable upon exercise of warrants. Jon D. and Linda W. Gruber Trust and J. Patterson McBaine are affiliates of one another.  The number of shares being sold for these affiliates are noted separately in this table.  Jon D. Gruber exercises voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder table for the September 2007 Financing beginning on page 55 of this prospectus.

 

 

 

(21)

 

Comprised of 7,267 shares of common stock issuable upon exercise of warrants. The selling stockholder is also the beneficial owner of the securities set forth under his name in the selling stockholder tables for the 2003 Financings and January 2004 Financing beginning on page 29 and 39 of this prospectus, respectively.

 

 

 

(22)

 

Comprised of 3,634 shares of common stock issuable upon exercise of warrants. The selling stockholder is also the beneficial owner of the securities set forth under his name in the selling stockholder tables for the 2003 Financings, January 2004 Financing, 2006 Financings, and September 2007 Financing beginning on page 29, 39, 49, and 55 of this prospectus, respectively.

 

 

 

(23)

 

Comprised of 3,634 shares of common stock issuable upon exercise of warrants. The selling stockholder is also the beneficial owner of the securities set forth under his name in the selling stockholder tables for the 2003 Financings, January 2004 Financing, 2006 Financings, and September 2007 Financing beginning on page 29, 39, 49, and 55 of this prospectus, respectively.

 

 

 

(24)

 

This selling shareholder is an “associated person” of Laidlaw and represents that he or she received these warrants as a designee of Laidlaw in the ordinary course of business and at the time of receiving the securities had no agreements or understandings, directly or indirectly, with any person to distribute them. Laidlaw was entitled to receive these securities as compensation for its services as placement agent in the ordinary course of business and at the time of receiving the securities had no agreements or understandings, directly or indirectly, with any person to distribute them. These shares are subject to a 180 day lock-up agreement in accordance with the requirements of NASD Rule 2710(g)(1).

 

48



 

(25)

 

Comprised of 23,131 shares of common stock issuable upon exercise of warrants.

 

 

 

(26)

 

Comprised of 20,000 shares of common stock issuable upon exercise of warrants.

 

 

 

(27)

 

Comprised of 12,000 shares of common stock issuable upon exercise of warrants.

 

 

 

(28)

 

Comprised of 12,000 shares of common stock issuable upon exercise of warrants.

 

 

 

(29)

 

Comprised of 3,131 shares of common stock issuable upon exercise of warrants.

 

 

 

(30)

 

Comprised of 11,664 shares of common stock issuable upon exercise of warrants. Based on information provided to the Company by the selling stockholder on March 19, 2008. Rockmore Capital and Rockmore Partners, each a limited liability company formed under the laws of the State of Delaware, serve as the investment manager and general partner, respectively, to Rockmore Investments (US) LP, a Delaware limited partnership, which invests all of its assets through Rockmore Master Fund, an exempted company formed under the laws of Bermuda. By reason of such relationships, Rockmore Capital and Rockmore Partners may be deemed to share dispositive power over the shares of our common stock owned by Rockmore Master Fund. Rockmore Capital and Rockmore Partners disclaim beneficial ownership of such shares of our common stock. Rockmore Partners has delegated authority to Rockmore Capital regarding the portfolio management decisions with respect to the shares of common stock owned by Rockmore Master Fund and, as of April 15, 2008, Mr. Bruce T. Bernstein and Mr. Brian Daly, as officers of Rockmore Capital, are responsible for the portfolio management decisions of the shares of common stock owned by Rockmore Master Fund. By reason of such authority, Messrs. Bernstein and Daly may be deemed to share dispositive power over the shares of our common stock owned by Rockmore Master Fund. Messrs. Bernstein and Daly disclaim beneficial ownership of such shares of our common stock and neither of such persons has any legal right to maintain such authority. No other person has sole or shared voting or dispositive power with respect to the shares of our common stock as those terms are used for purposes under Regulation 13D-G of the Securities Exchange Act of 1934, as amended. No person or “group” (as that term is used in Section 13(d) of the Securities Exchange Act of 1934, as amended, or the SEC’s Regulation 13D-G) controls Rockmore Master Fund.

 

Gary Shemano, Michael Jacks and William Corbett are registered agents of The Shemano Group (collectively “Shemano”).  We issued a portion of the July 2005 warrants to Shemano as compensation for Shemano’s services as placement agent in connection with the July 2005 Financing.  The Shemano Group is a broker-dealer, and as such, it is deemed to be an underwriter of 14,535 shares set forth in the table immediately above, held by Gary Shemano, Michael Jacks, and William Corbett, and offered pursuant to this prospectus. We do not have any underwriting agreement with Shemano. Shemano completed all services in connection with earning the shares and is under no obligation to sell the shares in this offering or pay any of the proceeds thereof to us. We did not pay and will not owe any discounts or commissions to Shemano. Shemano has no right to designate any member to our board of directors. We have no obligation to indemnify Shemano for violations of the Securities Act, other than the standard indemnification provisions of the registration rights agreement entered into with all of the selling shareholders in the July 2005 Financing regarding our liability for our inclusion of false or misleading information in this prospectus. We are not aware of any intention of Shemano or its affiliates to engage in passive market making transactions as permitted by Rule 103 of Regulation M. We are not aware of any intention of Shemano or its affiliates to engage in any transaction during the offering that stabilizes, maintains, or otherwise affects the market price of the offered securities.

 

2006 Financings

 

On March 17, 2006, we completed a secured debt financing in the aggregate amount of $1,550,000 (the “2006 Debt Financing”). As part of that financing, we issued a series of secured promissory notes in the aggregate amount of $1,550,000 (the “2006 Notes”) pursuant to a Note Purchase Agreement (the “Note Purchase Agreement”). The 2006 Notes were set to mature in full in March 2007, but could become due prior to that time upon the occurrence of certain events. As part of the 2006 Debt Financing, we also issued warrants to purchase an aggregate of 387,500 shares of Common Stock to the holders of the 2006 Notes (the “2006 Warrants”). The 2006 Warrants have a five-year term and had an initial exercise price $2.30 per share.  The shares of Common Stock issuable upon exercise of the 2006 Warrants have piggyback registration rights that require us to register these shares with the SEC. Pursuant to these registration rights, the shares of Common Stock issuable upon exercise of the 2006 Warrants are being registered hereunder.

 

In November and December 2006, we consummated a private placement financing (the “2006 Private Placement” and together with the 2006 Debt Financing, the “2006 Financings”) of an aggregate of 2,500 shares of our Series C Preferred

 

49



 

Stock and warrants to purchase an aggregate of 125,000 shares of Common Stock to certain accredited investors (the “2006

Private Placement Warrants”). The Series C Preferred Stock has a stated value of $1,000 per share and is initially convertible into Common Stock at a rate of $1.50 of the per share stated value. The 2006 Private Placement Warrants have a five-year term and an initial exercise price of $1.575 per share.  As part of the 2006 Private Placement, we also issued warrants to purchase an aggregate of 46,000 shares of Common Stock to certain placement agents (the “Placement Agent Warrants”). The Placement Agent Warrants each have a five-year term and an initial exercise price of $1.575 per share. We have agreed to register for resale all of the shares of Common Stock that are issuable upon conversion of the Series C Preferred Stock and upon exercise of the 2006 Private Placement Warrants and the Placement Agent Warrants.

 

Under the terms of the Note Purchase Agreement, the 2006 Private Placement would have caused an immediate acceleration of the full amounts owed under the 2006 Notes.  However, we received a written waiver of the acceleration of the 2006 Notes in connection with the 2006 Private Placement in consideration for the issuance of additional warrants to purchase an aggregate of up to 200,250 shares of Common Stock to the holders of the 2006 Notes (the “2006 Additional Warrants”) and the adjustment of the exercise prices of the 2006 Warrants from $2.30 per share to $1.80 per share. We have agreed to register for resale all of the shares of Common Stock issuable upon exercise of the 2006 Additional Warrants.

 

The table below presents information regarding the selling stockholders in the 2006 Financings and shares of Common Stock that they may offer and sell under this prospectus.

 

 

 

NUMBER OF
SHARES
BENEFICIALLY
OWNED BEFORE

 

SHARES OF
COMMON
STOCK
BEING

 

SHARES
BENEFICIALLY
OWNED AFTER
OFFERING

 

SELLING STOCKHOLDERS (1)

 

OFFERING

 

OFFERED

 

NUMBER

 

%

 

 

 

 

 

 

 

 

 

 

 

AJW Offshore Ltd. (2)

 

23,131

 

23,131

 

0

 

*

 

AJW Partners, LLC (3)

 

4,171

 

4,171

 

0

 

*

 

AJW Qualified Partners, LLC (4)

 

10,238

 

10,238

 

0

 

*

 

Asset Factoring Ansbacher Bahamas Ltd. (5)

 

37,919

 

37,919

 

0

 

*

 

Bru Holding Co. LLC (6)

 

143,333

 

143,333

 

0

 

*

 

Eugene & Natalie Ciner JTWROS (7)

 

3,792

 

3,792

 

0

 

*

 

William Corbett (8)

 

14,000

 

14,000

 

0

 

*

 

Corman Foundation, Inc. (9)

 

18,960

 

18,960

 

0

 

*

 

Cranshire Capital, L.P. (10)

 

94,798

 

94,798

 

0

 

*

 

Empire Financial Group, Inc. (11)

 

12,000

 

12,000

 

0

 

*

 

Equity Source Partners, LLC (12)

 

6,000

 

6,000

 

0

 

*

 

Goldberg Partners (13)

 

143,333

 

143,333

 

0

 

*

 

Sean Greene (14)

 

18,960

 

18,960

 

0

 

*

 

Gruber & McBaine International (15)

 

286,666

 

286,666

 

0

 

*

 

Iroquois Master Fund Ltd. (16)

 

71,099

 

71,099

 

0

 

*

 

Michael Jacks (17)

 

14,000

 

14,000

 

0

 

*

 

The Kybartai Trust (18)

 

37,919

 

37,919

 

0

 

*

 

Lagunitas Partners LP (19)

 

860,000

 

860,000

 

0

 

*

 

Little Bear Investments LLC (20)

 

54,604

 

54,604

 

0

 

*

 

J. Patterson McBaine (21)

 

286,666

 

286,666

 

0

 

*

 

 

50



 

 

 

NUMBER OF
SHARES
BENEFICIALLY
OWNED BEFORE

 

SHARES OF
COMMON
STOCK
BEING

 

SHARES
BENEFICIALLY
OWNED AFTER
OFFERING

 

SELLING STOCKHOLDERS (1)

 

OFFERING

 

OFFERED

 

NUMBER

 

%

 

New Millennium Capital Partners II, LLC (22)

 

379

 

379

 

0

 

*

 

Zachary Prensky (23)

 

97,074

 

97,074

 

0

 

*

 

RMW Envirovest (24)

 

18,960

 

18,960

 

0

 

*

 

Trudy C Taylor and Joan C. Taylor Co-Trustees Taylor Family Trust u/a/d June 10, 1983 (25)

 

19,908

 

19,908

 

0

 

*

 

Valkyrie Leasing, LLC (26)

 

75,839

 

75,839

 

0

 

*

 

Dean Willard (27)

 

71,666

 

71,666

 

0

 

*

 

 


* Represents beneficial ownership of less than 1%

 

(1)

 

The information related to voting and investment control is based on information provided to the Company by the selling stockholders as of December 27, 2006.

 

 

 

(2)

 

Comprised of 23,131 shares of common stock issuable upon exercise of warrants. Corey S. Ribotsky has voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder table for the September 2007 Financing beginning on page 55 of this prospectus.

 

 

 

(3)

 

Comprised of 4,171 shares of common stock issuable upon exercise of warrants. Corey S. Ribotsky has voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder table for the September 2007 Financing beginning on page 55 of this prospectus.

 

 

 

(4)

 

Comprised of 10,238 shares of common stock issuable upon exercise of warrants. Corey S. Ribotsky has voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder table for the September 2007 Financing beginning on page 55 of this prospectus.

 

 

 

(5)

 

Comprised of 37,919 shares of common stock issuable upon exercise of warrants. Charles Johnston is the vice president, investing of Asset Factoring Ansbacher Bahamas Ltd. and has voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder table for the September 2007 Financing beginning on page 55 of this prospectus.

 

 

 

(6)

 

Comprised of 133,333 shares of common stock issuable upon conversion of Series C Preferred Stock and 10,000 shares of common stock issuable upon exercise of warrants. Bruce Toll has voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder table for the 2003 Financings beginning on page 29 of this prospectus.

 

 

 

(7)

 

Comprised of 3,792 shares of common stock issuable upon exercise of warrants.

 

 

 

(8)

 

Comprised of 14,000 shares of common stock issuable upon exercise of warrants. The selling stockholder is also the beneficial owner of the securities set forth under his name in the selling stockholder tables for the 2003 Financings, January 2004 Financing, July 2005 Financing, and September 2007 Financing beginning on page 29, 39, 44, and 55 of this prospectus, respectively.

 

 

 

(9)

 

Comprised of 18,960 shares of common stock issuable upon exercise of warrants. James Corman, President of Corman Foundation, Inc. has voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder tables for the 2003 Financings and September 2007 Financing beginning on page 29 and 55 of this prospectus, respectively.

 

51



 

(10)

 

Comprised of 94,798 shares of common stock issuable upon exercise of warrants. Mitchell P. Kohn, President of Downsview Capital, Inc., the General Partner of Cranshire Capital, L.P., has sole voting and investment discretion over shares of common stock beneficially owned by Cranshire Capital, L.P. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder tables for the January 2004 Financing and September 2007 Financing beginning on page 39 and 55 of this prospectus, respectively.

 

 

 

(11)

 

Comprised of 12,000 shares of common stock issuable upon exercise of warrants. Steve Rabinivice, as Chief Executive Officer of Empire Financial Group, Inc., has voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder table for the September 2007 Financing beginning on page 55 of this prospectus.

 

 

 

(12)

 

Comprised of 6,000 shares of common stock issuable upon exercise of warrants. Cary Sucoff, Harvey Kohn, Scott Sucoff and Lewis Mason have voting and investment control over these shares.

 

 

 

(13)

 

Comprised of 133,333 shares of common stock issuable upon conversion of Series C Preferred Stock and 10,000 shares of common stock issuable upon exercise of warrants. John Goldberg has voting and investment control over these shares.

 

 

 

(14)

 

Comprised of 18,960 shares of common stock issuable upon exercise of warrants. The selling stockholder is also the beneficial owner of the securities set forth under his name in the selling stockholder tables for the 2003 Financings and September 2007 Financing beginning on page 29 and 55 of this prospectus, respectively.

 

 

 

(15)

 

Comprised of 266,666 shares of common stock issuable upon conversion of Series C Preferred Stock and 20,000 shares of common stock issuable upon exercise of warrants. Jon D. Gruber and J. Patterson McBaine, as managers of Gruber & McBaine Capital Management, exercise all voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder tables for the 2003 Financings, July 2005 Financing, March 2007 Financing, and September 2007 Financing beginning on page 29, 44, 53, and 55 of this prospectus, respectively.

 

 

 

(16)

 

Comprised of 71,099 shares of common stock issuable upon exercise of warrants. Joshua Silverman exercises sole voting and investment control over these shares. Mr. Silverman disclaims beneficial ownership of the shares held by Iroquois Master Fund Ltd. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder tables for the July 2005 Financing and September 2007 Financing beginning on page 44 and 55 of this prospectus, respectively.

 

 

 

(17)

 

Comprised of 14,000 shares of common stock issuable upon exercise of warrants directly. The selling stockholder is also the beneficial owner of the securities set forth under his name in the selling stockholder tables for the 2003 Financings, January 2004 Financing, July 2005 Financing, and September 2007 Financing beginning on page 29, 39, 44, and 55 of this prospectus, respectively.

 

 

 

(18)

 

Comprised of 37,919 shares of common stock issuable upon exercise of warrants. Wolf Prensky, Trustee of the Kyabrtai Trust, exercises voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder table for the September 2007 Financing beginning on page 55 of this prospectus.

 

 

 

(19)

 

Comprised of 800,000 shares of common stock issuable upon conversion of Series C Preferred Stock and 60,000 shares of common stock issuable upon exercise of warrants. Jon D. Gruber and J. Patterson McBaine, managers of Gruber & McBaine Capital Management, exercise all voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder tables for the 2003 Financings, July 2005 Financing, March 2007 Financing, and September 2007 Financing beginning on page 29, 44, 53, and 55 of this prospectus, respectively.

 

 

 

(20)

 

Comprised of 54,604 shares of common stock issuable upon exercise of warrants. Zachary Prensky and Jeffrey Mann exercise voting and investment control over these shares being sold by Little Bear Investments LLC. Zachary Prensky, an affiliate and 50% owner of Little Bear Investments LLC, directly owns 97,074 shares of common stock issuable upon exercise of warrants referenced in footnote 17 below. Little Bear Investments LLC disclaims any ownership or control over common stock and warrants held directly by Mr. Prensky. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder tables for the 2003 Financings, July 2005 Financing, and September 2007 Financing beginning on page 29, 44, and 55 of this prospectus, respectively.

 

52



 

(21)

 

Comprised of 266,666 shares of common stock issuable upon conversion of Series C Preferred Stock held directly by Mr. McBaine and 20,000 shares of common stock issuable upon exercise of warrants held directly by Mr. McBaine. The selling stockholder is also the beneficial owner of the securities set forth under his name in the selling stockholder tables for the 2003 Financings, July 2005 Financing, March 2007 Financing, and September 2007 Financing beginning on page 29, 44, 53, and 55 of this prospectus, respectively.

 

 

 

(22)

 

Comprised of 379 shares of common stock issuable upon exercise of warrants. Corey S. Ribotsky has voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder table for the September 2007 Financing beginning on page 55 of this prospectus.

 

 

 

(23)

 

Comprised of 97,074 shares of common stock issuable upon exercise of warrants. Zachary Prensky is an affiliate and 50% owner of Little Bear Investments LLC. Mr. Prensky beneficially owns the securities held by Little Bear Investments LLC referenced in footnote 15 above. The selling stockholder is also the beneficial owner of the securities set forth under his name in the selling stockholder tables for the July 2005 Financing and September 2007 Financing beginning on page 44 and 55 of this prospectus, respectively.

 

 

 

(24)

 

Comprised of 18,960 shares of common stock issuable upon exercise of warrants. Michael Withers has voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder table for the September 2007 Financing beginning on page 55 of this prospectus.

 

 

 

(25)

 

Comprised of 19,908 shares of common stock issuable upon exercise of warrants. Trude C. Taylor, Trustee of the Taylor Family Trust Dated June 10, 1983, has voting and investment control over these shares.

 

 

 

(26)

 

Comprised of 75,839 shares of common stock issuable upon exercise of warrants. Charles Simonyi has voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder tables for the 2003 Financings and September 2007 Financing beginning on page 29 and 55 of this prospectus, respectively.

 

 

 

(27)

 

Comprised of 66,666 shares of common stock issuable upon conversion of Series C Preferred Stock and 5,000 shares of common stock issuable upon exercise of warrants. The selling stockholder is also the beneficial owner of the securities set forth under his name in the selling stockholder table for the July 2005 Financing beginning on page 44 of this prospectus.

 

Selling stockholders in the 2006 Private Placement who are registered broker-dealers are “underwriters” within the meaning of the Securities Act.  In addition, selling stockholders who are affiliates of registered broker-dealers may be deemed to be “underwriters” within the meaning of the Securities Act if such selling stockholders (a) did not acquire its Series C Preferred Stock, warrants or underlying stock in the ordinary course of business or (b) had any agreement or understanding, directly or indirectly, with any person to distribute the Series C Preferred Stock, warrants or underlying common stock.

 

Michael Jacks and William Corbett are registered agents of Empire Financial Group, Inc. (“Empire”). We issued the warrants referenced in footnotes 8, 11 and 17 above to Empire as compensation for Empire’s services as placement agent in connection with the 2006 Private Placement.  Equity Source Partners, LLC (“Equity,” and together with Empire, the “Placement Agents”) was also issued the warrant referenced in footnote 12 above as compensation for Equity’s services as a placement agent in connection with the Private Placement. The Placement Agents are broker-dealers, and as such, may be deemed to be underwriters of an aggregate of 46,000 shares offered pursuant to this prospectus. We do not have any underwriting agreement with the Placement Agents. The Placement Agents completed all services in connection with earning the shares and are under no obligation to sell the shares in this offering or pay any of the proceeds thereof to us. We did not pay and will not owe any discounts or commissions to the Placement Agents. The Placement Agents have no right to designate any member to our board of directors. We have no obligation to indemnify the Placement Agents for violations of the Securities Act. We are not aware of any intention of the Placement Agents or their affiliates to engage in passive market making transactions as permitted by Rule 103 of Regulation M. We are not aware of any intention of the Placement Agents or their affiliates to engage in any transaction during the offering that stabilizes, maintains, or otherwise affects the market price of the offered securities.

 

March 2007 Financing

 

In March 2007, we completed a financing pursuant to which we sold to certain accredited investors (the “March 2007 Investors”) an aggregate of 1,500 shares of our Series D 8% Convertible Preferred Stock (the “Series D Preferred Stock”) at a stated value of $1,000 per share for aggregate gross proceeds of $1,500,000, and issued to the March 2007 Investors warrants (the “March 2007 Warrants”) to purchase up to an aggregate of 59,207 shares of Common Stock with an exercise price of $2.33 per share (the “March 2007 Financing”). As part of the March 2007 Financing, we entered into a registration rights

 

53



 

agreement (the “March 2007 Rights Agreement”) with the March 2007 Investors covering the resale of the shares of Common Stock underlying the Series D Preferred Stock, all shares of Common Stock issuable upon exercise of the March 2007 Warrants, all shares of Common Stock issuable as dividends on the Series D Preferred Stock, and all shares of Common Stock issuable upon any stock split, dividend or other distribution, recapitalization or similar event contemplated by Rule 416 of the Securities Act, with respect to the foregoing, with certain exceptions described in the March 2007 Rights Agreement.  Pursuant to these registration rights, the shares of Common Stock issuable upon exercise of the March 2007 Warrants and the shares of Common Stock underlying the Series D Preferred Stock are being registered hereunder.

 

The table below presents information regarding the selling stockholders in the March 2007 Financing and shares of Common Stock that they may offer and sell under this prospectus.

 

 

 

NUMBER OF
SHARES
BENEFICIALLY
OWNED
BEFORE

 

SHARES OF
COMMON
STOCK
BEING

 

SHARES
BENEFICIALLY
OWNED AFTER
OFFERING

 

SELLING STOCKHOLDERS (1)

 

OFFERING

 

OFFERED

 

NUMBER

 

%

 

 

 

 

 

 

 

 

 

 

 

Gruber & McBaine International (2)

 

76,380

 

76,380

 

0

 

*

 

Harrison H. Augur Smith Barney 401-K Prototype, Harrison H. Augur, Trustee (3)

 

56,578

 

56,578

 

0

 

*

 

Lagunitas Partners LP (4)

 

248,946

 

248,946

 

0

 

*

 

J. Patterson McBaine (5)

 

56,578

 

56,578

 

0

 

*

 

The Wallace Foundation (6)

 

63,368

 

63,368

 

0

 

*

 

Trustees of Hamilton College (7)

 

63,933

 

63,933

 

0

 

*

 

Robert D van Roijen, Jr. TTEE U/A DTD
12-14-82 FBO Robert D van Roijen, Jr. (8)

 

282,893

 

282,893

 

0

 

*

 

 


* Represents beneficial ownership of less than 1%

 

(1)

The information related to voting and investment control is based on information provided to the Company by the selling stockholders as of April 20, 2007.

 

 

(2)

Comprised of 71,052 shares of common stock issuable upon conversion of Series D Preferred Stock and 5,328 shares of common stock issuable upon exercise of warrants. Jon D. Gruber and J. Patterson McBaine, as managers of Gruber & McBaine Capital Management, exercise all voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder tables for the 2003 Financings, July 2005 Financing, 2006 Financings, and September 2007 Financing beginning on page 29, 44, 49, and 55 of this prospectus, respectively.

 

 

(3)

Comprised of 52,631 shares of common stock issuable upon conversion of Series D Preferred Stock and 3,947 shares of common stock issuable upon exercise of warrants. Harry Augur is a partner in both Auginco and Patience Partners LP and has shared voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder table for the September 2007 Financing beginning on page 55 of this prospectus.

 

 

(4)

Comprised of 231,578 shares of common stock issuable upon conversion of Series D Preferred Stock and 17,368 shares of common stock issuable upon exercise of warrants. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder tables for the 2003 Financings, July 2005 Financing, 2006 Financings, and September 2007 Financing beginning on page 29, 44, 49, and 55 of this prospectus, respectively.

 

54



 

(5)

Comprised of 52,631 shares of common stock issuable upon conversion of Series D Preferred Stock held directly by Mr. McBaine and 3,947 shares of common stock issuable upon exercise of warrants held directly by Mr. McBaine. Mr. McBaine, as a manager of Gruber & McBaine Capital Management, exercises all voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under his name in the selling stockholder tables for the 2003 Financings, July 2005 Financing, 2006 Financings, and September 2007 Financing beginning on page 29, 44, 49, and 55 of this prospectus, respectively.

 

 

(6)

Comprised of 58,947 shares of common stock issuable upon conversion of Series D Preferred Stock and 4,421 shares of common stock issuable upon exercise of warrants. Jon D. Gruber and J. Patterson McBaine, as managers of Gruber & McBaine Capital Management, exercise all voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder table for the September 2007 Financing beginning on page 55 of this prospectus.

 

 

(7)

Comprised of 59,473 shares of common stock issuable upon conversion of Series D Preferred Stock and 4,460 shares of common stock issuable upon exercise of warrants. Jon D. Gruber and J. Patterson McBaine, as managers of Gruber & McBaine Capital Management, exercise all voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder table for the September 2007 Financing beginning on page 55 of this prospectus.

 

 

(8)

Comprised of 263,157 shares of common stock issuable upon conversion of Series D Preferred Stock and 19,736 shares of common stock issuable upon exercise of warrants.  Robert D van Roijen, Jr. has voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder table for the September 2007 Financing beginning on page 55 of this prospectus.

 

Selling stockholders in the March 2007 Financing who are registered broker-dealers are “underwriters” within the meaning of the Securities Act.  In addition, such selling stockholders who are affiliates of registered broker-dealers may be deemed to be “underwriters” within the meaning of the Securities Act if such selling stockholders (a) did not acquire its Series D Preferred Stock, warrants or underlying stock in the ordinary course of business or (b) had any agreement or understanding, directly or indirectly, with any person to distribute the Series D Preferred Stock, warrants or underlying Common Stock.

 

September 2007 Financing

 

In September 2007, we completed a private placement financing pursuant to which we sold to certain accredited investors (the “September 2007 Investors”) an aggregate of 2,016,666 shares (the “September 2007 Shares”) of Common Stock, at a purchase price of $1.50 per share for aggregate gross proceeds of approximately $3.0 million, and issued to the September 2007 Investors warrants (the “September 2007 Warrants”) to purchase up to an aggregate of 1,008,333 shares of Common Stock with an exercise price of $1.67 per share (the “September 2007 Financing”). The September 2007 Warrants become exercisable on March 26, 2008.  As part of the September 2007 Financing, we entered into a registration rights agreement (the “September 2007 Rights Agreement”) with the September 2007 Investors covering the resale of the September 2007 Shares, all shares of Common Stock issuable upon exercise of the September 2007 Warrants, and all shares of Common Stock issuable upon any stock split, dividend or other distribution, recapitalization or similar event contemplated by Rule 416 of the Securities Act, with respect to the foregoing, with certain exceptions described in the September 2007 Rights Agreement.  Pursuant to these registration rights, the shares of Common Stock issuable upon exercise of the September 2007 Warrants and the September 2007 Shares are being registered hereunder.  Empire acted as placement agent and financial advisor to us in connection with the September 2007 Financing. In connection with its services, we issued Empire and certain of its affiliates warrants to purchase up to an aggregate of 151,249 shares of Common Stock and agreed to register these shares for resale. Accordingly, the shares of Common Stock issuable upon exercise of these warrants are being registered hereunder.

 

The table below presents information regarding the selling stockholders in the September 2007 Financing and shares of Common Stock that they may offer and sell under this prospectus.  The table also contains information for selling stockholders who hold (i) warrants previously issued by us (the “Prior Warrants”) and (ii) Series D Preferred Stock, each with certain antidilution and registration rights.  Upon the consummation of the September 2007 Financing, (i) the exercise price and number of shares issuable upon exercise of the Prior Warrants were adjusted, resulting in an additional 113,834 shares of Common Stock becoming issuable upon the exercise of the Prior Warrants, and (ii) the conversion price and number of shares issuable upon conversion of the Series D Preferred Stock were adjusted, resulting in an additional 210,528 shares of Common Stock becoming issuable upon conversion of the Series D Preferred Stock.  We agreed to register for

 

55



 

resale all of the shares of Common Stock issuable as a result of these antidilution adjustments upon exercise of the Prior Warrants and conversion of the Series D Preferred Stock.

 

 

 

NUMBER OF
SHARES
BENEFICIALLY
OWNED

 

SHARES OF
COMMON STOCK

 

SHARES BENEFICIALLY OWNED
AFTER OFFERING

 

SELLING STOCKHOLDERS (1)

 

BEFORE OFFERING

 

BEING OFFERED

 

NUMBER

 

%

 

 

 

 

 

 

 

 

 

 

 

AJW Offshore Ltd. (2)

 

4,627

 

4,627

 

0

 

*

 

AJW Partners, LLC (3)

 

835

 

835

 

0

 

*

 

AJW Qualified Partners, LLC (4)

 

2,048

 

2,048

 

0

 

*

 

Asset Factoring Ansbacher Bahamas Ltd. (5)

 

7,584

 

7,584

 

0

 

*

 

Bank of America NA & Harrison H. Augur Co-Trustees Laura T.H. Hoblitzelle T/U/W dtd 2/1/1929 FBO Harrison H. Augur (6)

 

75,000

 

75,000

 

0

 

*

 

Corman Foundation, Inc. (7)

 

3,792

 

3,792

 

0

 

*

 

Cranshire Capital, L.P. (8)

 

218,961

 

218,961

 

0

 

*

 

Empire Financial Group, Inc. (9)

 

44,415

 

44,415

 

0

 

*

 

Eugene and Natalie Ciner (10)

 

759

 

759

 

0

 

*

 

Gruber & McBaine International (11)

 

108,948

 

108,948

 

0

 

*

 

Harrison H. Augur Smith Barney 401-K Prototype, Harrison H. Augur, Trustee (12)

 

14,035

 

14,035

 

0

 

*

 

Iroquois Master Fund Ltd. (13)

 

139,220

 

139,220

 

0

 

*

 

J. Patterson McBaine (14)

 

89,035

 

89,035

 

0

 

*

 

JMR Capital Partners II LTD (15)

 

49,999

 

49,999

 

0

 

*

 

JMR Capital Partners LTD (16)

 

249,999

 

249,999

 

0

 

*

 

Jon D. and Linda W. Gruber Trust (17)

 

75,000

 

75,000

 

0

 

*

 

Kenneth H. Robertson (18)

 

24,999

 

24,999

 

0

 

*

 

Lagunitas Partners LP (19)

 

421,755

 

421,755

 

0

 

*

 

Little Bear Investments LLC (20)

 

7,200

 

7,200

 

0

 

*

 

Michael Jacks (21)

 

51,817

 

51,817

 

0

 

*

 

Neal Goldman IRA (22)

 

600,000

 

600,000

 

0

 

*

 

New Millennium Capital Partners II, LLC (23)

 

76

 

76

 

0

 

*

 

Patience Partners, L.P. (24)

 

75,000

 

75,000

 

0

 

*

 

Porter Partners, L.P. (25)

 

150,000

 

150,000

 

0

 

*

 

RHP Master Fund, Ltd. (26)

 

250,002

 

250,002

 

0

 

*

 

RMW Envirovest (27)

 

3,792

 

3,792

 

0

 

*

 

Robert D van Roijen, Jr. TTEE U/A DTD
12-14-82 FBO Robert D van Roijen, Jr. (28)

 

670,176

 

670,176

 

0

 

*

 

Sean Greene (29)

 

3,792

 

3,792

 

0

 

*

 

Taylor Family Trust, Trude C. Taylor,
Trustee (30)

 

3,982

 

3,982

 

0

 

*

 

The Kybartai Trust (31)

 

7,584

 

7,584

 

0

 

*

 

The Wallace Foundation (32)

 

15,719

 

15,719

 

0

 

*

 

Thomas R. Noonan IRA (33)

 

24,999

 

24,999

 

0

 

*

 

Trustees of Hamilton College (34)

 

15,860

 

15,860

 

0

 

*

 

Union Financial Corporation (35)

 

3,200

 

3,200

 

0

 

*

 

Valkyrie Leasing, LLC (36)

 

15,168

 

15,168

 

0

 

*

 

William Corbett (37)

 

51,817

 

51,817

 

0

 

*

 

Zachary Prensky (38)

 

19,415

 

19,415

 

0

 

*

 

 

56



 


* Represents beneficial ownership of less than 1%

 

 

 

(1)

 

The information related to voting and investment control is based on information provided to the Company by the selling stockholders as of November 5, 2007.

 

 

 

(2)

 

Comprised of 4,627 shares of common stock issuable upon exercise of warrants. Corey S. Ribotsky has voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder table for the 2006 Financings beginning on page 49 of this prospectus.

 

 

 

(3)

 

Comprised of 835 shares of common stock issuable upon exercise of warrants. Corey S. Ribotsky has voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder table for the 2006 Financings beginning on page 49 of this prospectus.

 

 

 

(4)

 

Comprised of 2,048 shares of common stock issuable upon exercise of warrants. Corey S. Ribotsky has voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder table for the 2006 Financings beginning on page 49 of this prospectus.

 

 

 

(5)

 

Comprised of 7,584 shares of common stock issuable upon exercise of warrants. Charles Johnston, vice president of investing of Asset Factoring Ansbacher Bahamas Ltd., has voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder table for the 2006 Financings beginning on page 49 of this prospectus.

 

 

 

(6)

 

Comprised of 50,000 shares of common stock held directly and 25,000 shares of common stock issuable upon exercise of warrants. Bank of America NA and Harrison H. Augur are co-trustees and share voting and investment control over these shares.

 

 

 

(7)

 

Comprised of 3,792 shares of common stock issuable upon exercise of warrants. James Corman, president of Corman Foundation, Inc., has voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder tables for the 2003 Financings and 2006 Financings beginning on page 29 and 49 of this prospectus, respectively.

 

 

 

(8)

 

Comprised of 133,334 shares of common stock held directly and 85,627 shares of common stock issuable upon exercise of warrants. Mitchell P. Kopin, the president of Downsview Capital, Inc., or DCI, the general partner of Cranshire Capital, L.P., or CCLP, has sole voting control and investment discretion over these shares. Each of Mitchell P. Kopin and DCI disclaims beneficial ownership of the shares held by CCLP. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder tables for the January 2004 Financing and 2006 Financings beginning on page 39 and 49 of this prospectus, respectively.

 

 

 

(9)

 

Comprised of 44,415 shares of common stock issuable upon exercise of warrants. Steve Rabinivice, the chief executive officer of Empire Financial Group, Inc., has voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder table for the 2006 Financings beginning on page 49 of this prospectus.

 

 

 

(10)

 

Comprised of 759 shares of common stock issuable upon exercise of warrants.

 

 

 

(11)

 

Comprised of 60,000 shares of common stock held directly, 18,948 shares of common stock issuable upon conversion of Series D Preferred Stock and 30,000 shares of common stock issuable upon exercise of warrants. Jon D. Gruber and J. Patterson McBaine, as managers of Gruber & McBaine Capital Management, LLC, have shared voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder tables for the 2003 Financings, July 2005 Financing, 2006 Financings, and March 2007 Financing beginning on page 29, 44, 49, and 53 of this prospectus, respectively.

 

 

 

(12)

 

Comprised of 14,035 shares of common stock issuable upon conversion of Series D Preferred Stock. Harrison H. Augur is the trustee and has sole voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder table for the March 2007 Financing beginning on page 53 of this prospectus.

 

 

 

(13)

 

Comprised of 83,333 shares of common stock held directly and 55,887 shares of common stock issuable upon exercise of warrants. Joshua Silverman has voting and investment control over these shares.Mr. Silverman

 

57



 

 

 

disclaims beneficial ownership over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder tables for the July 2005 Financing and 2006 Financings beginning on page 44 and 49 of this prospectus, respectively.

 

 

 

(14)

 

Comprised of 50,000 shares of common stock held directly, 14,035 shares of common stock issuable upon conversion of Series D Preferred Stock, and 25,000 shares of common stock issuable upon exercise of warrants. J. Patterson McBaine, as a manager of Gruber & McBaine Capital Management, LLC, has shared voting and investment control over the shares being sold by Gruber & McBaine International and Lagunitas Partners LP as referenced in footnotes 11 above and 19 below, respectively. The selling stockholder is also the beneficial owner of the securities set forth under his name in the selling stockholder tables for the 2003 Financings, July 2005 Financing, 2006 Financings, and March 2007 Financing beginning on page 29, 44, 49, and 53 of this prospectus, respectively.

 

 

 

(15)

 

Comprised of 33,333 shares of common stock held directly and 16,666 shares of common stock issuable upon exercise of warrants. Back Bay Management, or BBM, is the general partner of JMR Capital Partners II LTD. J. Michael Reisert is the president of BBM and has sole voting and investment control over these shares.

 

 

 

(16)

 

Comprised of 166,666 shares of common stock held directly and 83,333 shares of common stock issuable upon exercise of warrants. JMR Group is the general partner of JMR Capital Partners LTD. J. Michael Reisert is the president of JMR Group and has sole voting and investment control over these shares.

 

 

 

(17)

 

Comprised of 50,000 shares of common stock held directly and 25,000 shares of common stock issuable upon exercise of warrants.  Jon D. Gruber is the trustee and has voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder table for the July 2005 Financing beginning on page 44 of this prospectus.

 

 

 

(18)

 

Comprised of 16,666 shares of common stock held directly and 8,333 shares of common stock issuable upon exercise of warrants.

 

 

 

(19)

 

Comprised of 240,000 shares of common stock held directly, 61,755 shares of common stock issuable upon conversion of Series D Preferred Stock, and 120,000 shares of common stock issuable upon exercise of warrants. Jon D. Gruber and J. Patterson McBaine, managers of Gruber & McBaine Capital Management, LLC, have shared voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder tables for the 2003 Financings, July 2005 Financing, 2006 Financings, and March 2007 Financing beginning on page 29, 44, 49, and 53 of this prospectus, respectively.

 

 

 

(20)

 

Comprised of 7,200 shares of common stock issuable upon exercise of warrants. Zachary Prensky and Jeffrey Mann have shared voting and investment control over these shares. Zachary Prensky, an affiliate and 50% owner of Little Bear Investments LLC, or Little Bear, directly owns 19,415 shares of common stock issuable upon exercise of warrants referenced in footnote 38 below. Little Bear disclaims any ownership or control over common stock and warrants held directly by Mr. Prensky. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder tables for the 2003 Financings, July 2005 Financing, and 2006 Financings beginning on page 29, 44, and 49 of this prospectus, respectively.

 

 

 

(21)

 

Comprised of 51,817 shares of common stock issuable upon exercise of warrants. The selling stockholder is also the beneficial owner of the securities set forth under his name in the selling stockholder tables for the 2003 Financings, January 2004 Financing, July 2005 Financing, and 2006 Financings beginning on page 29, 39, 44, and 49 of this prospectus, respectively.

 

 

 

(22)

 

Comprised of 400,000 shares of common stock held directly and 200,000 shares of common stock issuable upon exercise of warrants. Neal Goldman has voting and investment control over these shares.

 

 

 

(23)

 

Comprised of 76 shares of common stock issuable upon exercise of warrants. Corey S. Ribotsky has voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder table for the 2006 Financings beginning on page 49 of this prospectus.

 

 

 

(24)

 

Comprised of 50,000 shares of common stock held directly and 25,000 shares of common stock issuable upon exercise of warrants. Harrison H. Augur and Robert van Roijen, Jr. are the managing partners of Patience Partners, L.P. and have shared voting and investment control over these shares.

 

58



 

(25)

 

Comprised of 100,000 shares of common stock held directly and 50,000 shares of common stock issuable upon exercise of warrants. Jeffrey H. Porter is the general partner of Porter Partners, L.P. and has voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder table for the January 2004 Financing beginning on page 39 of this prospectus.

 

 

 

(26)

 

Comprised of 166,668 shares of common stock held directly and 83,334 shares of common stock issuable upon exercise of warrants. RHP Master Fund, Ltd., or RHPMF, is a party to an investment agreement with Rock Hill Investment Management, L.P., or RHIM, a limited partnership of which the general partner is RHP General Partner, LLC. Pursuant to such agreement, RHIM directs the voting and disposition of shares owned by RHPMF. Messrs. Wayne Bloch and Peter Lockhart own all of the interests in RHP General Partner, LLC. The aforementioned entities and individuals disclaim beneficial ownership of the Company’s securities owned by RHPMF.

 

 

 

(27)

 

Comprised of 3,792 shares of common stock issuable upon exercise of warrants. Michael Withers has voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder table for the 2006 Financings beginning on page 49 of this prospectus.

 

 

 

(28)

 

Comprised of 400,000 shares of common stock held directly, 70,176 shares of common stock issuable upon conversion of Series D Preferred Stock, and 200,000 shares of common stock issuable upon exercise of warrants. Robert D. van Roijen, Jr. is the trustee and has voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder table for the March 2007 Financing beginning on page 53 of this prospectus.

 

 

 

(29)

 

Comprised of 3,792 shares of common stock issuable upon exercise of warrants. The selling stockholder is also the beneficial owner of the securities set forth under his name in the selling stockholder tables for the 2003 Financings and 2006 Financings beginning on page 29 and 49 of this prospectus, respectively.

 

 

 

(30)

 

Comprised of 3,982 shares of common stock issuable upon exercise of warrants. Trude C. Taylor is the trustee and has sole voting and investment control over these shares.

 

 

 

(31)

 

Comprised of 7,584 shares of common stock issuable upon exercise of warrants. Zachary Prensky is the trustee of the Kybartai Trust and has sole voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder table for the 2006 Financings beginning on page 49 of this prospectus.

 

 

 

(32)

 

Comprised of 15,719 shares of common stock issuable upon conversion of Series D Preferred Stock. The following are officers of The Wallace Foundation:  M. Christine DeVita, president, Rob D. Nagel, treasurer & director of investments, Mary E. Geras, assistant treasurer and director of finance, and Sharon W. Clark, director of operations. Any two such officers acting together may exercise voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder table for the March 2007 Financing beginning on page 53 of this prospectus.

 

 

 

(33)

 

Comprised of 16,666 shares of common stock held directly and 8,333 shares of common stock issuable upon exercise of warrants. Thomas R. Noonan has voting and investment control over these shares.

 

 

 

(34)

 

Comprised of 15,860 shares of common stock issuable upon conversion of Series D Preferred Stock. Peter J. Blanchfield, chief investment officer and Karen Leach, vice president of administration and finance, of the Trustees of Hamilton College have shared voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder table for the March 2007 Financing beginning on page 53 of this prospectus.

 

 

 

(35)

 

Comprised of 3,200 shares of common stock issuable upon exercise of warrants. Thomas R. Noonan is the president of Union Financial Corporation and has voting and investment control over these shares.

 

 

 

(36)

 

Comprised of 15,168 shares of common stock issuable upon exercise of warrants. Charles Simonyi has voting and investment control over these shares. The selling stockholder is also the beneficial owner of the securities set forth under its name in the selling stockholder tables for the 2003 Financings and 2006 Financings beginning on page 29 and 49 of this prospectus, respectively.

 

59



 

(37)

 

Comprised of 51,817 shares of common stock issuable upon exercise of warrants. The selling stockholder is also the beneficial owner of the securities set forth under his name in the selling stockholder tables for the 2003 Financings, January 2004 Financing, July 2005 Financing, and 2006 Financings beginning on page 29, 39, 44, and 49 of this prospectus, respectively.

 

 

 

(38)

 

Comprised of 19,415 shares of common stock issuable upon exercise of warrants. Zachary Prensky is an affiliate and 50% owner of Little Bear Investments LLC, or Little Bear. Mr. Prensky beneficially owns the securities held by Little Bear referenced in footnote 20 above. Mr. Prensky is also the trustee of The Kybartai Trust and beneficially owns the securities held by The Kybartai Trust referenced in footnote 31 above. The selling stockholder is also the beneficial owner of the securities set forth under his name in the selling stockholder tables for the July 2005 Financing and 2006 Financings beginning on page 44 and 49 of this prospectus, respectively.

 

Selling stockholders in the September 2007 Financing who are registered broker-dealers are “underwriters” within the meaning of the Securities Act.  In addition, selling stockholders who are affiliates of registered broker-dealers may be deemed to be “underwriters” within the meaning of the Securities Act if such selling stockholders (a) did not acquire its Common Stock, warrants or underlying stock in the ordinary course of business or (b) had any agreement or understanding, directly or indirectly, with any person to distribute the Common Stock, warrants or underlying common stock.

 

60



 

RELATIONSHIP OF SELLING STOCKHOLDERS TO THE COMPANY

 

Gruber & McBaine Capital Management, LLC and its affiliates, which include Lagunitas Partners LP and Gruber & McBaine International, beneficially own more than 10% of our issued and outstanding common stock.  J. Patterson McBaine, a selling stockholder, together with Jon D. Gruber, exercises voting and investment control over the shares held by Gruber & McBaine Capital Management, LLC, Lagunitas Partners LP, and Gruber & McBaine International. In addition, Empire Financial Group, Inc. served as a placement agent for the September 2007 Financing and 2006 Financings. None of the other selling stockholders listed above has held any position or office, or has had any material relationship, with us or any of our affiliates within the past three years.

 

PRINCIPAL STOCKHOLDERS

 

The following table sets forth information as of March 31, 2008, with respect to the beneficial ownership of shares of our common stock and Series B Preferred Stock by (i) each person known by us to be the beneficial owner of more than five percent of our common stock or Series B Preferred Stock, (ii) each director, (iii) each named executive officer and (iv) all directors and executive officers as a group .

 

 

 

Beneficial Ownership(1)

 

 

 

Series B Preferred Stock

 

Common Stock

 

Name and Address of Beneficial Owner

 

Number of
Shares

 

Percent of
Class (2)

 

Number of
Shares

 

Percent of
Class (3)

 

Directors and Named Executive Officers:

 

 

 

 

 

 

 

 

 

S. James Miller, Jr.(4)

 

0

 

*

 

694,442

 

3.7

%

John Callan(5)

 

0

 

*

 

70,967

 

*

 

David Carey(6)

 

0

 

*

 

13,340

 

*

 

G. Steve Hamm(7)

 

0

 

*

 

17,424

 

*

 

John Holleran(8)

 

0

 

*

 

29,355

 

*

 

David Loesch(9)

 

0

 

*

 

43,679

 

*

 

Wayne Wetherell(10)

 

0

 

*

 

325,180

 

1.8

 

William Willis(11)

 

0

 

*

 

224,172

 

1.2

 

Charles AuBuchon(12)

 

0

 

*

 

203,336

 

1.1

 

David Harding (13)

 

0

 

*

 

83,425

 

*

 

Total Shares Held By Directors and Executive Officers

 

0

 

*

 

1,705,320

 

8.7

 

5% Stockholders:

 

 

 

 

 

 

 

 

 

Gruber & McBaine Capital Management LLC 50 Osgood
Place San Francisco, CA(14)

 

0

 

*

 

4,249,916

 

22.4

 

Harvey and Helen Kohn (15)

 

0

 

*

 

1,025,808

 

5.5

 

Wesley Hampton

 

16,000

 

6.7

%

3,033

 

*

 

Howard Harrison(16)

 

20,000

 

8.4

 

4,197

 

*

 

Darrelyn Carpenter(17)

 

28,500

 

11.9

 

59,270

 

*

 

 


*

 

Less than one percent.

 

 

 

(1)

 

This table is based our records and Schedules 13D and 13G filed with the SEC. Unless otherwise indicated in the footnotes to this table and subject to community property laws where applicable, we believe that each of the stockholders named in this table has sole voting and investment power with respect to the shares indicated as beneficially owned. Unless otherwise indicated, the address for each listed stockholder is c/o ImageWare Systems, Inc., 10883 Thornmint Road, San Diego, CA 92127.

 

 

 

(2)

 

The percentages set forth below are based on 239,400 shares of Series B Preferred Stock outstanding as of March 31, 2008.  The holders of Series B Preferred Stock will have one vote for each share of common stock into which their shares of Series B Preferred Stock were convertible, with any fractional shares (determined on an aggregate conversion basis for each such holder) being rounded to the nearest whole share. As of March 31, 2008, each share of Series B Preferred Stock was convertible into approximately 0.1979 shares of our common stock.

 

 

 

(3)

 

The percentages set forth below are based on 18,332,788 shares of common stock outstanding as of March 31, 2008.

 

61



 

(4)

 

Mr. Miller serves as the Chairman of our Board of Directors and our Chief Executive Officer. Includes 84,680 shares held jointly with spouse and by sons and 389,085 options exercisable within 60 days of March 31, 2008 .

 

 

 

(5)

 

Includes 30,967 options exercisable within 60 days of March 31, 2008.

 

 

 

(6)

 

Includes 8,340 options exercisable within 60 days of March 31, 2008.

 

 

 

(7)

 

Includes 17,424 options exercisable within 60 days of March 31, 2008.

 

 

 

(8)

 

Includes 28,693 options exercisable within 60 days of March 31, 2008.

 

 

 

(9)

 

Includes 34,679 options exercisable within 60 days of March 31, 2008.

 

 

 

(10)

 

Includes 188,834 options exercisable within 60 days of March 31, 2008.

 

 

 

(11)

 

Includes 224,172 options exercisable within 60 days of March 31, 2008.

 

 

 

(12)

 

Includes 183,336 options exercisable within 60 days of March 31, 2008.

 

 

 

(13)

 

Includes 83,425 options exercisable within 60 days of March 31, 2008 .

 

 

 

(14)

 

Based on certain of our records and Schedule 13G filed with the SEC on January 29, 2008. Includes 610,164 shares issuable upon exercise of warrants.

 

 

 

(15)

 

Based on Schedule 13G filed with the SEC on June 12, 2007. Includes 385,748 shares issuable upon exercise of warrants.

 

 

 

(16)

 

The number of shares of common stock beneficially owned includes 406 shares held directly and 3,791 shares of common stock issuable upon conversion of Series B Preferred Stock.

 

 

 

(17)

 

The number of shares of common stock beneficially owned includes 51,027 shares held directly, 5,402 shares of common stock issuable upon conversion of Series B Preferred Stock, and 2,841 shares of common stock held by other individuals for which Mr. Carpenter is either custodian or trustee and exercises voting power.

 

PLAN OF DISTRIBUTION

 

We are registering the sale of shares of our common stock on behalf of the selling stockholders. The selling stockholders and any of their donees, pledgees, transferees or other successors-in-interest may, from time to time, sell any or all of their shares of our common stock on AMEX or any other stock exchange, market or trading facility on which the shares are traded or in private transactions. These sales may be at fixed or negotiated prices. The selling stockholders may use any one or more of he following methods when selling shares:

 

·                   ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;

 

·                   block trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction;

 

·                   purchases by a broker-dealer as principal and resale by the broker-dealer for its account;

 

·                   an exchange distribution in accordance with the rules of the applicable exchange;

 

·                   privately negotiated transactions;

 

·                   settlement of short sales entered into after the effective date of the registration statement of which this prospectus is a part;

 

62



 

·                   broker-dealers may agree with the selling stockholders to sell a specified number of such shares at a stipulated price per share;

 

·                   through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;

 

·                   a combination of any such methods of sale; or

 

·                   any other method permitted pursuant to applicable law.

 

The selling stockholders may also sell shares under Rule 144 under the Securities Act, if available, rather than under this prospectus.

 

Broker-dealers engaged by the selling stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts from the selling stockholders (or, if any broker-dealer acts as agent for the purchaser of shares, from the purchaser) in amounts to be negotiated, but, except as set forth in a supplement to this prospectus, in the case of an agency transaction not in excess of a customary brokerage commission in compliance with NASDR Rule 2440; and in the case of a principal transaction a markup or markdown in compliance with NASDR IM-2440.

 

In connection with the sale of the common stock or interests therein, the selling stockholders may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the common stock in the course of hedging the positions they assume. The selling stockholders may also sell shares of the common stock short and deliver these securities to close out their short positions entered into after the effective date of the registration statement of which this prospectus is a part, or loan or pledge the common stock to broker-dealers that in turn may sell these securities. The selling stockholders may also enter into option or other transactions with broker-dealers or other financial institutions or the creation of one or more derivative securities which require the delivery to such broker-dealer or other financial institution of shares offered by this prospectus, which shares such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).

 

The selling stockholders and any broker-dealers or agents that are involved in selling the shares may be deemed to be “underwriters” within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any profit on the resale of the shares purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act.

 

The Company is required to pay certain fees and expenses incurred by the Company incident to the registration of the shares. The Company has agreed to indemnify the selling stockholders, its directors and officers and each person who controls the selling stockholders (within the meaning of Section 15 of the Securities Act) against certain claims, losses, damages and liabilities, including liabilities under the Securities Act.

 

Because the selling stockholders may be deemed to be a “underwriters” within the meaning of the Securities Act, they will be subject to the prospectus delivery requirements of the Securities Act including Rule 172 thereunder. There is no underwriter or coordinating broker acting in connection with the proposed sale of the resale shares by the selling stockholders.

 

We agreed to keep this prospectus effective until the earlier of (i) the date on which the shares may be resold by the selling stockholders without registration and without regard to any volume limitations by reason of Rule 144(k) under the Securities Act or any other rule of similar effect or (ii) all of the shares have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule of similar effect.  The resale shares will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws.  In addition, in certain states, the resale shares may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with.

 

Under applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the resale shares may not simultaneously engage in market making activities with respect to the common stock for the applicable restricted period, as defined in Regulation M, prior to the commencement of the distribution. In addition, the selling stockholders will be subject to applicable provisions of the Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of shares of the common stock by the selling stockholders or any other person. We will make copies of this prospectus available to the selling stockholders for the purpose of satisfying the prospectus delivery requirements of the Securities Act.

 

63



 

EXPERTS

 

Stonefield Josephson, Inc., independent registered public accounting firm, has audited our financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2007, as set forth in its report (which contains an explanatory paragraph describing conditions that raise substantial doubt about our ability to continue as a going concern as described in Note 1 to the consolidated financial statements), which is incorporated by reference in this prospectus and elsewhere in the registration statement of which this prospectus forms a part. Our financial statements are incorporated by reference in reliance on Stonefield Josephson, Inc.’s report, given on their authority as experts in accounting and auditing.

 

LEGAL MATTERS

 

The validity of our common stock offered hereby has been passed upon for us by Paul, Hastings, Janofsky & Walker LLP, San Diego, California.

 

WHERE YOU CAN FIND MORE INFORMATION

 

This prospectus is part of a Post Effective Amendment on Form S-1 to Form SB-2 and Forms S-3 Registration Statement that we filed with the SEC. Certain information in the registration statement has been omitted from this prospectus in accordance with the rules and regulations of the SEC.

 

We electronically file annual, quarterly and special reports, proxy and information statements and other information with the SEC. The public may read and copy any materials we file with the SEC at the SEC’s Public Reference Room at 100 F Street, N.E., Washington, D.C. 20549. The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC also maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. The address of that site is http://www.sec.gov. Our website address is www.iwsinc.com. Information contained in, or accessible through, our website is not a part of this prospectus.

 

INCORPORATION OF CERTAIN INFORMATION BY REFERENCE

 

The SEC allows us to “incorporate by reference” the information we file with them. This means that we can disclose important information to you by referring to other documents filed with the SEC that contain that information.

 

The following documents filed with the SEC are incorporated by reference into this prospectus:

 

(a)   Annual Report on Form 10-K for the year ended December 31, 2007 filed with the SEC on April 15, 2008;

 

(b)   Current Reports on Form 8-K filed with the SEC, March 6, 2008, March 12, 2008, March 18, 2008, April 1, 2008, April 3, 2008, and April 4, 2008; and

 

(c)   Description of our common stock contained in our Registration Statement on Form 8-A filed on March 21, 2000 (File No. 001-15757), pursuant to Section 12(b) of the Exchange Act, including any amendment or report filed for the purpose of updating such description.

 

You may obtain a copy of any of the above-referenced documents, at no cost, from our website at www.iwsinc.com, or by writing or telephoning us at the following address:

 

Corporate Secretary
ImageWare Systems, Inc.
10883 Thornmint Road
San Diego, California 92127
(858) 673-8600

 

64



 

You should rely only on the information provided or incorporated by reference in this registration statement or any related prospectus. We have not authorized anyone to provide you with different information. You should not assume that the information in this registration statement or any related prospectus, including any information incorporated herein by reference, is accurate as of any date other than the date on the front of the applicable document, or such earlier date as is expressly stated or otherwise apparent with respect to such incorporated information in the applicable document, regardless of the time of delivery of this prospectus or any sale of our common stock. Our business, financial condition, results of operations and prospects may have changed since any such date.

 

65



 

Part II

 

INFORMATION NOT REQUIRED IN PROSPECTUS

 

Item 13 .                 Other Expenses of Issuance and Distribution

 

The following table lists the costs and expenses payable by the Registrant in connection with the sale of the common stock covered by this prospectus other than any sales commissions or discounts, which expenses will be paid by the selling stockholders. All amounts shown are estimates except for the SEC registration fee.

 

SEC registration fee

 

$

0

 

Legal fees and expenses

 

65,000

 

Accounting fees and expenses

 

5,000

 

Printing expenses

 

25,000

 

Miscellaneous fees and expenses

 

5,000

 

Total

 

$

100,000

 

 

Item 14 .                 Indemnification of Directors and Officers

 

The Registrant is incorporated under the laws of the State of Delaware. Section 145 of the Delaware General Corporation Law provides that a Delaware corporation may indemnify any persons who are, or are threatened to be made, parties to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of such corporation), by reason of the fact that such person was an officer, director, employee or agent of such corporation, or is or was serving at the request of such person as an officer, director, employee or agent of another corporation or enterprise. The indemnity may include expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such action, suit or proceeding, provided that such person acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the corporation’s best interests and, with respect to any criminal action or proceeding, had no reasonable cause to believe that his or her conduct was illegal. A Delaware corporation may indemnify any persons who are, or are threatened to be made, a party to any threatened, pending or completed action or suit by or in the right of the corporation by reason of the fact that such person was a director, officer, employee or agent of such corporation, or is or was serving at the request of such corporation as a director, officer, employee or agent of another corporation or enterprise. The indemnity may include expenses (including attorneys’ fees) actually and reasonably incurred by such person in connection with the defense or settlement of such action or suit provided such person acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the corporation’s best interests except that no indemnification is permitted without judicial approval if the officer or director is adjudged to be liable to the corporation. Where an officer or director is successful on the merits or otherwise in the defense of any action referred to above, the corporation must indemnify him or her against the expenses that such officer or director has actually and reasonably incurred. The Registrant’s amended and restated certificate of incorporation and amended and restated bylaws provide for the indemnification of the Registrant’s directors and officers to the fullest extent permitted under the Delaware General Corporation Law.

 

The Registrant’s amended and restated bylaws provide that expenses incurred by any officer or director in defending any such action, suit or proceeding in advance of its final disposition shall be paid by the Registrant, provided, however, that if required by the Delaware General Corporation Law, such expenses shall be advanced only upon delivery to the Registrant of an undertaking, by or on behalf of such director or officer, to repay all amounts so advanced if it shall ultimately be determined that such director or officer is not entitled to be indemnified by the Registrant.

 

Section 174 of the Delaware General Corporation Law provides, among other things, that a director who willfully or negligently approves of an unlawful payment of dividends or an unlawful stock purchase or redemption may be held liable for such actions. A director who was either absent when the unlawful actions were approved, or dissented at the time, may avoid liability by causing his or her dissent to such actions to be entered in the books containing minutes of the meetings of the board of directors at the time such action occurred or immediately after such absent director receives notice of the unlawful acts.

 

As permitted by the Delaware General Corporation Law, the Registrant has entered into indemnity agreements with each of its directors and executive officers that require the Registrant to indemnify such persons against any and all expenses including attorneys’, witness or other professional fees and related disbursements and other out-of-pocket costs incurred by such director or officer in connection with the investigation, defense or appeal of a proceeding or establishing or enforcing a

 

II-1



 

right to indemnification under the indemnity agreements, Delaware General Corporation Law or otherwise, and amounts paid in settlement by or on behalf of such director or officer, but will not include any judgments, fines or penalties actually levied against such director or officer for such individual’s violations of law. Proceedings that are covered by the indemnity agreements include any threatened, pending or completed action, suit, arbitration, alternate dispute resolution mechanism, investigation, inquiry, administrative hearing or any other actual, threatened or completed proceeding (including an action by or in the Registrant’s right), and whether civil, criminal, administrative or investigative in nature to which such director or officer is, was or at any time will be involved as a party, or is threatened to be made a party, by reason of the fact: (i) that such director or officer is or was a director or officer; or (ii) that such director or officer is or was serving at the Registrant’s request as a director, officer, employee or agent of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise, whether or not serving in such capacity at the time any liability or expense is incurred for which indemnification, reimbursement, or advancement of expenses may be provided under the indemnity agreements.

 

Such additional indemnity is not available, however, with respect to: (i) a final judgment rendered against such director or officer for an accounting, disgorgement or repayment of profits made from the purchase or sale by such individual of securities of the Registrant against such individual or in connection with a settlement by or on behalf of such individual to the extent it is acknowledged by him or her and the Registrant that such amount paid in settlement resulted from the individual’s conduct from which the individual received monetary personal profit, pursuant to the provisions of Section 16(b) of the Exchange Act or other provisions of any federal, state or local statute or rules and regulations thereunder; (ii) a final judgment that such director or officer’s conduct was in bad faith, knowingly fraudulent or deliberately dishonest or constituted willful misconduct (but only to the extent of such specific determination); (iii) on account of conduct that is established by a final judgment as constituting a breach of such director or officer’s duty of loyalty to the Registrant or resulting in any personal profit or advantage to which such individual is not legally entitled; (iv) claims for which payment is actually made to such director or officer under a valid and collectible insurance policy or under a valid and enforceable indemnity clause, bylaw or agreement, except in respect of any excess beyond payment under such insurance, clause, bylaw or agreement; or (v) remuneration paid to such director or officer, if it is determined by final judgment that such remuneration was in violation of law (and, in this respect, both the Registrant and such individual have been advised that the Commission believes that indemnification for liabilities arising under the federal securities laws is against public policy and is, therefore, unenforceable and that claims for indemnification should be submitted to appropriate courts for adjudication). Nor do the indemnity agreements provide for additional indemnity with respect to proceedings or claims initiated or brought by such director or officer against the Registrant or its directors, officers, employees or other agents, except with respect to: (a) indemnification required by applicable law; (b) proceedings authorized by the Registrant’s board of directors; (c) indemnification provided by the Registrant in its sole discretion pursuant to its powers under the Delaware General Corporation Law; or (d) proceedings brought to enforce a right to indemnification under the indemnity agreements. The indemnity agreements do not obligate the Registrant to pay for any amounts paid in settlement of a proceeding effected without the Registrant’s written consent. The indemnification agreements also set forth certain procedures that will apply in the event of a claim for indemnification thereunder.

 

The Registrant has an insurance policy covering its officers and directors with respect to certain liabilities, including liabilities arising under the Securities Act of 1933, as amended (the “Securities Act”) or otherwise.

 

Item 15.                 Recent Sales of Unregistered Securities

 

Since January 2005, we have issued the following securities that were not registered under the Securities Act:

 

(1)  In April 1, 2005, the Registrant sold and issued to Argus Solutions Ltd., a New South Wales, Australia corporation and accredited investor, an aggregate of 71,225 shares of the Registrant’s common stock for aggregate gross proceeds of approximately $250,000. This transaction was exempt from registration under Section 4(2) of the Securities Act.

 

(2)  On July 22, 2005, the Registrant sold and issued to accredited investors 1,203,489 shares of the Registrant’s common stock, and warrants to purchase up to an aggregate of 457,356 shares of the Registrant’s common stock, for aggregate gross proceeds of approximately $3.1 million. Additionally, the Registrant issued the finder in the transaction a warrant to purchase up to an aggregate of 90,262 shares of the Registrant’s common stock. These transactions were exempt from registration under Section 4(2) of the Securities Act.

 

(3)  On July 28, 2005, the Registrant sold and issued to accredited investors 193,798 shares of the Registrant’s common stock, and warrants to purchase up to an aggregate of 73,642 shares of the Registrant’s common stock, for aggregate gross proceeds of approximately $500,000. Additionally, the Registrant issued the finder in the transaction a warrant to purchase up to an aggregate of 14,534 shares of the Registrant’s common stock. These transactions were exempt from registration under Section 4(2) of the Securities Act.

 

II-2



 

(4)  On March 17, 2006, the Registrant consummated a loan in the aggregate amount of $1,550,000 (the “Loan”) from multiple lenders (the “Lenders”) in consideration for the issuance of secured promissory notes (the “Notes”) to the Lenders. In connection with the Loan, the Registrant issued the Lenders warrants to purchase up to an aggregate of 387,500 shares of the Registrant’s common stock. This transaction was exempt from registration under Section 4(2) of the Securities Act.

 

(5)  On November 14, 2006, the Registrant sold and issued to accredited investors (the “Series C Investors”) an aggregate of 2,300 shares of the Registrant’s Series C 8% Convertible Preferred Stock (the “Series C Financing”) and issued to the Series C Investors warrants to purchase up to an aggregate of 115,000 shares of the Registrant’s common stock, for aggregate gross proceeds of $2,300,000. In connection with the transaction, the Registrant issued the placement agent and its affiliates warrants to purchase up to an aggregate of 40,000 shares of the Registrant’s common stock. These transactions were exempt from registration under Section 4(2) of the Securities Act and Rule 506 promulgated thereunder.

 

Additionally, the consummation of the Series C Financing caused all amounts outstanding under the Notes to become immediately due and payable in full. In consideration for the Lender’s written waiver of the acceleration of the Notes in connection with the Series C Financing the Registrant issued the Lenders warrants to purchase up to an aggregate of 200,250 shares of the Registrant’s common stock. This transaction was also exempt from registration under Section 4(2) of the Securities Act and Rule 506 promulgated thereunder.

 

(6)  On March 9, 2007, the Registrant sold and issued to accredited investors (the “Series D Investors”) an aggregate of 1,500 shares of the Registrant’s Series D 8% Convertible Preferred Stock and issued to the Series D Investors warrants to purchase up to an aggregate of 59,207 shares of the Registrant’s common stock, for aggregate gross proceeds of $1,500,000. This transaction was exempt from registration under Section 4(2) of the Securities Act and Rule 506 promulgated thereunder.

 

(7)  On September 25, 2007, the Registrant sold and issued to accredited investors (the “Investors”) an aggregate of 2,016,666 shares of the Registrant’s common stock, and issued to the Investors warrants (the “September 2007 Investor Warrants”) to purchase up to an aggregate of 1,008,333 shares of the Registrant’s common stock, for aggregate gross proceeds of approximately $3,000,000. Additionally, the Registrant issued the placement agent in the transaction a warrant to purchase up to an aggregate of 151,249 shares of the Registrant’s common stock. This transaction was exempt from registration under Section 4(2) of the Securities Act and Rule 506 promulgated thereunder.

 

(8)  On December 19, 2007, the Registrant sold and issued to an accredited investor, Sol Logic, 677,940 shares of restricted common stock of the Registrant (the “Initial Shares”), and, in the event certain milestones are achieved, the Registrant will issue to Sol Logic the number of shares of restricted common stock (the “Additional Shares”), equal to the quotient obtained by dividing $1,921,924 by the greater of (A) $1.10 and (B) the volume weighted average closing price of the Registrant’s common stock over the 20 trading-day period immediately prior to the date the Additional Shares are issued, as reported on the American Stock Exchange or the Over-the-Counter Bulletin Board. The Initial Shares were issued to Sol Logic in consideration for certain assets of Sol Logic, including customer contracts, software licenses and intellectual property. This transaction was exempt from registration under Section 4(2) of the Securities Act.

 

(9)  On March 12, 2008, the Registrant reduced the price of the Warrants, which initially had an exercise price of $1.67 per share, to an exercise price of $1.00 per share, in consideration for their immediate exercise (the “Warrant Repricing”) by the Investors who participated in the Warrant Repricing (the “Participating Investors”).  In addition, the Registrant also issued to the Participating Investors new warrants to purchase up to an aggregate of 270,833 shares of the Registrant’s common stock.  The Registrant received aggregate gross proceeds of $541,666 from the Warrant Repricing.  This transaction was exempt from registration under Section 4(2) of the Securities Act and Rule 506 promulgated thereunder.

 

Item 16.                 Exhibits and Financial Statement Schedules

 

(a)   Exhibits

 

Exhibit
Number

 

Description

2.1

 

Stock Purchase Agreement, dated March 1, 2005, between the Registrant and Argus Solutions Ltd. (incorporated by reference to Exhibit 2.1 to the Registrant’s Current Report on Form 8-K, filed March 9, 2005).

2.2

 

Agreement and Plan of Merger, dated October 27, 2005 (incorporated by reference to Annex A to the Registrant’s Definitive Proxy Statement on Schedule 14A, filed November 15, 2005).

3.1

 

Certificate of Incorporation (incorporated by reference to Annex B to the Registrant’s Definitive Proxy Statement on Schedule 14A, filed November 15, 2005).

 

II-3



 

Exhibit
Number

 

Description

3.2

 

Bylaws (incorporated by reference to Annex C to the Registrant’s Definitive Proxy Statement on Schedule 14A, filed November 15, 2005).

3.3

 

Certificate of Designations of Preferences, Rights and Limitations of Series C 8% Convertible Preferred Stock dated November 2, 2006, as amended (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K, filed November 20, 2006).

3.4

 

Certificate of Designations of Preferences, Rights and Limitations of Series D 8% Convertible Preferred Stock dated March 8, 2007 (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K, filed March 15, 2007).

4.1

 

Warrant to Purchase Common Stock in favor of Imperial Bank, dated January 15, 1998 (incorporated by reference to Exhibit 10.42 to the Registrant’s Registration Statement on Form SB-2 (No. 333-93131), filed December 20, 1999, as amended).

4.2

 

Registration Rights Agreement, dated May 22, 2002, by and between the Registrant and Perseus 2000 L.L.C. (incorporated by reference to Exhibit 10.3 to the Registrant’s Current Report on Form 8-K, filed May 24, 2002).

4.3

 

Warrant to Purchase Common Stock, dated June 13, 2003, issued by the Registrant to L.F. Global Holdings, LLC (incorporated by reference to Exhibit 10.5 to the Registrant’s Current Report on Form 8-K, filed June 20, 2003).

4.4

 

Form of Warrant dated November 24, 2003 (incorporated by reference to Exhibit 99.2 to the Registrant’s Current Report on Form 8-K, filed February 9, 2004).

4.5

 

Form of Registration Rights Agreement dated November 24, 2003 (incorporated by reference to Exhibit 99.3 to the Registrant’s Current Report on Form 8-K, filed February 9, 2004).

4.6

 

Form of Registration Rights Agreement dated March 13, 2003 (incorporated by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-QSB, filed May 15, 2003).

4.7

 

Form of Warrant dated January 29, 2004 (incorporated by reference to Exhibit 99.5 to the Registrant’s Current Report on Form 8-K, filed February 9, 2004).

4.8

 

Form of Registration Rights Agreement dated January 29, 2004 (incorporated by reference to Exhibit 99.8 to the Registrant’s Current Report on Form 8-K, filed February 9, 2004).

4.9

 

Form of Warrant dated July 22, 2005 and dated July 28, 2005 (incorporated by reference to Exhibit A to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K, filed July 26, 2005).

4.10

 

Form of Warrant dated March 17, 2006 (incorporated by reference to Exhibit 4.1 to the Registrant’s Quarterly Report on Form 10-Q, filed May 22, 2006).

4.11

 

Registration Rights Agreement, dated November 14, 2006 by and among the Registrant and certain investors (incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K, filed November 20, 2006).

4.12

 

Form of Warrant to Purchase Common Stock dated November 14, 2006 (incorporated by reference to Exhibit 10.3 to the Registrant’s Current Report on Form 8-K, filed November 20, 2006).

4.13

 

Registration Rights Agreement, dated March 9, 2007, by and among the Registrant and certain accredited investors (incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K, filed March 15, 2007).

4.14

 

Form of Warrant to Purchase Common Stock dated March 9, 2007 (incorporated by reference to Exhibit 10.3 to the Registrant’s Current Report on Form 8-K, filed March 15, 2007).

4.15

 

Registration Rights Agreement, dated September 25, 2007, by and among the Registrant and certain accredited investors (incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K, filed September 26, 2007).

4.16

 

Form of Warrant to Purchase Common Stock dated September 25, 2007 (incorporated by reference to Exhibit 10.3 to the Registrant’s Current Report on Form 8-K, filed September 26, 2007).

4.17

 

Registration Rights Agreement, dated December 19, 2007, by and among the Registrant, Sol Logic, and Wink Jones, as the representative of Sol Logic (incorporated by reference to Exhibit 4.1 to the Registrant’s Current Report on Form 8-K, filed December 21, 2007).

4.18

 

Form of Warrant to Purchase Common Stock dated March 12, 2008 (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K, filed March 18, 2008).

4.19

 

Amendment No.1 to Registration Rights Agreement, dated March 28, 2008, by and among the Registrant, Sol Logic, and Wink Jones, as the representative of Sol Logic (incorporated by reference to Exhibit 4.1 to the Registrant’s Current Report on Form 8-K, filed April 1, 2008).

5.1

 

Opinion of Paul, Hastings, Janofsky & Walker LLP**

10.1

 

Employment Agreement, dated September 27, 2005, between the Registrant and S. James Miller (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K, filed September 30, 2005).

 

II-4



 

Exhibit
Number

 

Description

10.2

 

Employment Agreement, dated September 27, 2005, between the Registrant and Wayne G. Wetherell (incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K, filed September 30, 2005).

10.3

 

Change of Control and Severance Benefits Agreement, dated October 31, 2005, between Registrant and Charles Aubuchon (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K, filed November 3, 2005).

10.4

 

Offer of Employment Letter Agreement, dated December 19, 2007, between the Registrant and Frank Mitchell (incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K, filed December 21, 2007).

10.5

 

Form of Indemnification Agreement entered into by the Registrant with its directors and executive officers (incorporated by reference to Exhibit 10.4 to the Registrant’s Registration Statement on Form SB-2 (No. 333-93131), filed December 20, 1999, as amended).

10.6

 

1994 Employee Stock Option Plan (incorporated by reference to Exhibit 10.6 to the Registrant’s Registration Statement on Form SB-2 (No. 333-93131), filed December 20, 1999, as amended).

10.7

 

1994 Nonqualified Stock Option Plan (incorporated by reference to Exhibit 10.7 to the Registrant’s Registration Statement on Form SB-2 (No. 333-93131), filed December 20, 1999, as amended).

10.8

 

Amended and Restated 1999 Stock Plan Award (incorporated by reference to Appendix B of the Registrant’s Definitive Proxy Statement on Schedule 14A, filed November 21, 2007).

10.9

 

Form of Stock Option Agreement (incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K, filed July 14, 2005).

10.10

 

2001 Equity Incentive Plan (incorporated by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-QSB, filed November 14, 2001).

10.11

 

Form of Restricted Stock Bonus Agreement (incorporated by reference to Exhibit 99.3 to the Registrant’s Registration Statement on Form S-8, filed November 27, 2001).

10.12

 

Form of Stock Option Agreement (incorporated by reference to Exhibit 99.2 to the Registrant’s Registration Statement on Form S-8, filed November 27, 2001).

10.13

 

Note and Warrant Purchase Agreement, dated May 22, 2002, by and between the Registrant and Perseus (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K, filed May 24, 2002).

10.14

 

Form of Securities Purchase Agreement dated November 14, 2003 (incorporated by reference to Exhibit 99.1 to the Registrant’s Current Report on Form 8-K, filed February 9, 2004).

10.15

 

Form of Securities Purchase Agreement dated January 29, 2004 (incorporated by reference to Exhibit 99.4 to the Registrant’s Current Report on Form 8-K, filed February 9, 2004).

10.16

 

Offer of Restricted Stock in Exchange for Certain Stock Options Previously Granted — Offer Made to James Miller (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-QSB, filed August 16, 2004).

10.17

 

Offer of Restricted Stock in Exchange for Certain Stock Options Previously Granted — Offer Made to Wayne Wetherell, dated March 30, 2004 (incorporated by reference to Exhibit 10.3 to the Registrant’s Quarterly Report on Form 10-QSB, filed August 16, 2004).

10.18

 

Form of Securities Purchase Agreement dated July 22, 2005 and July 28, 2005 (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K, filed July 26, 2005).

10.19

 

Security Agreement, dated March 17, 2006, executed by the Registrant in favor of Little Bear Investments, LLC (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K, filed March 23, 2006).

10.20

 

Form of Secured Promissory Note dated March 17, 2006 (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q, filed May 22, 2006).

10.21

 

Securities Purchase Agreement, dated November 14, 2006 by and among the Registrant and certain accredited investors (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K, filed November 20, 2006).

10.22

 

Securities Purchase Agreement, dated March 9, 2007, by and among the Registrant and certain accredited investors (incorporated by reference to Exhibit 10.1 to the Registrant Current Report on Form 8-K, filed March 15, 2007).

10.23

 

Securities Purchase Agreement, dated September 25, 2007, by and among the Registrant and certain accredited investors (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K, filed September 26, 2007).

10.24

 

Asset Purchase Agreement and Plan of Reorganization, by and among Sol Logic, Frank Mitchell, as shareholder of Sol Logic, and Wink Jones, as the representative of Sol Logic (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K, filed December 21, 2007).

10.25

 

Amendment No.1 to Asset Purchase Agreement and Plan of Reorganization, by and between the Registrant and Wink Jones, as the representative of Sol Logic (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K, filed April 1, 2008).

10.26

 

Product Line Purchase Agreement, dated November 30, 2006, by and between the Registrant and PhotoLynx, Inc. (incorporated by reference to Exhibit 10.3 to the Registrant’s Current Report on Form 8-K, filed December 26, 2006).

 

II-5



 

Exhibit
Number

 

Description

10.27

 

Standard Commercial Lease, dated September 26, 2003, by and between Thornmint I and the Registrant (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-QSB, filed November 14, 2003).

10.28

 

Amendment to Office Lease, dated June 12, 2006, by and between Thornmint I and the Registrant (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q, filed August 14, 2006).

10.29

 

Office Lease, dated September 7, 2006, by and between Union Bank of California as Trustee for Quest Group Trust VII and the Registrant (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q, filed November 20, 2006).

10.30

 

Office Space Lease between I.W. Systems Canada Registrant and Dundeal Canada (GP) Inc. dated June 1, 2006 (incorporated by reference to Exhibit 10.40 to the Registrant’s Annual Report on Form 10-K, filed April 17, 2007).

21.1

 

Subsidiaries of the Registrant (incorporated by reference to Exhibit 21.1 to the Registrant’s Registration Statement on Form S-1, filed January 18, 2008).

23.1

 

Consent of Stonefield Josephson, Inc., Independent Registered Public Accounting Firm

24.1

 

Power of Attorney**

 


** Previously filed.

 

Item 17.                 Undertakings

 

(a)  The undersigned registrant hereby undertakes:

 

(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

 

(i) To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933, as amended (the “Securities Act”);

 

(ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Securities and Exchange Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement.

 

(iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement.

 

(2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

 

(4) That, for the purpose of determining liability under the Securities Act to any purchaser, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness; provided, however, that no statement made in the registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.

 

(b)  Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful

 

II-6



 

defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.

 

II-7



 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Diego, State of California, on April 15, 2008.

 

 

IMAGEWARE SYSTEMS, INC.

 

 

 

By:

/s/ Wayne Wetherell

 

 

  Wayne Wetherell

 

 

  Chief Financial Officer

 

Pursuant to the requirements of the Securities Act of 1933, as amended, this Amendment No. 1 on Form S-1 to Registration Statement on Form SB-2 and Forms S-3 has been signed by the following persons in the capacities and on the dates indicated.

 

SIGNATURE

 

TITLE(S)

 

DATE

 

 

 

 

 

*

 

Chief Executive Officer and Chairman of the

 

April 15, 2008

S. James Miller, Jr.

 

Board (Principal Executive Officer)

 

 

 

 

 

 

 

/s/ Wayne Wetherell

 

Senior Vice President, Administration and Chief

 

April 15, 2008

Wayne Wetherell

 

Financial Officer (Principal Financial and

 

 

 

 

Accounting Officer)

 

 

 

 

 

 

 

*

 

Director

 

 

John Callan

 

 

 

April 15, 2008

 

 

 

 

 

*

 

Director

 

 

David Carey

 

 

 

April 15, 2008

 

 

 

 

 

*

 

Director

 

 

G. Steve Hamm

 

 

 

April 15, 2008

 

 

 

 

 

*

 

Director

 

 

John L. Holleran

 

 

 

April 15, 2008

 

 

 

 

 

*

 

Director

 

 

David Loesch

 

 

 

April 15, 2008

 

*By:

/s/ Wayne Wetherell

 

 

 

April 15, 2008

 Wayne Wetherell

 

 

 

 

 Attorney-in-fact

 

 

 

 

 

II-8



 

EXHIBIT INDEX

 

Exhibit
Number

 

Description

2.1

 

Stock Purchase Agreement, dated March 1, 2005, between the Registrant and Argus Solutions Ltd. (incorporated by reference to Exhibit 2.1 to the Registrant’s Current Report on Form 8-K, filed March 9, 2005).

2.2

 

Agreement and Plan of Merger, dated October 27, 2005 (incorporated by reference to Annex A to the Registrant’s Definitive Proxy Statement on Schedule 14A, filed November 15, 2005).

3.1

 

Certificate of Incorporation (incorporated by reference to Annex B to the Registrant’s Definitive Proxy Statement on Schedule 14A, filed November 15, 2005).

3.2

 

Bylaws (incorporated by reference to Annex C to the Registrant’s Definitive Proxy Statement on Schedule 14A, filed November 15, 2005).

3.3

 

Certificate of Designations of Preferences, Rights and Limitations of Series C 8% Convertible Preferred Stock dated November 2, 2006, as amended (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K, filed November 20, 2006).

3.4

 

Certificate of Designations of Preferences, Rights and Limitations of Series D 8% Convertible Preferred Stock dated March 8, 2007 (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K, filed March 15, 2007).

4.1

 

Warrant to Purchase Common Stock in favor of Imperial Bank, dated January 15, 1998 (incorporated by reference to Exhibit 10.42 to the Registrant’s Registration Statement on Form SB-2 (No. 333-93131), filed December 20, 1999, as amended).

4.2

 

Registration Rights Agreement, dated May 22, 2002, by and between the Registrant and Perseus 2000 L.L.C. (incorporated by reference to Exhibit 10.3 to the Registrant’s Current Report on Form 8-K, filed May 24, 2002).

4.3

 

Warrant to Purchase Common Stock, dated June 13, 2003, issued by the Registrant to L.F. Global Holdings, LLC (incorporated by reference to Exhibit 10.5 to the Registrant’s Current Report on Form 8-K, filed June 20, 2003).

4.4

 

Form of Warrant dated November 24, 2003 (incorporated by reference to Exhibit 99.2 to the Registrant’s Current Report on Form 8-K, filed February 9, 2004).

4.5

 

Form of Registration Rights Agreement dated November 24, 2003 (incorporated by reference to Exhibit 99.3 to the Registrant’s Current Report on Form 8-K, filed February 9, 2004).

4.6

 

Form of Registration Rights Agreement dated March 13, 2003 (incorporated by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-QSB, filed May 15, 2003).

4.7

 

Form of Warrant dated January 29, 2004 (incorporated by reference to Exhibit 99.5 to the Registrant’s Current Report on Form 8-K, filed February 9, 2004).

4.8

 

Form of Registration Rights Agreement dated January 29, 2004 (incorporated by reference to Exhibit 99.8 to the Registrant’s Current Report on Form 8-K, filed February 9, 2004).

4.9

 

Form of Warrant dated July 22, 2005 and dated July 28, 2005 (incorporated by reference to Exhibit A to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K, filed July 26, 2005).

4.10

 

Form of Warrant dated March 17, 2006 (incorporated by reference to Exhibit 4.1 to the Registrant’s Quarterly Report on Form 10-Q, filed May 22, 2006).

4.11

 

Registration Rights Agreement, dated November 14, 2006 by and among the Registrant and certain investors (incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K, filed November 20, 2006).

4.12

 

Form of Warrant to Purchase Common Stock dated November 14, 2006 (incorporated by reference to Exhibit 10.3 to the Registrant’s Current Report on Form 8-K, filed November 20, 2006).

4.13

 

Registration Rights Agreement, dated March 9, 2007, by and among the Registrant and certain accredited investors (incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K, filed March 15, 2007).

4.14

 

Form of Warrant to Purchase Common Stock dated March 9, 2007 (incorporated by reference to Exhibit 10.3 to the Registrant’s Current Report on Form 8-K, filed March 15, 2007).

4.15

 

Registration Rights Agreement, dated September 25, 2007, by and among the Registrant and certain accredited investors (incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K, filed September 26, 2007).

4.16

 

Form of Warrant to Purchase Common Stock dated September 25, 2007 (incorporated by reference to Exhibit 10.3 to the Registrant’s Current Report on Form 8-K, filed September 26, 2007).

4.17

 

Registration Rights Agreement, dated December 19, 2007, by and among the Registrant, Sol Logic, and Wink Jones, as the representative of Sol Logic (incorporated by reference to Exhibit 4.1 to the Registrant’s Current Report on Form 8-K, filed December 21, 2007).

 



 

Exhibit
Number

 

Description

4.18

 

Form of Warrant to Purchase Common Stock dated March 12, 2008 (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K, filed March 18, 2008).

4.19

 

Amendment No.1 to Registration Rights Agreement, dated March 28, 2008, by and among the Registrant, Sol Logic, and Wink Jones, as the representative of Sol Logic (incorporated by reference to Exhibit 4.1 to the Registrant’s Current Report on Form 8-K, filed April 1, 2008).

5.1

 

Opinion of Paul, Hastings, Janofsky & Walker LLP**

10.1

 

Employment Agreement, dated September 27, 2005, between the Registrant and S. James Miller (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K, filed September 30, 2005).

10.2

 

Employment Agreement, dated September 27, 2005, between the Registrant and Wayne G. Wetherell (incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K, filed September 30, 2005).

10.3

 

Change of Control and Severance Benefits Agreement, dated October 31, 2005, between Registrant and Charles Aubuchon (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K, filed November 3, 2005).

10.4

 

Offer of Employment Letter Agreement, dated December 19, 2007, between the Registrant and Frank Mitchell (incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K, filed December 21, 2007).

10.5

 

Form of Indemnification Agreement entered into by the Registrant with its directors and executive officers (incorporated by reference to Exhibit 10.4 to the Registrant’s Registration Statement on Form SB-2 (No. 333-93131), filed December 20, 1999, as amended).

10.6

 

1994 Employee Stock Option Plan (incorporated by reference to Exhibit 10.6 to the Registrant’s Registration Statement on Form SB-2 (No. 333-93131), filed December 20, 1999, as amended).

10.7

 

1994 Nonqualified Stock Option Plan (incorporated by reference to Exhibit 10.7 to the Registrant’s Registration Statement on Form SB-2 (No. 333-93131), filed December 20, 1999, as amended).

10.8

 

Amended and Restated 1999 Stock Plan Award (incorporated by reference to Appendix B of the Registrant’s Definitive Proxy Statement on Schedule 14A, filed November 21, 2007).

10.9

 

Form of Stock Option Agreement (incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K, filed July 14, 2005).

10.10

 

2001 Equity Incentive Plan (incorporated by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-QSB, filed November 14, 2001).

10.11

 

Form of Restricted Stock Bonus Agreement (incorporated by reference to Exhibit 99.3 to the Registrant’s Registration Statement on Form S-8, filed November 27, 2001).

10.12

 

Form of Stock Option Agreement (incorporated by reference to Exhibit 99.2 to the Registrant’s Registration Statement on Form S-8, filed November 27, 2001).

10.13

 

Note and Warrant Purchase Agreement, dated May 22, 2002, by and between the Registrant and Perseus (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K, filed May 24, 2002).

10.14

 

Form of Securities Purchase Agreement dated November 14, 2003 (incorporated by reference to Exhibit 99.1 to the Registrant’s Current Report on Form 8-K, filed February 9, 2004).

10.15

 

Form of Securities Purchase Agreement dated January 29, 2004 (incorporated by reference to Exhibit 99.4 to the Registrant’s Current Report on Form 8-K, filed February 9, 2004).

10.16

 

Offer of Restricted Stock in Exchange for Certain Stock Options Previously Granted — Offer Made to James Miller (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-QSB, filed August 16, 2004).

10.17

 

Offer of Restricted Stock in Exchange for Certain Stock Options Previously Granted — Offer Made to Wayne Wetherell, dated March 30, 2004 (incorporated by reference to Exhibit 10.3 to the Registrant’s Quarterly Report on Form 10-QSB, filed August 16, 2004).

10.18

 

Form of Securities Purchase Agreement dated July 22, 2005 and July 28, 2005 (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K, filed July 26, 2005).

10.19

 

Security Agreement, dated March 17, 2006, executed by the Registrant in favor of Little Bear Investments, LLC (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K, filed March 23, 2006).

10.20

 

Form of Secured Promissory Note dated March 17, 2006 (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q, filed May 22, 2006).

10.21

 

Securities Purchase Agreement, dated November 14, 2006 by and among the Registrant and certain accredited investors (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K, filed November 20, 2006).

10.22

 

Securities Purchase Agreement, dated March 9, 2007, by and among the Registrant and certain accredited investors (incorporated by reference to Exhibit 10.1 to the Registrant Current Report on Form 8-K, filed March 15, 2007).

10.23

 

Securities Purchase Agreement, dated September 25, 2007, by and among the Registrant and certain accredited investors (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K, filed September 26, 2007).

 



 

Exhibit
Number

 

Description

10.24

 

Asset Purchase Agreement and Plan of Reorganization, by and among Sol Logic, Frank Mitchell, as shareholder of Sol Logic, and Wink Jones, as the representative of Sol Logic (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K, filed December 21, 2007).

10.25

 

Amendment No.1 to Asset Purchase Agreement and Plan of Reorganization, by and between the Registrant and Wink Jones, as the representative of Sol Logic (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K, filed April 1, 2008).

10.26

 

Product Line Purchase Agreement, dated November 30, 2006, by and between the Registrant and PhotoLynx, Inc. (incorporated by reference to Exhibit 10.3 to the Registrant’s Current Report on Form 8-K, filed December 26, 2006).

10.27

 

Standard Commercial Lease, dated September 26, 2003, by and between Thornmint I and the Registrant (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-QSB, filed November 14, 2003).

10.28

 

Amendment to Office Lease, dated June 12, 2006, by and between Thornmint I and the Registrant (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q, filed August 14, 2006).

10.29

 

Office Lease, dated September 7, 2006, by and between Union Bank of California as Trustee for Quest Group Trust VII and the Registrant (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q, filed November 20, 2006).

10.30

 

Office Space Lease between I.W. Systems Canada Registrant and Dundeal Canada (GP) Inc. dated June 1, 2006 (incorporated by reference to Exhibit 10.40 to the Registrant’s Annual Report on Form 10-K, filed April 17, 2007).

21.1

 

Subsidiaries of the Registrant (incorporated by reference to Exhibit 21.1 to the Registrant’s Registration Statement on Form S-1, filed January 18, 2008).

23.1

 

Consent of Stonefield Josephson, Inc., Independent Registered Public Accounting Firm

24.1

 

Power of Attorney**

 


**Previously filed

 


Imageware (AMEX:IW)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas Imageware.
Imageware (AMEX:IW)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas Imageware.